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Preface 
This	  thesis	  is	  written	  as	  a	  partial	  fulfillment	  of	  the	  requirements	  to	  obtain	  a	  PhD	  degree	  at	  the	  Tech-­‐
nical	  University	  of	  Denmark	   (DTU).	  The	  work	  presented	   in	   this	   thesis	  was	  carried	  out	   from	  August	  
2011	   to	  March	   2015	   at	   the	   Infection	  Microbiology	   Group	   (IMG),	   Department	   of	   Systems	   Biology,	  
DTU,	  under	  the	  supervision	  of	  Professor	  Søren	  Molin	  and	  Associate	  Professor	  Lars	  Jelsbak.	  From	  Sep-­‐
tember	   2014	   to	   December	   2014	   the	  work	  was	   carried	   out	   at	   the	   CfB	   group	   at	   the	  Novo	  Nordisk	  
Foundation	  Center	  for	  Biosustainability,	  DTU.	  Part	  of	  the	  work	  was	  carried	  out	  in	  close	  collaboration	  
with	  Associate	  Professor	   Jason	  Papin	  and	   Jennie	  Bartell	   from	  University	  of	  Virginia,	  USA.	  This	  PhD	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Abstract 
Biological	   systems	  are	  complex.	  When	  we	  want	   to	  understand	  biological	  processes	  we	  often	  need	  
advanced	  methods	  to	  reveal	  the	  relationship	  between	  genotype	  and	  phenotype.	  
The	   focus	  of	   this	   thesis	  has	  been	  to	  extract	  biological	  meaningful	   features	   from	  complex	  data	  sets	  
and	   to	   use	  mathematical	  modeling	   to	   uncover	   how	   human	   pathogens	   adapt	   to	   the	   human	   host.	  
Pseudomonas	  aeruginosa	  infections	  in	  cystic	  fibrosis	  patients	  are	  used	  as	  a	  model	  system	  for	  under-­‐
standing	  these	  adaptation	  processes.	  	  
The	   exploratory	   systems	   biology	   approach	   facilitates	   identification	   of	   important	   phenotypes	   and	  
metabolic	  pathways	  that	  are	  necessary	  or	  related	  to	  establishment	  of	  chronic	  infections.	  Archetypal	  
analysis	  showed	  to	  be	  successful	  in	  extracting	  relevant	  phenotypes	  from	  global	  gene	  expression	  da-­‐
ta.	  Furthermore,	  genome-­‐scale	  metabolic	  modeling	  showed	  to	  be	  useful	  in	  connecting	  the	  genotype	  
to	  phenotype	  at	  a	  systemic	   level.	  Particular	  metabolic	  subsystems	  were	  identified	  as	   important	  for	  
metabolic	  adaptation	  in	  P.	  aeruginosa.	  One	  altered	  metabolic	  phenotype	  was	  connected	  to	  a	  genetic	  
change;	  a	  finding	  that	  was	  possible	  through	  the	  systems	  characterization	  and	  which	  was	  not	  identi-­‐
fied	  by	  classical	  molecular	  biology	  approaches	  where	  genes	  and	  reactions	  typically	  are	  investigated	  
in	  a	  one	  to	  one	  relationship.	  	  
This	  thesis	  is	  an	  example	  of	  how	  mathematical	  approaches	  and	  modeling	  can	  facilitate	  new	  biologi-­‐
cal	  understanding	  and	  provide	  new	  surprising	  ideas	  to	  important	  biological	  processes.	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Dansk resumé 
Biologiske	  systemer	  er	  komplekse.	  Når	  vi	  ønsker	  at	  forstå	  biologiske	  processer,	  har	  vi	  ofte	  brug	  for	  
avancerede	  metoder	  til	  at	  afsløre	  sammenhængen	  mellem	  en	  organismes	  arveanlæg	  og	  dens	  obser-­‐
vérbare	  karaktertræk.	  
Fokus	   for	   denne	  Ph.d.-­‐afhandling	   har	   været	   at	   ekstrahere	   biologiske	  meningsfulde	   egenskaber	   fra	  
komplekse	  datasæt	  samt	  at	  bruge	  matematisk	  modellering	  til	  at	  afdække,	  hvordan	  sygdomsfremkal-­‐
dende	   bakterier	   udvikler	   sig	   under	   kroniske	   infektioner	   i	   mennesket.	   Infektioner	   med	   bakterien	  
Pseudomonas	  aeruginosa	  i	  cystisk	  fibrose	  patienter	  er	  anvendt	  som	  model-­‐system	  til	  at	  forstå	  disse	  
tilpasningsprocesser.	  
Den	  anvendte	  systembiologi-­‐metode	  muliggør	  identifikation	  af	  vigtige	  karaktertræk	  og	  stofskiftere-­‐
aktioner	  som	  er	  nødvendige	  eller	  relaterede	  til	  etablering	  af	  kroniske	  infektioner.	  "Arketype-­‐analyse"	  
viste	  sig	  at	  være	  nyttig	  til	  ekstrahering	  af	  relevante	  karaktertræk	  fra	  data.	  Derudover	  viste	  matema-­‐
tisk	  modellering	  af	  hele	  stofskiftet	  sig	  også	  at	  være	  nyttig	  til	  at	  forstå	  hvordan	  de	  overordnede	  stof-­‐
skiftereaktioner	  i	  bakterien	  ændrer	  sig.	  Specifikke	  stofskiftereaktioner	  blev	  identificeret	  som	  væren-­‐
de	  vigtige	  for	  tilpasningen	  af	  P.	  aeruginosa.	  En	  specifik	  ændring	  i	  stofskiftet	  blev	  koblet	  til	  en	  gene-­‐
tisk	  ændring.	  Denne	  opdagelse	  var	  mulig	  ved	  hjælp	  af	  den	  anvendte	  systembiologiske	  metode,	  men	  
havde	  derimod	  ikke	  været	  mulig	  gennem	  klassiske	  molekylærbiologiske	  metoder,	  hvor	  reaktioner	  og	  
gener	  typisk	  undersøges	  i	  et	  en-­‐til-­‐en	  forhold.	  
Denne	  afhandling	  er	  et	  eksempel	  på,	  hvordan	  matematiske	  metoder	  og	  modellering	  kan	  føre	  til	  ny	  
biologisk	  forståelse	  og	  bidrage	  med	  nye	  overraskende	  ideer	  til	  vigtige	  biologiske	  processer	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Technological	   advances	   during	   the	   past	   10-­‐15	   years	   have	   led	   to	   generation	   of	   numerous	   high-­‐
throughput	  data	  sets	  including	  whole-­‐genome	  sequences	  and	  global	  gene	  expression	  data.	  The	  rap-­‐
idly	  growing	  number	  of	  high-­‐throughput	  data	  sets	  has	  raised	  a	  demand	  for	  new	  analytical	  tools	  that	  
can	  assist	  in	  generating	  biological	  understanding	  from	  these	  data.	  There	  is	  a	  need	  for	  modeling	  ap-­‐
proaches	  to	  assist	   in	  connecting	  genotype	  to	  phenotype	  at	  a	  systemic	   level	  and	  for	  analytical	  tools	  
that	  can	  extract	  biological	  features	  from	  the	  complex	  high-­‐throughput	  data	  sets,	  both	  of	  which	  are	  
important	  elements	  of	  systems	  biology	  (Bordbar	  et	  al,	  2014;	  Heinemann	  &	  Sauer,	  2010).	  
Systems	  biology	  contains	  elements	  from	  chemistry,	  biology,	  engineering	  and	  computer	  science	  and	  
it	  deals	  with	  integration	  of	  technology,	  biology	  and	  computation	  (Aebersold	  et	  al,	  2000;	  Ideker	  et	  al,	  
2001).	  Systems	  biology	  can	  be	  described	  as	  the	  multidisciplinary	  approach	  to	  investigating	  the	  com-­‐
plexity	  of	  an	  organism	  (Hindré	  et	  al,	  2012).	   In	  molecular	  biology	  genes	  are	  often	   investigated	   indi-­‐
vidually	  to	  assign	  a	  function	  to	  a	  single	  gene.	  	  Systems	  biology	  deals	  with	  the	  understanding	  of	  how	  
molecular	  components	  collectively	  give	  rise	  to	  phenotype	  and	  physiology	  and	  in	  systems	  biology	  the	  
interrelationship	   of	   all	   elements	   in	   a	   system	   is	   studied	   rather	   than	   studying	   them	   one	   at	   a	   time	  
(Gunawardena,	  2014;	  Hood,	  2003).	  	  
One	  area	  where	  there	  is	  a	  need	  for	  connecting	  the	  genotype	  to	  a	  phenotype	  at	  a	  systemic	  level	  is	  in	  
our	  pursuit	  of	  understanding	  pathogen	  behavior	  in	  terms	  of	  what	  makes	  a	  pathogen	  a	  pathogen	  and	  
how	  does	  a	  pathogen	  evolve	  (de	  Lorenzo,	  2015).	  A	  human	  pathogen	  is	  characterized	  by	  being	  able	  
to	  colonize	  and	  grow	  within	  the	  human	  host	  and	  cause	  disease	  (Madigan	  &	  Martinko,	  2006a).	  The	  
latter	  is	  often	  due	  to	  virulence	  factors	  produced	  by	  the	  pathogen.	  There	  has	  been	  a	  lot	  of	  attention	  
to	   virulence	   factors	   produced	   by	   human	   pathogens	   (Rahme	   et	   al,	   1995;	   McDermott	   et	   al,	   2011;	  
Clatworthy	  et	  al,	  2007;	  Eisenreich	  et	  al,	  2010).	  However,	  it	  is	  also	  important	  to	  understand	  how	  the	  
pathogens	  beyond	  virulence	  factors	  are	  able	  to	  grow	  within	  the	  human	  host	  and	  how	  they	  adapt	  to	  
the	  host	  environment	  to	  ensure	  survival.	  Metabolism	  can	  be	  defined	  as	  all	  chemical	   reactions	   in	  a	  
living	  organism	  including	  pathways	  necessary	  to	  degrade	  nutrients	  in	  the	  surrounding	  environment	  
to	  obtain	  energy	   for	  survival	  and	  growth	   (Madigan	  &	  Martinko,	  2006b).	  Therefore,	   in	  order	   to	  un-­‐
derstand	  pathogen	  behavior	  in	  terms	  of	  how	  they	  survive	  in	  the	  host	  environment,	  it	  is	  necessary	  to	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study	  metabolism	  and	  when	  we	  try	   to	  eradicate	   invading	  pathogens	   from	  the	  human	  host,	   insight	  
into	  pathogen	  metabolism	  is	  crucial	  (de	  Lorenzo,	  2014).	  	  
The	   opportunistic	   pathogenic	   bacterium	  Pseudomonas	   aeruginosa	   is	   an	   ideal	  model	   organism	   for	  
understanding	   these	  processes.	  Environmental	  P.	  aeruginosa	  strains	  have	  optimized	  their	  metabo-­‐
lism	  for	  survival	  in	  their	  natural	  environment	  outside	  the	  human	  host.	  During	  long-­‐term	  infections	  in	  
the	   CF	   lung	   environment	  P.	   aeruginosa	  will	  most	   likely	   undergo	   adaptation	   to	   obtain	   a	  metabolic	  
phenotype,	  which	  is	  optimal	  for	  survival	  in	  the	  human	  host	  environment.	  The	  identification	  of	  meta-­‐
bolic	   pathways	   that	   change	   during	   adaptation	  may	   therefore	   uncover,	  which	  metabolic	   pathways	  
are	   important	   for	  pathogenesis.	   Since	  metabolism	   is	   a	   complex	  network	  of	   chemical	   reactions	  we	  
need	  a	  systemic	  approach,	  which	  consider	  all	  reactions	  at	  ones.	  In	  general,	  identification	  of	  pheno-­‐
typic	  patterns	  that	  characterizes	  pathogen	  persistence	  is	  desired.	  
I	  consider	  systems	  biology	  to	  fall	  within	  the	  field	  of	  research	  termed	  discovery	  science	  or	  exploratory	  
research	  in	  contrast	  to	  hypothesis-­‐driven	  research,	  but	  it	  can	  also	  be	  argued	  that	  it	  is	  a	  combination	  
of	  both	  (Aebersold	  et	  al,	  2000;	  Ideker	  et	  al,	  2001).	  Hypothesis-­‐driven	  research	  is	  well	  established	  and	  
accepted	  and	   it	   is	  based	  on	  concrete	  hypothesis	  backed	  up	  by	  theory.	  Exploratory	  research	  on	  the	  
other	  hand,	  examines	  unknown	  areas	  with	  little	  or	  no	  supporting	  theory	  and	  the	  fundamental	  idea	  is	  
to	   explain	   variations	   observed	   in	   data	  without	   prior	   knowledge	   (Haufe,	   2013;	  Waters,	   2007).	   This	  
can	  be	  a	  great	  advantage	  in	  providing	  new	  knowledge,	  but	  at	  the	  same	  time	  it	  is	  a	  big	  challenge	  for	  
systems	   biology	   because	   the	   limited	   level	   of	   detail	   and	   mechanistic	   insight	   can	   be	   considered	   a	  
weakness.	   Often	   the	   systems	   analysis	   is	   followed	   up	   by	   multiple	   hypothesis-­‐driven	   experiments,	  
which	  makes	  these	  studies	  quite	  comprehensive	  in	  terms	  of	  resources	  and	  collaborations	  across	  dif-­‐
ferent	  academic	  disciplines.	  Therefore,	  when	  we	  model	  a	  system	  we	  often	  need	  to	  make	  compro-­‐
mises	  between	  the	  size	  of	  the	  system	  we	  wish	  to	  consider	  and	  the	  level	  of	  detail	  at	  which	  we	  model	  
the	  system	  (Heinemann	  &	  Sauer,	  2010).	  	  
Aim	  of	  project	  
The	  overall	  aim	  of	  this	  PhD	  project	   is	  to	  gain	  more	  knowledge	  in	  the	  adaptation	  process	  of	  human	  
pathogens	   during	   chronic	   infections	   through	   a	   systems	   biology	   approach.	   The	   system	   biology	   ap-­‐
proach	  consists	  in	  extracting	  biological	  knowledge	  from	  complex	  data	  sets	  through	  advanced	  explor-­‐
atory	  methods.	  The	  project	  can	  be	  divided	  into	  two	  parts,	  which	  are	  represented	  by	  Paper	  1	  (Chap-­‐
ter	  5)	  and	  Paper	  2	  (Chapter	  6)	  respectively:	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(1)	  The	  first	  project	  aims	  to	  identify	  patterns	  in	  global	  gene	  expression	  data	  sets	  through	  Archetypal	  
Analysis,	  and	  to	  understand	  the	  biological	  meaning	  of	  these	  patterns	  related	  to	  the	  adaptation	  pro-­‐
cess	  of	  Pseudomonas	  aeruginosa	  during	  long-­‐term	  airway	  infections	  of	  cystic	  fibrosis	  patients.	  
(2)	  The	  second	  project	  aims	  to	  identify	  which	  metabolic	  pathways	  that	  change	  during	  adaptation	  of	  
Pseudomonas	  aeruginosa	  to	  the	  cystic	  fibrosis	  lung	  environment	  through	  a	  combined	  experimental	  
and	   computational	   approach	   including	   isotope-­‐labeling	   experiments	   and	   genome-­‐scale	   metabolic	  
modeling.	  
Outline	  of	  thesis	  
The	  next	   chapter	   (Chapter	  2)	   introduces	  P.	  aeruginosa	  and	  cystic	   fibrosis,	  which	   is	   followed	  by	  an	  
introduction	  into	  feature	  extraction	  in	  data	  analysis	  in	  Chapter	  3	  and	  genome-­‐scale	  metabolic	  mod-­‐
elling	  including	  the	  concept	  of	  isotope-­‐labeling	  experiments	  in	  Chapter	  4.	  The	  results	  of	  this	  PhD	  pro-­‐
ject	  are	  described	  in	  Paper	  1	  (Chapter	  5)	  and	  Paper	  2	  (Chapter	  6)	  and	  I	  recommend	  reading	  Paper	  1	  
and	  Paper	  2	  before	  the	  discussion	  in	  Chapter	  7.	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Pseudomonas aeruginosa and cystic fibrosis 
Pseudomonas	  aeruginosa	  
We	  use	  the	  gram-­‐negative	  bacterium	  Pseudomonas	  aeruginosa	  as	  a	  model	  organism	  to	  investigate	  
pathogen	   adaptation	   in	   a	   human	   host	   environment.	   P.	   aeruginosa	   is	   an	   opportunistic	   pathogen,	  
which	  means	  that	  it	  rarely	  infects	  healthy	  individuals,	  but	  it	  is	  a	  major	  cause	  of	  infections	  in	  patients	  
with	  cystic	  fibrosis	  (CF)	  and	  it	  is	  also	  causing	  infections	  in	  immunocompromised	  individuals	  and	  peo-­‐
ple	  with	   severe	  burns	   and	  diabetes	  mellitus	   (Ramos,	   2004).	   It	   is	   easy	   to	   isolate	   from	   the	  environ-­‐
ment,	  where	  it	  is	  often	  found	  in	  soil,	  water	  and	  plants.	  Usually,	  the	  P.	  aeruginosa	  infections	  are	  ac-­‐
quired	  from	  the	  environmental	  sources,	  but	  transmission	  between	  CF	  patients	  also	  occurs	  (Jelsbak	  et	  
al,	  2007).	  
Cystic	  fibrosis	  
Cystic	   fibrosis	   is	  an	  autosomal	   recessive	  disorder	  caused	  by	  a	  mutation	   in	   the	  cystic	   fibrosis	   trans-­‐
membrane	  conductance	  regulator	  (CFTR)	  gene.	  It	  is	  the	  most	  common	  inherited	  disease	  among	  Cau-­‐
casians,	  where	   it	  appears	   in	  approximately	  one	  out	  of	  2500	  newborns	   (Folkesson	  et	  al,	  2012).	  The	  
CFTR	  gene	  encodes	  a	  chloride	  channel	  responsible	  for	  epithelial	  ion	  transport.	  Impaired	  function	  of	  
this	  channel	  mostly	  affects	  the	  airways	  of	  the	  lungs,	  but	  it	  is	  also	  causing	  gastrointestinal,	  nutritional	  
and	  other	  abnormalities	   (Lyczak	  et	  al,	   2002;	  Gilligan,	  1991).	   In	  healthy	   lungs,	   the	  airway	  epithelial	  
cells	  are	  covered	  with	  a	  periciliary	  liquid	  layer	  (PCL)	  and	  an	  upper	  mucus	  layer	  (Figure	  1).	  Together	  
they	  form	  an	  essential	  part	  of	  the	  mucociliary	  clearance,	  which	  provides	  protection	  towards	  inhaled	  
particles	  including	  microorganisms.	  Inhaled	  particles	  get	  stuck	  on	  the	  upper	  mucus	  layer	  and	  the	  PCL	  
(separating	  the	  mucus	  layer	  from	  the	  epithelial	  cell	  surface)	  facilitates	  motility	  of	  cilia	  that	  serve	  as	  
an	  escalator	  to	  remove	  the	  inhaled	  particles	  (Buchanan	  et	  al,	  2009;	  Knowles	  &	  Boucher,	  2002).	  
In	  CF	  patients,	  one	  consequence	  of	  the	  defect	  chloride	  channel	  is	  dehydration	  of	  the	  PCL	  and	  a	  thick	  
mucus	  layer	  in	  the	  airways,	  which	  impairs	  the	  mucociliary	  clearance	  and	  the	  CF	  patients	  are	  there-­‐
fore	   very	   susceptible	   to	   airway	   infections	   (Figure	   1)	   (Lyczak	   et	   al,	   2002;	   Gilligan,	   1991;	   Govan	   &	  
Deretic,	  1996).	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Figure 1.  Comparison of the mucocil iary clearance between 
normal airway epithelium and cystic  f ibrosis  airway epithelium.  
The normal airway epithelium is covered by a hydrated periciliary liquid lay-
er (PCL) and on top of this thin mucus layer. Motion of the cilia ensures a 
unidirectional flow of mucus and thereby excretion of any inhaled bacte-
rium. In the cystic fibrosis (CF) airway, a thick mucus layer covers the epithe-
lium due to dehydration of the periciliary liquid layer. Motion of the cilia is 
impaired and bacteria can persist in the CF airway. The figure is modified 
from (Lyczak et al, 2002; Folkesson et al, 2012). 
Airway	  infections	  in	  cystic	  fibrosis	  patients	  
In	  addition	  to	  P.	  aeruginosa,	  a	  range	  of	  different	  microorganisms	  are	  associated	  with	  CF	  lung	  infec-­‐
tions	   including	   the	  bacterial	   species	  Staphylococcus	  aureus,	  Haemophilus	   influenzae,	  Streptococcus	  
pneumonia,	  Burkholderia	  cepacia,	  Burkholderia	  pseudomallei	  and	  also	  the	  fungal	  species	  Aspergillus	  
and	  Candida	  are	  frequently	  observed	  (Burns	  et	  al,	  1998;	  Foweraker,	  2009).	  The	  prevalence	  of	  these	  
species	  changes	  over	  time,	  where	  the	  first	  lung	  infections	  of	  the	  cystic	  fibrosis	  patients	  often	  appear	  
in	  early	  childhood	  with	  S.	  aureus	  and	  H.	  influenzae	  and	  later,	  P.	  aeruginosa	  becomes	  most	  dominant	  
(Harrison,	  2007).	  Often	  the	  patients	  have	  recurrent	  acute	  infections	  with	  P.	  aeruginosa,	  but	  eventu-­‐
ally	  these	  infections	  turn	  chronic	  where	  P.	  aeruginosa	  cannot	  be	  eradicated	  despite	  of	  host	  immune	  
response	  and	  intensive	  antibiotic	  treatment.	  These	  chronic	  infections	  result	  in	  prolonged	  inflamma-­‐
tory	  response	  leading	  to	  destruction	  of	  the	  lung	  tissue	  and	  loss	  of	  lung	  function,	  and	  chronic	  infec-­‐
tions	  with	  P.	  aeruginosa	  are	  the	  main	  cause	  of	  morbidity	  and	  mortality	  in	  CF	  patients	  (Döring	  et	  al,	  
2012).	  
Treatment	  and	  prognosis	  
The	  CF	  patients	  are	  treated	  with	  a	  range	  of	  different	  antibiotics.	  Eradication	  of	  early	   infection	  and	  
prevention	  of	  chronic	  infection	  has	  been	  associated	  with	  clinical	  benefits	  (Döring	  et	  al,	  2012).	  In	  in-­‐
dustrialized	  countries,	  antibiotic	  therapy	  has	  played	  a	  major	  role	  in	  increasing	  mean	  life	  expectancy	  
from	  14	  years	  for	  CF	  patients	  born	  in	  1969	  to	  more	  than	  40	  years	  for	  CF	  patients	  born	  in	  2010	  (Cystic	  
fibrosis	  foundation	  patient	  registry	  2009	  annual	  data	  report,	  2010;	  Döring	  et	  al,	  2012).	  In	  the	  Copen-­‐
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with	  antibiotics,	  whereas	   the	  patients	  chronically	   infected	  with	  P.	  aeruginosa	   continuously	   receive	  
suppressive	  antibiotic	  therapy	  (Döring	  et	  al,	  2000;	  Høiby	  et	  al,	  2005).	  	  
The	  cystic	  fibrosis	  lung	  environment	  
When	  P.	  aeruginosa	  enters	  the	  airways	  of	  a	  CF	  patient	  it	  meets	  a	  lot	  of	  physical	  changes.	  The	  transi-­‐
tion	  from	  the	  natural	  environment	  to	  the	  lung	  environment	  is	  characterized	  by	  changes	  in	  tempera-­‐
ture,	   nutrient	   accessibility,	   gas	   composition	   (e.g.	   oxygen	   and	   carbon	   dioxide)	   and	   composition	   of	  
surrounding	  microbes	  and	  presence	  of	  polymorphonuclear	  neutrophils	   (PMNs)	  of	  the	   immune	  sys-­‐
tem	  (Hauser	  et	  al,	  2011).	  In	  addition	  to	  that,	  P.	  aeruginosa	  is	  exposed	  to	  a	  range	  of	  antibiotics	  while	  
being	   inside	   the	   human	   airways	   as	   described	   above.	   It	   has	   been	   shown	   that	  P.	   aeruginosa	   grows	  
within	  the	  characteristic	  CF	  sticky	  mucus,	  where	  it	  meets	  hypoxic	  conditions	  (Ohman	  &	  Chakrabarty,	  
1982;	  Worlitzsch	  et	  al,	  2002;	  Palmer	  et	  al,	  2005).	  The	  nutrient	  composition	  of	  the	  CF	  mucus	  has	  pre-­‐
viously	  been	  analyzed	  and	  a	  synthetic	  CF	  sputum	  medium	  (SCFM)	  was	  defined	  to	  mimic	  the	  CF	  mu-­‐
cus	  composition	  (Palmer	  et	  al,	  2007).	  The	  CF	  mucus	  is	  characterized	  by	  being	  rich	  in	  amino	  acids	  and	  
it	  also	  contains	  glucose	  and	  lactate	  (Palmer	  et	  al,	  2007).	  Although	  being	  a	  nutrient-­‐rich	  environment,	  
the	  CF	  lungs	  also	  provide	  stressful	  conditions	  for	  invading	  pathogens	  due	  to	  the	  frequent	  antibiotic	  
treatment	  and	  host	  immune	  response	  (Folkesson	  et	  al,	  2012).	  Oxidative	  stress	  results	  from	  reactive	  
oxygen	  species	  (ROS)	  produced	  by	  PMNs	  as	  part	  of	  the	  host	  immune	  response	  to	  infection	  (Hull	  et	  
al,	  1997;	  Høiby,	  2006).	  Most	  recently,	   it	  has	  also	  been	  suggested	  that	  antibiotics	  may	  induce	  inter-­‐
cellular	  ROS	  production	  in	  bacteria	  (Dwyer	  et	  al,	  2014;	  Kohanski	  et	  al,	  2010).	  The	  presence	  of	  oxida-­‐
tive	  stress	  can	  induce	  bacterial	  mutation	  rates	  and	  select	  for	  variants	  that	  are	  less	  sensitive	  to	  oxida-­‐
tive	  stress	  (Folkesson	  et	  al,	  2012).	  	  
Adaptation	  of	  Pseudomonas	  aeruginosa	  
The	   ability	   of	   P.	   aeruginosa	   to	   thrive	   and	   persist	   in	   the	   human	   lung	   environment	   is	   facilitated	  
through	  its	  large	  metabolic	  versatility	  and	  regulatory	  genes	  (Ramos,	  2004),	  but	  also	  through	  genetic	  
mutations	  as	  observed	  for	  many	  clinical	  isolates	  of	  P.	  aeruginosa	  (Smith	  et	  al,	  2006;	  Yang	  et	  al,	  2011;	  
Dettman	  et	  al,	  2013).	  
The	   adaptation	   process	   of	   P.	   aeruginosa	   is	   interesting	   from	   several	   points	   of	   view.	   First	   of	   all,	  
knowledge	  on	  adaptation	   can	  guide	  new	   therapeutic	   intervention.	   For	  example	   reactions	   that	  be-­‐
come	  essential	   for	   adapted	   strains	  of	  P.	  aeruginosa	  compared	   to	   the	  original	   infecting	   strains	   can	  
serve	  as	  targets	  for	  future	  antibiotics.	  Second,	  the	  fact	  that	  P.	  aeruginosa	  persists	   in	  the	  lung	  envi-­‐
ronment	  over	  many	  decades	  allow	  us	  to	  study	  long-­‐term	  evolution	  of	  a	  pathogen	  inside	  the	  human	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host.	  The	  knowledge	  gained	  from	  adaptation	  studies	  of	  P.	  aeruginosa	   is	  also	  relevant	  for	   industrial	  
applications.	   The	   process	   by	  which	  P.	  aeruginosa	   reshapes	   its	  metabolism	   to	   fit	   the	   new	  environ-­‐
ment	  can	  be	  parallel	  to	  the	  way	  we	  wish	  to	  engineer	  a	  production	  organism	  to	  obtain	  a	  certain	  phe-­‐
notype	  in	  an	  industrial	  setting.	  
Past	  studies	  of	  within-­‐host	  evolution	  of	  Pseudomonas	  aeruginosa	  
The	  transition	  from	  initial	  colonization	  to	  chronic	  infection	  of	  P.	  aeruginosa	  is	  often	  followed	  by	  ob-­‐
served	  phenotypic	   changes	   in	  P.	  aeruginosa	  caused	  by	  genetic	   adaptation	   to	   the	  CF	   lung	  environ-­‐
ment.	  Frequently	  observed	  phenotypic	  changes	  include	  a	  slow-­‐growth	  phenotype	  (at	  least	  in	  vitro),	  
conversion	   to	   a	  mucoid	   phenotype,	   gain	   of	   antibiotic	   resistance,	   loss	   of	   motility,	   loss	   of	   quorum	  
sensing,	  appearance	  of	  small	  colony	  variants,	   increased	  mutation	  rate	   (hereafter	   ‘hypermutators’),	  
decreased	  production	  of	   virulence	   factors	   and	   cell	   envelope	   changes	   (Harrison,	   2007;	   Burns	  et	   al,	  
1998;	  Lyczak	  et	  al,	  2002).	  Among	  the	  listed	  phenotypes	  are	  the	  mucoid	  phenotype	  and	  the	  hypermu-­‐
tator	  that	  I	  will	  return	  to	  in	  the	  discussion.	  	  
The	  mucoid	  phenotype	   is	  most	  often	  caused	  by	  a	  mutation	   in	  the	  anti-­‐sigma	  factor	  mucA	  and	   it	   is	  
characterized	  by	  a	  high	  production	  of	  alginate,	  which	  is	  easy	  to	  detect	  on	  laboratory	  growth	  plates,	  
since	  the	  bacterial	  colonies	  appear	  very	  moist	  and	  sticky	  (Ciofu	  et	  al,	  2008;	  Rau	  et	  al,	  2010).	  Alginate	  
is	  thought	  to	  protect	  the	  bacteria	  from	  phagocytosis	  by	  neutrophils	  and	  macrophages	  and	  to	  resist	  
oxidative	   stress	   (Mathee	  et	  al,	   1999;	  Oliver	  &	  Weir,	   1985).	  However,	   a	   conversion	  back	   to	   a	  non-­‐
mucoid	  phenotype	  also	  appears	  in	  clinical	   isolates,	  why	  it	   is	  speculated	  that	  it	  may	  not	  be	  the	  algi-­‐
nate	  production	  itself	  providing	  the	  adaptive	  advantage,	  but	  maybe	  alginate	  production	  is	  a	  second-­‐
ary	  effect	  of	  the	  mucA	  mutation	  (Damkiær	  et	  al,	  2013;	  Rau	  et	  al,	  2010).	  
Hypermutators	   are	   frequently	   observed	   among	   isolates	   of	  P.	   aeruginosa	   isolated	   from	   chronic	   CF	  
infections,	  but	  the	  hypermutators	  are	  also	  widespread	  among	  other	  pathogenic	  bacteria	  suggesting	  
that	   being	   a	   hypermutator	   is	   an	   advantage	   in	   pathogenesis	   (Weigand	   &	   Sundin,	   2012;	   Oliver	   &	  
Mena,	  2010;	  Hogardt	  et	  al,	  2007;	  Sundin	  &	  Weigand,	  2007).	  The	  mutator	  phenotype	  has	  been	  asso-­‐
ciated	  with	  an	  evolutionary	  advantage	  during	  bacterial	  adaptation	  to	  new	  environments	  or	  stressful	  
conditions	   (Oliver	   &	  Mena,	   2010).	   Hypermutation	   creates	   genetic	   and	   phenotypic	   variations	   in	   a	  
population	  and	  it	  is	  suggested	  that	  hypermutation	  is	  a	  mechanism	  for	  acceleration	  of	  bacterial	  evo-­‐
lution	  (Oliver	  &	  Mena,	  2010).	  
Over	  the	  past	  years,	  there	  has	  been	  an	  increasing	  number	  of	  genomic	  studies	  of	  P.	  aeruginosa	  with	  
the	  aim	  of	  understanding	  pathogen	  behavior	  inside	  the	  human	  host	  (Tümmler	  et	  al,	  2014;	  Yang	  et	  al,	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2011;	  Marvig	  et	  al,	  2015).	  One	  extensive	  study	  from	  2011	  (Yang	  et	  al,	  2011)	  (including	  genome	  se-­‐
quencing,	  transcriptional	  profiling	  and	  phenotypic	  arrays)	  characterizes	  the	  within-­‐host	  evolution	  of	  
a	  particular	  P.	  aeruginosa	  clone	  type,	  P.	  aeruginosa	  DK2	  (formerly	  known	  as	  the	  'b'	  clone),	  which	  has	  
successfully	  been	   transmitted	  between	  patients	  attending	   the	  Copenhagen	  CF	  clinic	   (Jelsbak	  et	  al,	  
2007).	  The	  DK2	  clone	  was	  isolated	  for	  the	  first	  time	  in	  the	  Copenhagen	  CF	  clinic	  in	  1973.	  Since	  then	  it	  
has	  caused	  chronic	  infections	  in	  several	  patients	  and	  it	  has	  now	  persisted	  in	  the	  CF	  lung	  environment	  
for	   four	  decades.	  The	   study	  of	  multiple	  DK2	  strains	   isolated	   from	  1973	   to	  2007,	   revealed	   that	   the	  
DK2	   lineage	  underwent	  an	   initial	  period	  of	   rapid	  adaptation	  before	  1979	  and	   important	  mutations	  
were	  identified	  in	  global	  regulatory	  genes	  (Yang	  et	  al,	  2011).	  Phenotypic	  characterization	  of	  catabolic	  
performances	  showed	  that	  the	  adapted	  phenotype	  had	  lost	  its	  catabolic	  function	  on	  various	  carbon	  
and	  nitrogen	  sources	  compared	  to	  the	  phenotype	  of	  the	  initial	  strains	  (Yang	  et	  al,	  2011).	  
In	   a	   recent	   study	   a	   list	   of	   52	   so-­‐called	   pathoadaptive	   genes	  were	   identified	   among	   474	   genome-­‐
sequenced	   clinical	   P.	   aeruginosa	   isolates	   representing	   36	   different	   lineages	   (Marvig	   et	   al,	   2015).	  
Pathoadaptive	  genes	  are	  described	  as	  genes	  in	  which	  mutations	  optimize	  pathogen	  fitness	  and	  they	  
are	   identified	   as	   genes	   in	   which	  mutations	   appear	   very	   frequently	   in	   the	   36	   lineages.	   The	   list	   of	  
pathoadaptive	  genes	  includes	  genes	  that	  are	  well-­‐known	  to	  be	  involved	  in	  adaptation.	  The	  list	  also	  
includes	   genes	  potentially	   important	   for	   adaptation,	  which	  have	  not	   been	  emphasized	  previously.	  
This	  type	  of	  study	  is	  very	  valuable	  in	  creating	  an	  overview	  of	  common	  genetic	  adaptation.	  However,	  
we	  must	  not	  neglect	  mutations	  in	  genes	  that	  may	  not	  appear	  often	  enough	  to	  be	  considered	  among	  
the	  pathoadaptive	  genes,	  since	  diverse	  genetic	  mutations	  could	  result	  in	  the	  same	  functional	  effect.	  
We	  therefore	  need	  also	  to	  focus	  our	  attention	  to	  adaptive	  changes	  that	  appear	  on	  a	  functional	  level	  
-­‐	  for	  example	  on	  metabolism.	  However,	  little	  is	  known	  about	  metabolic	  adaptation	  of	  P.	  aeruginosa	  
inside	   the	   CF	   lung	   and	   in	   general	   in	   vivo	  metabolism	  of	   bacterial	   pathogens	   is	   poorly	   understood	  
(Eisenreich	  et	  al,	  2010).	  
A	   well-­‐annotated	   genome	   will	   give	   us	   information	   about	   the	   organism’s	   metabolic	   repertoire	   in	  
terms	  of	  a	  list	  of	  metabolic	  reactions	  that	  are	  possible	  based	  on	  proteins	  encoded	  in	  the	  genome.	  A	  
study	  of	  metabolism	  will	   add	   information	  on	  pathway	  activities	  and	  understanding	  of	  which	  path-­‐
ways	  are	  essential	  for	  survival	  under	  given	  conditions.	  Identification	  of	  pathways	  necessary	  for	  with-­‐
in-­‐host	  pathogen	  survival	  will	  bring	  us	  a	  step	  closer	  to	  new	  treatment	  strategies.	  
Present	  study:	  applying	  systems	  biology	  tools	  in	  the	  data	  interpretation	  process	  
Traditional	  long-­‐term	  evolution	  experiments	  carried	  out	  in	  vitro	  focus	  on	  adaptive	  events	  connected	  
to	   defined	   selective	   pressures	   (Cooper	   et	   al,	   2003;	   Elena	   &	   Lenski,	   2003).	   For	   our	  model	   system	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many	  unknown	  parameters	  may	   influence	   the	  adaptation	  and	   it	   is	   therefore	  a	  more	  complex	   task	  
both	  to	   identify	  the	  adaptive	  phenotypes	  and	  to	  define	  the	  relevant	  selective	  pressures	  present	   in	  
the	  CF	  lung	  environment.	  	  
When	  P.	  aeruginosa	  adapts	  to	  the	  CF	   lung	  environment	   it	  will	  adapt	   in	  response	  to	  many	  changed	  
factors	  at	  one	  time.	  It	  is	  far	  from	  the	  simple	  case	  where	  adaptive	  evolution	  is	  observed	  in	  response	  
to	  for	  example	  a	  single	  antibiotic	  or	  carbon	  source	  in	  a	  test	  tube	  experiment.	  Therefore	  the	  analysis	  
of	  P.	  aeruginosa	  adaptation	  is	  also	  complicated.	  We	  need	  to	  consider	  many	  objectives	  and	  here	  the	  
exploratory	  analysis	  as	  discussed	  in	  Chapter	  1	  may	  have	  its	  benefits.	  Instead	  of	  formulating	  clear	  hy-­‐
potheses	  about	  adaptation,	  we	  ask	  what	  we	  can	  learn	  about	  adaptation	  from	  the	  available	  data	  sets.	  	  
As	  described	  above,	  identification	  of	  pathoadaptive	  genes	  can	  be	  done	  without	  focusing	  directly	  on	  
the	  function	  of	  the	  genes.	  Instead	  multiple	  adapted	  strains	  are	  compared	  and	  if	  the	  same	  single	  nu-­‐
cleotide	  polymorphism	   (SNP)	   appears	  more	   frequently	   than	   it	  would	  be	   expected	   statistically	   it	   is	  
indicating	  that	  the	  SNP	  has	  a	  function	  for	  adaptation	  (Feliziani	  et	  al,	  2014;	  Marvig	  et	  al,	  2015).	  Alt-­‐
hough	  these	  individual	  SNPs	  may	  be	  linked	  to	  phenotypes	  through	  genome	  annotations,	  we	  will	  not	  
be	  able	  to	  deduce	  how	  the	  combination	  of	  SNPs	  may	  affect	  the	  phenotype	  of	  the	  organism.	  Experi-­‐
mentally,	  it	  is	  possible	  to	  genetically	  engineer	  a	  SNP	  or	  a	  combination	  of	  SNPs	  into	  a	  wild	  type	  strain	  
and	  compare	  the	  physiology	  between	  the	  strain	  with	  and	  without	  the	  mutation.	  However,	  one	  chal-­‐
lenge	   connected	   to	   studying	  metabolism	   is	   that	  metabolism	   changes	   rapidly	   in	   response	   to	   envi-­‐
ronmental	   changes.	   Therefore,	   it	   can	   be	   difficult	   to	   measure	   the	   relevant	   metabolic	   phenotype,	  
since	  the	  growth	  environment	  can	  very	  likely	  influence	  the	  effect	  of	  the	  SNP,	  and	  the	  conditions	  in	  
the	  laboratory	  may	  not	  be	  optimal	  to	  study	  an	  effect	  within	  the	  human	  airways.	  	  
Our	  ultimate	  aim	  is	  to	  understand	  how	  metabolism	  changes	  during	  adaptation	  in	  the	  CF	  lung	  envi-­‐
ronment	  at	  a	  systemic	  level.	  One	  way	  to	  accomplish	  that	  can	  be	  to	  model	  this	  effect	  in	  silico	  by	  inte-­‐
grating	   information	   from	   genetic	   mutations	   and	   gene	   regulation	   through	   global	   gene	   expression	  
studies	  into	  a	  genome-­‐scale	  metabolic	  model	  of	  P.	  aeruginosa.	  
The	  next	  chapters	  will	  introduce	  different	  analytical	  methods	  that	  can	  be	  used	  to	  extract	  information	  
from	   complex	   high-­‐throughput	   data	   sets	   and	   introduce	   the	   concepts	   in	   genome-­‐scale	   metabolic	  
modeling.
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Data analysis - Feature extraction from complex data sets 
High-­‐dimensional	  datasets	   are	  essential	   to	   systems	  biology.	  When	  you	  deal	  with	  high-­‐dimensional	  
data	  sets	  it	  is	  often	  desired	  to	  reduce	  the	  number	  of	  dimensions	  in	  order	  to	  extract	  features	  of	  the	  
data	  set.	  The	  general	  principle	  is	  to	  identify	  a	  few	  components	  that	  can	  represent	  the	  data	  set	  and	  
each	  point	  in	  the	  data	  set	  can	  then	  be	  described	  by	  a	  combination	  of	  these	  components.	  	  
	  




A.  Raw data. The original data set is 
composed of 20 data points.  
 
B  Principal component analysis 
(PCA). The principal components are 
defined as orthogonal vectors in the 
orientation of maximum variance. 
  
C K-means clustering. Three clusters 
are represented by cluster centroids 
(orange dots), which are the mean 
values of the data points within 
each cluster. 
 
D Archetypal analysis. Three arche-
types are representing the data set 
as extreme points (blue dots). All 
data points can be described as a 
combination of archetypes.	  
	  
Imagine	  a	  case	  where	  we	  have	  20	  data	  points.	  It	  would	  be	  much	  easier	  if	  we	  could	  reduce	  the	  num-­‐
ber	  of	  points	  that	  we	  have	  to	  interpret.	  If	  we	  can	  describe	  the	  whole	  data	  sets	  by	  finding	  for	  example	  
three	  representative	  points	  (or	  components)	  we	  have	  succeeded	  in	  making	  a	  dimension	  reduction,	  
which	  facilitates	  easier	  interpretation.	  	  
This	  chapter	  will	  provide	  some	  conceptual	  background	  on	  the	  commonly	  used	  dimension-­‐reduction	  
techniques,	  principal	  component	  analysis	  (PCA)	  and	  k-­‐means	  clustering,	  and	  also	  introduce	  the	  con-­‐
cept	  of	  archetypal	  analysis,	  which	   is	  applied	  for	  gene	  expression	  data	  analysis	   in	  Paper	  1.	  For	  sim-­‐
plicity,	   I	  have	  decided	  to	   leave	  out	  mathematical	   formulas.	  However,	   they	  appear	   in	   the	  Materials	  
A B
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and	  Methods	  section	  of	  Paper	   1.	  The	  concepts	  of	  PCA,	  k-­‐means	  clustering	  and	  archetypal	  analysis	  
are	  illustrated	  in	  Figure	  2.	  
Principal	  component	  analysis	  
One	  widely	  used	  dimension-­‐reduction	  technique	   is	  principle	  component	  analysis.	   In	  PCA,	   the	  com-­‐
ponents	  are	  defined	  in	  such	  a	  way	  that	  they	  represent	  most	  variance	  present	  in	  the	  dataset,	  while	  
being	  orthogonal	  to	  each	  other.	  The	  data	   is	  transformed	  into	  a	  new	  coordinate	  system,	  where	  the	  
first	  axis	  is	  placed	  in	  direction	  of	  most	  variance	  and	  this	  is	  defined	  as	  the	  first	  principal	  component	  
(PC1).	  The	  second	  component	  (PC2)	  is	  orthogonal	  to	  PC1	  and	  again	  oriented	  to	  account	  for	  most	  var-­‐
iance	  given	  the	  orthogonality	  constraint	  to	  PC1.	  The	  number	  of	  components	  equals	  the	  number	  of	  
data	  points	  and	  the	  subsequent	  components	  are	  defined	  similar	  to	  PC1	  and	  PC2.	  Each	  data	  point	  will	  
be	  assigned	  a	  coordinate	  for	  each	  principal	  component.	  The	  data	  can	  then	  be	  visualized	  by	  plotting	  
data	  as	  a	  combination	  of	  two	  or	  three	  principal	  components.	  This	  visualization	  possibility	  of	  other-­‐
wise	  complex	  data	  sets	  makes	  PCA	  popular	  (Friedman	  et	  al,	  2009).	  PCA	  has	  a	  large	  degree	  of	  flexibil-­‐
ity	  and	  it	  is	  perfect	  for	  capturing	  variance	  in	  data.	  However,	  the	  principal	  components	  may	  be	  hard	  
to	  characterize	  due	  to	  their	  complex	  representation	  (Mørup	  &	  Hansen,	  2012).	  
K-­‐means	  clustring	  
K-­‐means	  clustering	  is	  a	  method	  that	  separates	  all	  observations	  in	  a	  data	  set	  into	  a	  pre-­‐defined	  num-­‐
ber	  of	  subsets	  or	  clusters.	  For	  each	  defined	  cluster	  the	  mean	  of	  observations	  is	  defined	  as	  the	  cluster	  
centroid	  (or	  component).	  The	  k-­‐means	  clustering	  algorithm	  identifies	  the	  clusters,	  so	  that	  each	  data	  
point	  within	  a	  cluster	  is	  closest	  to	  its	  own	  cluster	  centroid	  (Friedman	  et	  al,	  2009).	  The	  benefit	  of	  clus-­‐
tering	   approaches	   is	   that	   the	   features	   of	   the	   cluster	   components	   are	   similar	   to	   the	   data	   and	   this	  
makes	  the	  results	  easier	  to	  interpret.	  However,	  the	  rigid	  assignment	  of	  data	  points	  into	  a	  single	  clus-­‐
ter	  may	  cause	  loss	  of	   information	  connected	  to	  similarities	  between	  data	  points	  assigned	  to	  differ-­‐
ent	  clusters	  (Mørup	  &	  Hansen,	  2012).	  	  
Archetypal	  analysis	  
Archetypal	  analysis	  estimates	  the	  principle	  convex	  hull	  of	  the	  data	  set,	  which	  can	  be	  described	  as	  a	  
minimal	  set	  of	  points	  that	  can	  wrap	  a	  given	  data	  set	  (Cutler	  &	  Breiman,	  1994).	  Archetypal	  analysis	  is	  
different	   from	  k-­‐means	  clustering	   in	   that	   it	   identifies	   the	  extreme	  (but	   representative)	  data	  points	  
(archetypes)	  in	  the	  data.	  Each	  data	  point	  can	  then	  be	  described	  as	  a	  combination	  of	  archetypes	  and	  
each	  archetype	  can	  be	  described	  as	  a	  combination	  of	  data	  points.	  Archetypal	  analysis	  thereby	  also	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includes	  the	  features	  of	  factorization	  like	  PCA.	  In	  archetypal	  analysis	  a	  pre-­‐defined	  number	  of	  com-­‐
ponents	  are	  identified,	  so	  that	  each	  data	  point	  is	  best	  described	  by	  a	  combination	  of	  these	  compo-­‐
nents	  (Friedman	  et	  al,	  2009).	  The	  archetypes	  will	  often	  be	  placed	  at	  the	  surface	  of	  the	  convex	  hull	  
and	   the	   advantage	   of	   archetypal	   analysis	   is	   that	   these	   extreme	   profiles	   are	  more	   likely	   easier	   to	  
characterize	  (Mørup	  &	  Hansen,	  2012).	  
PCA,	  k-­‐means	  clustering	  and	  archetypal	  analysis	  all	   fall	  within	  the	  statistical	  category	  unsupervised	  
learning.	  The	  goal	  of	  unsupervised	  learning	  is	  to	  reduce	  dimensionality	  of	  data,	  cluster	  data	  and	  to	  
find	  the	  hidden	  sources	  and	  causes	  of	  the	  data	  (Roweis	  &	  Ghahramani,	  1999).	  In	  Paper	  1	  we	  apply	  
these	  three	  methods	  for	  analysis	  of	  gene	  expression	  data.	  We	  use	  the	  methods	  to	  identify	  patterns	  
or	  similarities	  between	  samples	  (each	  of	  which	  has	  its	  own	  gene	  expression	  profile).	  Thereby	  we	  find	  
expression	   patterns	   that	   represent	   the	   total	   data	   set	   instead	   of	   analyzing	   each	   expression	   profile	  
individually.	  The	  use	  of	  different	  unsupervised	  learning	  techniques	  can	  be	  compared	  to	  visualizing	  a	  
problem	  wearing	  different	  sets	  of	  glasses	  or	  from	  different	  angles.	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Genome-scale metabolic modeling 
The	   increasing	   amount	  of	   genome-­‐scale	  data	   and	  whole	   genome	   sequences	   since	   the	  1990s	  have	  
enabled	  development	  of	  genome-­‐scale	  metabolic	  models	  accounting	   for	  metabolism	  at	  a	  systemic	  
level	  (Covert	  et	  al,	  2001).	  	  Genome-­‐scale	  metabolic	  models	  are	  mathematical	  representations	  of	  the	  
interactions	  between	  metabolites,	  enzymes,	  and	  genes	   that	  enable	  metabolic	  activity	   such	  as	  pro-­‐
duction	  of	  biomass	  and	   synthesis	  of	   important	  byproducts	   through	   the	   catabolism	  of	   growth	   sub-­‐
strates	  in	  the	  environment.	  
The	  first	  published	  genome	  scale	  metabolic	  model	  was	  developed	  for	  H.	  influenzae	  and	  published	  in	  
1999	  by	  Edwards	  and	  Palsson	  (Edwards	  &	  Palsson,	  1999).	  Since	  then	  various	  models	  have	  been	  de-­‐
veloped	   for	   different	   organisms	   and	   updated	   versions	   of	   the	  models	   are	   generated	   as	   new	   infor-­‐
mation	  becomes	  available	  (Feist	  et	  al,	  2009).	  The	  first	  genome	  scale	  metabolic	  model	  of	  P.	  aerugino-­‐
sa	  was	   published	   in	   2008	   (Oberhardt	  et	   al,	   2008).	   This	   chapter	  will	   introduce	   the	   concepts	   of	   ge-­‐
nome-­‐scale	  metabolic	  modeling	  and	  round	  off	  with	  application	  examples.	  
Genome-­‐scale	  metabolic	  model	  reconstruction	  
The	  process	  of	  reconstructing	  a	  genome	  scale	  metabolic	  model	  is	  visualized	  in	  Figure	  3.	  First,	  a	  com-­‐
plete	  list	  of	  reactions	  present	  in	  the	  organism	  of	  choice	  is	  defined	  based	  on	  the	  genome	  annotation	  
and	   through	   review	   of	   databases	   and	   literature	   (Oberhardt	   et	   al,	   2009).	   The	  model	   can	   be	   built	  
manually	  or	  a	  draft	  model	   can	  also	  be	  generated	   through	  different	   semi-­‐automated	   tools	  e.g.	   the	  
online	  generation	  of	  genome-­‐scale	  metabolic	  models	  using	   the	   tool	   'Model	  SEED'	   (Overbeek	  et	  al,	  
2005).	  The	  quality	  of	  the	  first	  model	  draft	  will	  rely	  on	  how	  well	  the	  genome	  annotation	  is	  and	  how	  
much	  is	  known	  about	  metabolism	  in	  the	  organism	  from	  the	  literature.	  The	  modeling	  process	  will	  also	  
give	   rise	   to	   improved	   annotation	   through	   identification	   of	   incomplete	   pathways	   for	   example	   con-­‐
nected	  to	  catabolism	  of	  substrates	  (known	  to	  be	  degraded	  in	  the	  organism)	  or	  production	  of	  metab-­‐
olites	  that	  are	  observed	  experimentally	  (Bartell	  et	  al,	  2014;	  Monk	  et	  al,	  2013).	  The	  resulting	  genome-­‐
scale	  model	  can	  be	  considered	  as	  a	  collection	  of	  all	  known	  metabolic	  pathways	  in	  the	  organism	  in-­‐
cluding	   information	  about	  which	  enzymes	  are	  catalyzing	  the	  reactions	   linked	  to	  genes	  that	  are	  en-­‐
coding	  the	  enzymes	  -­‐	   the	  so-­‐called	  Gene-­‐Protein-­‐Reaction	  (GPR)	  relationship.	  The	  physical	  product	  
of	  the	  model	  at	  this	  stage	  could	  be	  an	  excel	  spreadsheet	  with	  reactions	  listed	  in	  rows	  and	  for	  each	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reaction	  information	  about	  metabolite	  substrates	  and	  products	  and	  genes	  related	  to	  that	  reaction.	  
The	  next	  step	  is	  to	  convert	  the	  model	  into	  a	  stoichiometric	  matrix	  S,	  which	  is	  the	  mathematical	  rep-­‐
resentation	  of	  the	  model.	  The	  stoichiometric	  matrix	  S	  is	  an	  m	  x	  n	  matrix	  where	  m	  equals	  the	  number	  
of	  metabolites	  and	  n	  equals	  the	  number	  of	  reactions.	  The	  numbers	  inside	  the	  S	  matrix	  indicates	  the	  
stoichiometry	  between	  substrates	  and	  products	  for	  a	  given	  reaction.	  For	  all	  metabolites	  that	  are	  not	  
involved	  in	  the	  given	  reaction	  the	  values	  in	  S	  will	  be	  listed	  as	  zeros,	  substrates	  will	  take	  negative	  val-­‐
ues	   and	   products	   will	   take	   positive	   values	   (Figure	   3B)	   (Becker	   &	   Palsson,	   2008;	   Oberhardt	   et	   al,	  
2009).	  	  
	  
Figure 3.  Genome-scale metabolic  modeling.  
A.  Genome annotations and information from literature form the base of the 
metabolic model. The genome map is from (Weigand & Sundin, 2012).  
B.  All metabolic reactions are listed in Excel including connections between reac-
tions, metabolites and genes. This information can be translated into a stoichio-
metric matrix (S), which is the mathematical representation of the model. C.  
Fluxes can now be calculated and constraints can be applied to the model to find 
the optimal solution. The figure in panel C is modified from (Orth et al, 2010).	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In	  silico	  flux	  predictions	  
Flux	  balance	  analysis	  (FBA)	  is	  an	  in	  silico	  prediction	  of	  flux	  profiles	  through	  a	  metabolic	  network.	  FBA	  
is	  based	  on	  the	  assumption	  that	  all	  metabolites	  are	  at	  steady	  state.	  That	  means	  that	  the	  metabolite	  
concentrations	   are	   constant,	   and	   hence	   that	   the	   sum	  of	   reaction	   fluxes	   producing	   or	   importing	   a	  
given	  metabolite	  equal	  the	  sum	  of	  reaction	  fluxes	  that	  are	  consuming	  or	  exporting	  the	  same	  metab-­‐
olite.	  Mathematically	   it	  can	  be	  written	  as	  Equation	  1,	  where	  S	   is	  the	  Stoichiometric	  matrix	  and	  v	   is	  
the	  flux	  vector,	  which	  represents	  the	  fluxes	  through	  all	  reactions	  in	  the	  network	  (Varma	  &	  Palsson,	  
1994;	  Edwards	  &	  Covert,	  2002).	  	  
	  
	   S⋅v	  =	  0	   (Equation	  1)	  
	   ai	  <	  vi	  <	  bi	   (Equation	  2)	  
	   Max(vbiomass)	   (Equation	  3)	  
	  
Experimentally,	  the	  steady-­‐state	  requirement	  can	  be	  achieved	  under	  exponential	  growth.	  FBA	  uses	  
linear	  programming	  to	  determine	  a	  solution	  of	  fluxes	  through	  the	  metabolic	  network	  that	  fulfill	  this	  
steady	  state	  assumption	  and	  also	  additional	  defined	  constraints	  while	  optimizing	  an	  objective	  func-­‐
tion	  (for	  example	  maximizing	  biomass	  production)	  (Haggart	  et	  al,	  2011).	  	  
Typical	   constraints	   applied	   to	   FBA	  are	  defined	   reaction	  boundaries	   (Equation	  2).	   If	   unconstrained,	  
these	  can	  be	  mathematically	  defined	  as	  lower	  and	  upper	  bounds	  (ai	  and	  bi	  respectively)	  being	  arbi-­‐
trarily	  set	  to	  for	  example	  -­‐1000	  and	  +1000.	  Some	  bounds	  can	  be	  constrained	  based	  on	  literature	  and	  
experiments.	  Knowledge	  about	   irreversible	   reactions	  can	   for	  example	  change	  the	   lower	  bounds	   to	  
zero.	  Both	  upper	  and	  lower	  bounds	  can	  also	  be	  set	  to	  zero	  to	  simulate	  a	  gene	  (or	  reaction)	  knockout.	  	  
The	  most	  commonly	  used	  objective	   function	   in	  constrained	  based	  modeling	   like	  FBA	   is	  maximizing	  
biomass	   production	   (the	   rate	   at	  which	  metabolic	   compounds	   are	   converted	   into	   biomass	   compo-­‐
nents	  such	  as	  nucleic	  acids,	  proteins	  and	   lipids)	  (Orth	  et	  al,	  2010).	  The	  biomass	  objective	  finds	  the	  
flux	   solution	  with	   the	   highest	   in	   silico	   biomass	   yield	   among	   the	   possible	   solutions	   to	   the	   network	  
(Equation	  4).	  However,	  other	  objective	  functions	  can	  be	  defined	  e.g.	  minimizing	  or	  maximizing	  ATP	  
production,	  and	  even	  a	  combination	  of	  objective	  functions	  can	  be	  defined	  (Schuetz	  et	  al,	  2007).	  
When	  evaluating	  fluxes	  through	  a	  system	  it	  can	  also	  be	  relevant	  to	  perform	  a	  flux	  variability	  analysis	  
(FVA).	  FVA	  determines	  the	  variability	  of	  each	  reaction,	  while	  maintaining	  the	  optimal	  objective	  func-­‐
tion	  value	  (e.g.	  maximum	  biomass	  production	  level).	  The	  maximum	  objective	  function	  value	  is	  first	  
determined	   through	   FBA,	  which	   allows	   reaction	   fluxes	  within	   the	   defined	   bounds.	   Then,	   for	   each	  
Chapter 4 │Genome-scale metabolic modeling 	  
	  
Technical University of Denmark Page 18 of 121 
 
reaction	   the	  minimum	   and	  maximum	   reaction	   fluxes	   are	   determined	  with	   the	   constraint	   applied,	  
that	  the	  maximum	  objective	  function	  value	  should	  be	  maintained.	  FVA	  thereby	  gives	  you	  the	  range	  
of	  possible	  solutions	  for	  a	  given	  reaction	  to	  fulfill	  the	  objective	  function.	  The	  study	  of	  FVA	  will	  give	  a	  
more	   robust	   analysis	   of	   metabolic	   activity	   since	   specific	   reaction	   fluxes	   proposed	   by	   the	   model	  
through	  FBA	  could	  be	  one	  of	  many	  solutions	  to	  the	  objective	  function,	  whereas	  the	  FVA	  is	  more	  the	  
solution	  space	  (Haggart	  et	  al,	  2011).	  
Integration	  of	  data	  sets	  into	  genome-­‐scale	  metabolic	  models	  
The	  genome-­‐scale	  models	  can	  be	  combined	  with	  transcriptomic	  data	  or	  other	  omics	  data,	  which	  will	  
add	  an	  additional	   layer	  of	  constraints	   for	  reaction	  fluxes	   (Bordbar	  et	  al,	  2014).	  The	  model	  only	  ac-­‐
counts	  for	  metabolic	  genes;	  that	  means	  genes	  that	  are	  directly	  involved	  in	  the	  metabolic	  reactions.	  
However,	   integration	  of	  gene	  expression	  data	  will	  make	  a	   fingerprint	  of	   regulatory	   events	   causing	  
reactions	  to	  be	  inactive	  due	  or	  active	  due	  to	  down-­‐regulated	  or	  up-­‐regulated	  gene	  expression.	  
A	  variety	  of	  transcriptome	  integration	  tools	  have	  been	  developed	  over	  the	  past	  10	  years	  (Becker	  &	  
Palsson,	  2008;	  Zur	  et	  al,	  2010;	  Jensen	  et	  al,	  2011;	  Machado	  &	  Herrgård,	  2014).	  Among	  the	  tools	  are	  
both	  discrete	  and	  continuous	   integrations,	  but	  there	   is	  no	  clear	  preference	  when	  the	  methods	  are	  
compared	  (Machado	  &	  Herrgård,	  2014).	  One	  option	  is	  to	  develop	  proposed	  ‘off’	  and	  ‘on’	  gene	  activi-­‐
ty	  levels	  based	  on	  gene	  expression	  values.	  Although	  gene	  expression	  levels	  do	  not	  necessarily	  reflect	  
flux	  levels,	  the	  gene	  expression	  values	  can	  help	  to	  guide	  the	  determination	  of	  the	  correct	  phenotype	  
among	  the	  space	  of	  solutions	  from	  the	  metabolic	  network	  (Machado	  &	  Herrgård,	  2014).	  
Another	  layer	  of	  constraints	  can	  be	  based	  on	  genetic	  variations.	  If	  we	  wish	  to	  model	  differences	  in	  
metabolic	   phenotypes	   due	   to	   genetic	   variations	   between	   strains,	  we	   need	   to	   define	   how	   genetic	  
variations	  should	  be	  implemented	  into	  the	  models.	  When	  we	  look	  at	  SNPs	  in	  light	  of	  genetic	  adapta-­‐
tion	  of	  an	  organism	  there	  are	  different	  ways	  of	  evaluating	  whether	  the	  SNP	  has	  any	  functional	  effect	  
on	  the	  organism.	  The	  SNPs	  can	  be	  divided	  into	  silent,	  missense	  and	  nonsense	  mutations.	  The	  silent	  
mutations	  do	  not	  result	   in	  an	  amino	  acid	  change	  in	  the	  encoded	  protein	  and	  it	   is	  "tempting"	  to	  in-­‐
terpret	  this,	  as	  the	  SNP	  has	  no	  functional	  effect.	  However,	  silent	  mutations	  may	  have	  an	  impact	  on	  
regulation,	  why	  they	  shouldn't	   just	  be	  neglected.	  For	  example	  a	  silent	  mutation	   in	  Mycobacterium	  
tuberculosis	  has	   been	   associated	  with	   antibiotic	   resistance	  by	   converting	   a	   region	   adjacent	   to	   the	  
silent	  mutation	   into	   an	   alternate	   promoter	   (Ando	   et	   al,	   2014).	  Missense	  mutations	   on	   the	   other	  
hand	  do	  result	   in	  a	  change	  in	  amino	  acid	  composition	  in	  the	  encoded	  protein.	   In	  order	  to	  evaluate	  
the	  effect	  of	   a	  missense	  mutation,	   it	   can	  be	   relevant	   to	   look	  at	   the	  properties	  of	   the	  original	   and	  
substituting	   amino	   acid.	   In	   2009	   an	   algorithm	   called	   SIFT	   ("Sorting	   Intolerant	   from	   Tolerant")	  was	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developed	  with	  the	  aim	  of	  predicting	  effects	  of	  coding	  missense	  SNPs	  on	  protein	  function	  (Kumar	  et	  
al,	  2009).	  The	  algorithm	  takes	  the	  amino	  acid	  properties	  into	  consideration	  when	  calculating	  a	  score	  
for	   the	   probability	   of	   the	   protein	   function	   being	   affected.	   Finally,	   nonsense	   mutations	   result	   in	  
frame-­‐shifts	  of	  the	  mRNA	  translation	  and	  the	  resulting	  amino	  acid	  sequence	  after	  a	  nonsense	  muta-­‐
tion	  must	  be	  assumed	  dysfunctional.	  The	  impact	  of	  a	  nonsense	  SNP	  therefore	  depends	  on	  where	  the	  
SNP	  is	  located	  in	  the	  sequence,	  where	  an	  early	  nonsense	  SNP	  most	  likely	  result	  in	  a	  non-­‐functional	  
protein,	  whereas	  a	  late	  nonsense	  SNP	  can	  result	  in	  impaired	  or	  sustained	  function	  of	  the	  protein.	  
For	  our	  study	  presented	  in	  Paper	  2	  we	  have	  chosen	  to	  define	  three	  different	  constraints	  that	  should	  
resemble	  SNP	  impact.	  All	  of	  the	  reaction	  bound	  constraints	  are	  based	  on	  original	  FVA	  ranges	  calcu-­‐
lated	  without	  implementing	  constraints	  due	  to	  SNPs.	  Then,	  these	  FVA	  ranges	  are	  adjusted	  in	  a	  way	  
to	  resemble	  the	  likelihood	  of	  functional	  impact	  of	  the	  SNP.	  Thus,	  silent	  SNPs	  and	  missense	  SNPs	  that	  
are	  predicted	  to	  be	  tolerated	  by	  the	  SIFT	  algorithm	  are	  implemented	  as	  constraints	  for	  the	  affected	  
reactions	   defined	   as	   10%	   reduced	   FVA	   range.	  Missense	   SNPs	   that	   are	   predicted	   to	   affect	   protein	  
function	   are	   implemented	  with	   constraints	   defined	   as	   50%	   reduced	   FVA	   range.	   Finally,	   nonsense	  
mutations	  are	  implemented	  as	  a	  constraint	  reducing	  FVA	  range	  of	  the	  affected	  reaction	  with	  90%.	  	  	  	  	  
Constraints	   can	   also	   be	   stated	  based	  on	   known	   fluxes	   through	   the	  network.	   Isotope	   labeling	   sub-­‐
strates	   can	  be	  used	   to	  determine	   fluxes	   through	  different	   convergent	  pathways	   (del	  Castillo	  et	  al,	  
2007;	  Nanchen	  et	  al,	  2007;	  Wiechert,	  2001).	  The	  concept	  is	  illustrated	  in	  Figure	  4	  and	  is	  briefly	  de-­‐
scribed	  below.	  
When	  a	  heterogeneous	  labeled	  substrate	  as	  [1-­‐13C]-­‐glucose	  (glucose	  labeled	  with	  the	  13C	  carbon	  iso-­‐
tope	  at	  position	  1)	  is	  catabolized,	  different	  labeling	  patterns	  on	  downstream	  intermediates	  (e.g.	  py-­‐
ruvate)	  will	  occur	  depending	  on	  which	  pathway	  glucose	  has	  been	  degraded	  through	  (Figure	  4).	  The	  
degradation	  of	  glucose	   into	  pyruvate	  can	  happen	   through	   three	  alternate	  pathways;	  The	  Embden-­‐
Meyerhof	   Parnas	   (EMP)	   pathway	   (standard	   glycolysis	   in	   textbooks),	   the	   pentose	   phosphate	   (PP)	  
pathway	  and	  finally	  the	  Entner	  Doudoroff	  (ED)	  pathway.	  If	  one	  glucose	  molecule	  is	  degraded	  through	  
the	  EMP	  pathway	  the	   labeled	  carbon	  will	  end	  up	   in	  the	  third	  position	  for	  one	  out	  of	  two	  pyruvate	  
molecules.	   If	  one	  glucose	  molecule	   is	  degraded	  through	  the	  PP	  pathway,	   the	   labeled	  carbon	  atom	  
will	  end	  up	  in	  CO2	  and	  no	  labeled	  pyruvate	  will	  occur.	  If	  one	  glucose	  molecule	  is	  degraded	  through	  
the	  ED	  pathway	  the	  labeled	  carbon	  will	  end	  up	  in	  the	  first	  position	  for	  one	  out	  of	  two	  pyruvate	  mol-­‐
ecules.	   The	   resulting	  mix	   of	   pyruvate	  molecules	  with	   different	   labeling	   patterns	   can	   therefore	   be	  
applied	  to	  calculate	  how	  much	  glucose	  is	  degraded	  through	  each	  of	  the	  pathways	  (Thøgersen,	  2010).	  
If	   we	   know	   the	   relative	   activities	   of	   these	   pathways,	   this	   information	   can	   be	   integrated	   into	   the	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model	  by	  constraining	  the	  reactions	  to	  attain	  these	  values.	  Labeling	  patterns	  on	  other	   intracellular	  
metabolites	  will	  likewise	  be	  useful	  for	  determining	  reaction	  fluxes.	  
	  
	  
Figure 4.  Isotope-labeling experiment.  
Glucose can be degraded into two molecules 
of pyruvate through three alternate path-
ways: Embden-Meyerhof-Parnas pathway 
(EMP), Entner-Doudoroff pathway (ED) and 
Pentose Phosphate pathway (PP). The labeled 
carbon atom from [1-13C]-labeled glucose 
ends up at different positions in pyruvate 
dependent on which pathway is used to de-
grade glucose. Figure adapted from 
(Thøgersen, 2010). 
	  
Applications	  of	  genome-­‐scale	  metabolic	  models	  
One	  major	  contribution	  from	  genome	  scale	  metabolic	  models	  is	  derived	  from	  the	  model	  reconstruc-­‐
tion	  process	   itself.	  The	  reconstruction	  of	   the	  model	  will	  give	  rise	  to	   improved	  genome	  annotation.	  
This	   happens	   through	   identification	   of	   pathways	   that	   are	   known	   to	   operate	   in	   the	   organism,	   but	  
which	  are	  not	  complete	  in	  the	  in	  silico	  model.	  Searching	  for	  genes	  encoding	  proteins	  that	  are	  known	  
to	  catalyze	  the	  relevant	  reactions	  can	  complete	  those	  pathways.	  Through	  directed	  blast	  analysis	  new	  
gene	  annotations	   can	   thus	  be	  made.	  The	  manual	   curation	  process	  of	   the	  model	  will	  make	   the	   re-­‐
searcher	   relate	   information	   from	   the	   literature	   to	   databases	   and	   sometimes	   clarify	   discrepancies	  
(Oberhardt	  et	  al,	  2008;	  Monk	  et	  al,	  2013).	  
The	  application	  of	  the	  genome-­‐scale	  metabolic	  models	  that	  is	  closest	  to	  our	  use	  in	  Paper	  2	  is	  contex-­‐
tualizing	  high-­‐throughput	  data	  sets,	  where	  the	  model	  is	  used	  as	  a	  tool	  for	  analyzing	  high-­‐throughput	  
data	  and	  for	  predicting	  the	  systemic	   impact	  of	   information	  stored	  in	  the	  data.	  The	  model	  as	  a	  tool	  
thereby	  allows	  us	   to	   interpret	   these	  high-­‐throughput	  data	  at	  a	  network	   level.	  One	  example	  where	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transcriptome	  data	   is	  combined	  with	  genome-­‐scale	  metabolic	  models	   to	  define	  metabolic	   require-­‐
ments	  of	  Listeria	  monocytogenes	  during	  infection	  (Lobel	  et	  al,	  2012).	  Another	  study	  integrate	  gene	  
expression	  data	  to	  make	  comparisons	  between	  P.	  aeruginosa	  strains	  representing	  different	  stages	  of	  
adaptation	  and	  they	  make	  in	  silico	  predictions	  to	  determine	  production	  of	  virulence	  factors,	  growth	  
capabilities	  and	  essential	  genes	  (Oberhardt	  et	  al,	  2010).	  
The	  models	   can	   also	   be	   used	   for	   comparative	  modeling	   analysis	   where	   two	   or	  more	  models	   are	  
compared	  to	  evaluate	  for	  example	  differences	  in	  metabolic	  capacity	  between	  models.	  One	  example	  
is	  the	  study	  by	  Bartell	  et	  al	  (Bartell	  et	  al,	  2014)	  where	  they	  compare	  metabolic	  capabilities	  and	  con-­‐
textualizes	   genetic	   differences	   between	   Burkholderia	   cenocepacia	   and	   Burkholderia	  multivorans.	  
Another	  study	  compare	  55	  genome-­‐scale	  metabolic	  models	  of	  Escherichia	  coli	  in	  order	  to	  character-­‐
ize	   the	  pan	   (collective)	   and	   core	   (shared)	  metabolic	   capabilities	  of	   the	  E.	   coli	   species	   (Monk	  et	  al,	  
2013).	  Through	  their	  comparative	  analyses,	  they	  are	  able	  to	  group	  the	  individual	  strains	  into	  correct	  
pathotypes	  and	  environmental	  niches	  based	  on	  the	  in	  silico	  strain-­‐specific	  metabolic	  capabilities	  and	  
they	  suggest	  that	  a	  small	  number	  of	  nutrient	  sources	  can	  be	  used	  to	  classify	  different	  E.	  coli	   types	  
(Monk	  et	  al,	  2013).	  
Genome-­‐scale	  metabolic	  models	  are	  often	  used	   in	   the	  biotech	   industry	   for	  making	  predictions	   for	  
optimized	  product	  yield	  or	  quality	  that	  is	  useful	  prior	  to	  metabolic	  engineering	  (Puchałka	  et	  al,	  2008;	  
Kjeldsen	  &	  Nielsen,	  2009).	  One	  example	  is	  to	  apply	  the	  model	  for	  making	  predictions	  about	  reduced	  
byproduct	   formation.	   It	   is	   possible	   that	   knockout	   of	   certain	   genes	  will	   disrupt	   the	   byproduct	   for-­‐
mation.	  The	  models	  allow	  the	  researcher	  to	  make	   in	  silico	  knockout	  studies,	  which	   is	   less	  resource	  
demanding	  than	  the	  corresponding	   in	  vitro	  experiments	  of	  gene	  knockouts.	  The	  model	  can	  help	  to	  
select	  among	  a	   list	  of	  candidate	  genes	  based	  on	   the	  model	  predictions	  and	   the	  number	  of	  experi-­‐
mental	   knockouts	   can	   therefore	  be	   reduced.	  Another	   application	  of	   genome	   scale	  modeling	   in	   an	  
industrial	   context	  could	  be	   identification	  of	  missing	  pathways	   for	  production	  of	  a	  desired	  product.	  
The	  missing	  pathways	  could	  be	  constructed	   in	  silico	  and	  the	  model	  analysis	  could	  indicate	  whether	  
the	  reactions	  are	  feasible	  in	  the	  context	  of	  the	  available	  metabolic	  pathways	  in	  the	  organism.	  In	  the	  
study	   by	   Kjeldsen	   and	   Nielsen,	   they	   used	   genome-­‐scale	  metabolic	  modeling	   for	   optimizing	   lysine	  
yield	  in	  the	  bacterium	  Corynebacterium	  glutamicum	  (Kjeldsen	  &	  Nielsen,	  2009).	  
The	  model	  can	  also	  be	  used	  to	  make	  in	  silico	  predictions	  of	  essential	  genes,	  which	  is	  highly	  relevant	  
when	   studying	   pathogens,	   since	   essential	   genes	   can	   serve	   as	   targets	   for	   therapeutic	   intervention	  
(Oberhardt	  et	  al,	  2008;	  Bartell	  et	  al,	  2014;	  Wodke	  et	  al,	  2013).	  In	  silico	  essential	  gene	  analysis	  is	  car-­‐
ried	  out	  by	  removing	  one	  gene	  at	  a	  time	  from	  the	  model.	  If	  the	  model	  fails	  to	  produce	  biomass	  after	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the	  deletion,	  the	  gene	  is	  called	   in	  silico	  essential.	  Some	  times	  more	  genes	  account	  for	  one	  reaction	  
and	   this	   reaction	  will	   only	   be	   disrupted	   if	   all	   of	   the	   genes	   (with	   an	   'or'	   relationship)	   are	   removed	  
from	  the	  model.	  Therefore	  it	  is	  also	  interesting	  to	  perform	  an	  essential	  reaction	  analysis,	  where	  one	  
reaction	  at	  a	   time	   is	   removed	   from	  the	  model	   in	  order	   to	   identify	   in	  silico	  essential	   reactions.	  The	  
analysis	  of	  essential	  genes	  is	  often	  used	  to	  validate	  genome	  scale	  metabolic	  models	  since	  these	  val-­‐
ues	   are	   easy	   to	   compare	  with	   experimentally	   determined	   essential	   genes	   (Oberhardt	   et	   al,	   2008;	  
Monk	  et	  al,	  2013).	  
Genome-­‐scale	  metabolic	  modeling	  is	  applied	  in	  Paper	  2	  to	  contextualize	  the	  impact	  of	  SNPs	  and	  al-­‐
tered	  gene	  expression	  on	  metabolism	  at	  a	  systemic	  level.	  Subsystems	  subject	  to	  metabolic	  changes	  
are	  identified	  as	  well	  as	  genes	  that	  become	  essential	  during	  the	  adaptation	  of	  P.	  aeruginosa	  to	  the	  
CF	  lung	  environment.	  The	  modeling	  approach	  is	  also	  utilized	  to	  make	  predictions	  about	  the	  selective	  
forces	  within	  the	  CF	  lung	  environment	  and	  to	  evaluate	  the	  feasibility	  of	  suspected	  metabolic	  chang-­‐
es.	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Archetypal analysis of diverse Pseudomonas
aeruginosa transcriptomes reveals adaptation
in cystic fibrosis airways
Juliane Charlotte Thøgersen1, Morten Mørup2, Søren Damkiær1, Søren Molin1 and Lars Jelsbak1*
Abstract
Background: Analysis of global gene expression by DNA microarrays is widely used in experimental molecular
biology. However, the complexity of such high-dimensional data sets makes it difficult to fully understand the
underlying biological features present in the data.
The aim of this study is to introduce a method for DNA microarray analysis that provides an intuitive interpretation
of data through dimension reduction and pattern recognition. We present the first “Archetypal Analysis” of global
gene expression. The analysis is based on microarray data from five integrated studies of Pseudomonas aeruginosa
isolated from the airways of cystic fibrosis patients.
Results: Our analysis clustered samples into distinct groups with comprehensible characteristics since the
archetypes representing the individual groups are closely related to samples present in the data set. Significant
changes in gene expression between different groups identified adaptive changes of the bacteria residing in the
cystic fibrosis lung. The analysis suggests a similar gene expression pattern between isolates with a high mutation
rate (hypermutators) despite accumulation of different mutations for these isolates. This suggests positive selection
in the cystic fibrosis lung environment, and changes in gene expression for these isolates are therefore most likely
related to adaptation of the bacteria.
Conclusions: Archetypal analysis succeeded in identifying adaptive changes of P. aeruginosa. The combination of
clustering and matrix factorization made it possible to reveal minor similarities among different groups of data,
which other analytical methods failed to identify. We suggest that this analysis could be used to supplement
current methods used to analyze DNA microarray data.
Keywords: Archetypal analysis, Gene expression, Pseudomonas aeruginosa, Cystic fibrosis, Hypermutators
Background
DNA microarrays simultaneously monitor expression
levels of thousands of genes, and this technology is widely
used in experimental molecular biology. However, the
complexity of such high-dimensional data sets makes it dif-
ficult to fully comprehend the underlying biological fea-
tures present in the data. Different dimension reduction
techniques aim to find patterns in high complexity data
sets. The choice of analytical method can influence the in-
terpretation of the data, and it can be useful to combine
different methods.
K-means clustering and principal component analysis
(PCA) are techniques for unsupervised pattern recogni-
tion commonly used in microarray data analysis. K-means
clustering aims to group samples (or genes) with similar
behavior [1]. Each sample is then assigned to a cluster rep-
resented by a cluster centroid. PCA is an orthogonal linear
transformation transforming the data into a new coord-
inate system where the axes are oriented to account for
maximal variation in the data set. PCA decomposes
data into a set of uncorrelated variables called principal
components [2-4].
Clustering approaches give easy interpretable features
but pay a price in terms of modeling flexibility, because
each sample must be grouped in only one cluster and no
intermediate between clusters is allowed. PCA on the
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other hand can lead to complex representations from
which we learn relatively little about the data. Archetypal
analysis (AA) combines the virtues of both clustering
and PCA in that AA results in easy interpretable compo-
nents that have added flexibility over clustering by
allowing intermediates [5]. Cutler and Breiman first intro-
duced AA in 1994, where they used AA to analyze air pol-
lution and head shape [6]. Later, AA has been applied in
the identification of extreme practices in benchmarking
and market research and signal enhancement and feature
extraction of IR image sequences [7,8]. Recently, AA has
been shown to be useful in extracting features from differ-
ent high-dimensional data sets including neuroimaging,
computer vision and text mining data sets [5] and also in
identifying extreme and representative human genotypes
within the human population [9].
AA estimates the principle convex hull of a data set.
The convex hull can be described as a minimal set of
points that can wrap a given data set. The idea of AA is
to find a few representative points (archetypes) in a data
set such that all data can be described as a convex com-
bination of these archetypes. The archetypes are related
to experimental data but they are not necessarily ob-
served points in the data set. Each archetype represents
distinct characteristic features. Explaining data as a com-
bination of these features can make the data set easier
to interpret [5]. Unlike PCA, AA is not restricted by
orthogonality, and it is possible that this method will
clarify biologically meaningful features that are not dis-
covered by PCA, while resulting in a more detailed ac-
count of the data than given by clustering approaches
such as k-means clustering.
AA has been shown to be useful in extracting features
from different high-dimensional data sets. So far, the
method has not been applied to gene expression data des-
pite clear advantages such as the intuitive and straight-
forward interpretation of the AA components. AA can be
considered an unmixing approach that decomposes each
observation into a weighted average of features defining
distinct aspects in the data. In the related unmixing frame-
work for gene expression data proposed in [10] the data is
projected to a PCA subspace. In this subspace each obser-
vation is defined as convex combinations of features
forming the simplex with smallest volume among candi-
date simplices that are found by an iterative boundary
growing procedure that is terminated when all obser-
vations are enclosed. Contrary to this framework, AA
operates directly on the full data and as the features are
constrained to be convex combinations of the observations
the archetypes will not in general enclose all observations.
Variation of phenotypes found in nature has recently
been described as weighted averages of archetypes, where
archetypes represent phenotypes that are optimized for a
single adaptive task [11]. The phenotype space will often
be arranged in a simple geometric shape where archetypes
represent the corners, and the closer a point is to a corner
the more important the corresponding task is to fitness in
the organism’s habitat [11]. From this it can be concluded
that it is possible to identify the tasks that are important
for fitness by analyzing these corners [12]. Furthermore,
the variation within a species (the combination of arche-
types) reflects the different environments it inhabits [11].
The message of the paper by Shoval et al. (Science) [11]
clearly illustrates the value of AA and the idea of consider-
ing a phenotype space as a combination of extreme but
representative points, which is exactly the concept of this
present analysis: Archetypal Analysis.
In this study, we apply AA to five gene expression data
sets for Pseudomonas aeruginosa isolated from the lungs
of cystic fibrosis patients. The five data sets were based
on different experimental conditions including growth
medium and growth state during cell harvesting. A method
like PCA most likely captures this experimental variance in
the first few components. The first components will make
restrictions for the additional components due to the or-
thogonality constraint, and information that is linked to
the real biological difference between the samples may be
difficult to extract. Since AA is not restricted by orthogon-
ality like PCA, we propose that AA will be able to extract
biological information despite the different experimental
conditions of the five studies. We show how AA succeeds
in identifying genes that undergo changes in gene expres-
sion during evolutionary adaptation of the bacteria to the
cystic fibrosis lung.
Methods
The diagram in Figure 1 illustrates the process of AA.
First data is collected and pre-processed. Pre-processing
includes extraction of the raw data cel-files in R by use
of the package affy [13]. Then, data is normalized using
the qspline method [14] and gene expression index values
are calculated using robust multiarray average expression
measure [15]. The next stage is to apply the AA algorithm
to the expression matrix and calculate explained variance
in order to evaluate the solution. Once the archetypes
are defined, it is possible to see how samples cluster to-
gether based on their relation to the archetypes. Finally,
the archetypes can be characterized in a biological con-
text based on their gene expression profiles. The gene
expression values were not calculated relative to control
strains since different control strains were used across
the five analyzed studies.
Data collection
We analyzed cDNA microarray data from four previously
published in vitro studies (study 1–4) of P. aeruginosa sam-
pled from CF lung infections. Three of the data sets were
obtained from the online NCBI Gene Expression Omnibus
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(GEO) Database with the accession numbers GSE21966
[16], GSE31227 [17] and GSE10362 [18]. The fourth data
set by Lee et al. [19] was obtained through request directly
to the corresponding author. A fifth data set was generated
for this study (study 5). An overview of the microarray data
set is shown in Table 1.
Study 1 [16]. This gene expression data set consists of
17 samples (in duplicates) representing clonal isolates
sampled from three CF patients on timescales ranging
from 3 months to 8 years. Two of the patients each har-
bored a unique clone (A and B), whereas a strain replace-
ment occurred in the third patient, and two individual
clones Ca and Cb were therefore isolated from this pa-
tient. For each isolate, information about colony mor-
phology is available, and for the present analysis, we
grouped these morphotypes into two categories: Mucoid
(‘mucoid’ morphotypes) and non-mucoid (‘dwarf ’ and
‘classic’ morphotypes).
The experimental procedures are fully described by
Huse et al. [16]. In brief, cells were grown in synthetic cys-
tic fibrosis sputum medium (SCFSM) to an optical density
read at 600 nm (OD600) of 0.4-0.5 prior to Affymetrix
P. aeruginosa GeneChip microarray analysis. The strains
P. aeruginosa PAO1 and P. aeruginosa PA14 (referred to
as PAO1 and PA14 respectively) were included as controls
in their study. PAO1 was originally isolated from a burn
wound [20] and has been widely used as a reference strain
for studies of P. aeruginosa. PA14 is a highly virulent
laboratory strain that most likely represents an environ-
mental strain of P. aeruginosa, although it has also been
isolated from CF lungs in Europe [21,22].
Study 2 [17]. This data set consists of different clonal
lineages isolated from the lungs of CF patients (B6, B12,
B38, CF30, CF46, CF66, CF105, CF114, CF173, CF211,
CF243, CF333 and CF506) between 1973 and 2008 span-
ning early stage infection to chronic stage infection [23].
Many of the isolates from study 2 share the same clonal
type called “DK2”. The data set consists of 29 samples in
triplicates. One group of samples was isolated from CF
children between 2006 and 2008 and these isolates rep-
resent early stage infection. Each isolate was character-
ized based on two colony morphotypes; mucoid and
non-mucoid. The data set includes a sequential mucoid
and non-mucoid paired strain, where the non-mucoid
strain (B38-2NM) was generated in vitro by allelic re-
placement of its mucA allele [24]. Cells were grown in
Luria-Bertani (LB) medium to OD600 of 0.5 (OD600 = 1
for samples #129-140) prior to Affymetrix P. aeruginosa
GeneChip microarray analysis. PAO1 was included as con-
trol in this study.
Study 3 [19]. This data set consists of twelve clonally re-
lated, sequential mucoid and non-mucoid paired P. aeru-
ginosa isolates. The isolates were obtained from three CF
patients. All isolates from study 3 share the same clonal
type called “DK1”. Cells were grown in beef broth (BB) to
an OD600 of 1 prior to Affymetrix P. aeruginosa GeneChip
microarray analysis. Each experiment was done in du-
plicate. Isolates with high mutation rates (hereafter,
“hypermutators”) were identified within the data set.
Study 4 [18]. This data set consists of eight sequential
isogenic isolates recovered over a period of three to five
years from a single CF patient (patient M). The isolates in-
cluded both hypermutators and non-hypermutators and
one isolate was mucoid. Cells were grown in LB medium
and harvested during late-logarithmic growth phase at op-
tical density above 3. Each sample was triplicated.
Study 5 (this study). This data set consists of four iso-
lates from the same patient (CF211). The isolates are two
mucoid/non-mucoid pairs isolated together in 1997 and
2006 respectively. Cells were grown in BB to an OD600 of 1
prior to Affymetrix P. aeruginosa GeneChip microarray
analysis. Microarray data were generated using Affymetrix
protocols as previously described [23]. Each experiment
was done in triplicates. The isolates share the same clone
type “DK2” as many of the isolates from study 2, but the
experimental conditions are similar to those in study 3.
Archetypal analysis
The fundamental principle of AA is briefly introduced
below. AA is fully described by Cutler and Breiman [6].
AA is defined by the decomposition
X≈XCS;
s:t: C ≥ 0;
XN
n¼1




Figure 1 Flow diagram of the archetypal analysis. First, data is collected and pre-processed. Then, Archetypal Analysis is applied resulting in a
clustering of samples based on the closest defined archetype. Finally, the archetypes are characterized and evaluated in a biological context.
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Table 1 List of samples
Sample # Sample name Study Patient Clone Year Mucoid Mutator State1 Medium2 OD3
[1,2] Huse_A1 Study 1 A “A” ~1983 No N/A Early SCFSM 0.4-0.5
[3,4] Huse_A2 Study 1 A “A” ~1984 No N/A Early SCFSM 0.4-0.5
[5,6] Huse_A3.1 (m) Study 1 A “A” ~1985 Yes N/A Early SCFSM 0.4-0.5
[7,8] Huse_A3.2 Study 1 A “A” ~1985 No N/A Early SCFSM 0.4-0.5
[9,10] Huse_A4 (m) Study 1 A “A” ~1986 Yes N/A Early SCFSM 0.4-0.5
[11,12] Huse_B1 Study 1 B “B” ~1983 No N/A Early SCFSM 0.4-0.5
[13,14] Huse_B2.1 Study 1 B “B” ~1987 No N/A Late SCFSM 0.4-0.5
[15,16] Huse_B2.2 Study 1 B “B” ~1987 No N/A Late SCFSM 0.4-0.5
[17,18] Huse_B2.3 (m) Study 1 B “B” ~1987 Yes N/A Late SCFSM 0.4-0.5
[19,20] Huse_B3.1 (m) Study 1 B “B” ~1991 Yes N/A Late SCFSM 0.4-0.5
[21,22] Huse_B3.2 Study 1 B “B” ~1991 No N/A Late SCFSM 0.4-0.5
[23,24] Huse_B3.3 (m) Study 1 B “B” ~1991 Yes N/A Late SCFSM 0.4-0.5
[25,26] Huse_Ca1 Study 1 C “Ca” ~1983 No N/A Early SCFSM 0.4-0.5
[27,28] Huse_Ca2 (m) Study 1 C “Ca” ~1983 Yes N/A Early SCFSM 0.4-0.5
[29,30] Huse_Cb1 (m) Study 1 C “Cb” ~1987 Yes N/A Early SCFSM 0.4-0.5
[31,32] Huse_Cb2 Study 1 C “Cb” ~1987 No N/A Late SCFSM 0.4-0.5
[33,34] Huse_Cb3 (m) Study 1 C “Cb” ~1987 Yes N/A Late SCFSM 0.4-0.5
[35-36] Huse_PA14 Study 1 N/A “PA14” N/A No N/A wt SCFSM 0.4-0.5
[37-38] Huse_PAO1 Study 1 N/A “PAO1” N/A No N/A wt SCFSM 0.4-0.5
[39-41] Yang_PAO1 Study 2 N/A “PAO1” N/A No N/A wt LB 0.5
[42-47] Yang_CF510-2006 Study 2 N/A “WTB” N/A No N/A N/A LB 0.5
[48-50] Yang_B6.0 Study 2 B6 “B6” ~2005 No N/A Early LB 0.5
[51-53] Yang_B6.4 Study 2 B6 “B6” ~2007 No N/A Early LB 0.5
[54-56] Yang_B12.0 Study 2 B12 “B12” ~2005 No N/A Early LB 0.5
[57-59] Yang_B12.4 Study 2 B12 “B12” ~2007 No N/A Early LB 0.5
[60-62] Yang_B12.7 Study 2 B12 “B12” ~2009 No N/A Early LB 0.5
[63-65] Yang_B38.1 Study 2 B38 “B38” ~2005 No N/A Early LB 0.5
[66-68] Yang_B38.2 (m) Study 2 B38 “B38” N/A Yes N/A Early LB 0.5
[69-71] Yang_B38.2 Study 2 B38 “B38” ~2005 No N/A Early LB 0.5
[72-74] Yang_B38.6 (m) Study 2 B38 “B38” ~2006 Yes N/A Early LB 0.5
[75-77] Yang_CF43-1973 Study 2 CF43 “DK2” 1973 No N/A Early LB 0.5
[78-80] Yang_CF66-1973 Study 2 CF66 “DK2” 1973 No N/A Late LB 0.5
[81-83] Yang_CF105_1973 Study 2 CF105 “DK2” 1973 No N/A Early LB 0.5
[84-86] Yang_CF114_1973 Study 2 CF114 “DK2” 1973 No N/A Early LB 0.5
[87-89] Yang_CF30-1979 Study 2 CF30 “DK2” 1979 No N/A Late LB 0.5
[90-92] Yang_CF173-1984 Study 2 CF173 ”DK2” 1984 No N/A Late LB 0.5
[93-95] Yang_CF333-1991 Study 2 CF333 ”DK2” 1991 No N/A Late LB 0.5
[96-98] Yang_CF66-1992 Study 2 CF66 “DK2” 1992 No N/A Late LB 0.5
[99-101] Yang_CF333_1997 Study 2 CF333 “DK2” 1997 No N/A Late LB 0.5
[102-104] Yang_CF173-2002 Study 2 CF173 “DK2” 2002 No N/A Late LB 0.5
[105-107] Yang_CF243-2002 Study 2 CF243 “DK2” 2002 No N/A Late LB 0.5
[108-110] Yang_CF333-2003 Study 2 CF333 “DK2” 2003 No N/A Late LB 0.5
[111-113] Yang_CF173-2005 Study 2 CF173 “DK2” 2005 No N/A Late LB 0.5
[114-116] Yang_CF333-2005 Study 2 CF333 “DK2” 2005 No N/A Late LB 0.5
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Where we use the notation S ≥ 0 to denote that
the entries of a matrix S are constrained non-negative.
The archetypes (components) are given as the columns
of the matrix A defined by A = XC such that the col-
umns of A are formed by convex combinations of the
samples.
A K-component AA finds a matrix with elements
Amk defining K M-dimensional archetypes and each
data point can be represented by a convex combin-
ation of these archetypes. Each archetype thereby has
a specific gene profile that is saved in the k’th column
of A, i.e. ak. The coefficients (α1, α2, .., αK) for a given
data point xn are saved in the nth column of the
matrix S, i.e. sn, with elements Skn. The values of these
coefficients range from 0 to 1 and the sum of the co-
efficients equals 1.
The AA algorithm as for PCA and k-means attempts




X‐ASð Þ2mn¼ X‐ASk k2F
Where M is the number of attributes and N the num-
ber of observations.
Determining the characteristics of each of the arche-
types can clarify the features of the data set.
Principal component analysis and k-means clustering
Principal component analysis and k-means clustering
were applied to the same data set.
Table 1 List of samples (Continued)
[117-119] Yang_CF333-2007.1 Study 2 CF333 “DK2” 2007 No N/A Late LB 0.5
[120-122] Yang_CF333-2007.2 (m) Study 2 CF333 “DK2” 2007 Yes N/A Late LB 0.5
[123-125] Yang_CF333-2007.3 (m) Study 2 CF333 “DK2” 2007 Yes N/A Late LB 0.5
[126-128] Yang_CF66-2008 Study 2 CF66 “DK2” 2008 No N/A Late LB 0.5
[129-131] SD_CF211-1997 (m) Study 5 CF211 “DK2” 1997 Yes N/A Late LB 1
[132-134] SD_CF211-1997 Study 5 CF211 “DK2” 1997 No N/A Late LB 1
[135-137] SD_CF211-2006 (m) Study 5 CF211 “DK2” 2006 Yes N/A Late LB 1
[138-140] SD_CF211-2006 Study 5 CF211 “DK2” 2006 No N/A Late LB 1
[141-142] Lee_CF30-1992 (m) Study 3 CF30 “DK1” 1973 Yes No Late BB 1
[143-144] Lee_CF30-1992 Study 3 CF30 “DK1” 1973 No No Late BB 1
[145-146] Lee_CF30-2001 (m) Study 3 CF30 “DK1” 2001 Yes No Late BB 1
[147-148] Lee_CF30-2001 Study 3 CF30 “DK1” 2001 No No Late BB 1
[149-150] Lee_CF46-1988 (m) Study 3 CF46 “DK1” 1988 Yes No Late BB 1
[151-152] Lee_CF46-1988 Study 3 CF46 “DK1” 1988 No No Late BB 1
[153-154] Lee_CF46-1997 (m) HYP Study 3 CF46 “DK1” 1997 Yes Yes Late BB 1
[155-156] Lee_CF46-1997 HYP Study 3 CF46 “DK1” 1997 No Yes Late BB 1
[157-158] Lee_CF128-1992 (m) Study 3 CF128 “DK1” 1992 Yes No Late BB 1
[159-160] Lee_CF128-1992 HYP Study 3 CF128 “DK1” 1992 No Yes Late BB 1
[161-162] Lee_CF128-2002 (m) Study 3 CF128 “DK1” 2002 Yes No Late BB 1
[163-164] Lee_CF128-2002 HYP Study 3 CF128 “DK1” 2002 No Yes Late BB 1
[165-167] Hob_1998 Study 4 M “M” 1998 No No Late LB >3
[168–170] Hob_1998 (m) Study 4 M “M” 1998 Yes No Late LB >3
[171-173] Hob_1999 Study 4 M “M” 1999 No No Late LB >3
[174–176] Hob_2001 Study 4 M “M” 2001 No No Late LB >3
[177-179] Hob_1999 HYP Study 4 M “M” 1999 No Yes Late LB >3
[180-182] Hob_2001.1 HYP Study 4 M “M” 2001 No Yes Late LB >3
[183-185] Hob_2001.2 HYP Study 4 M “M” 2001 No Yes Late LB >3
[186-188] Hob_2001.3 HYP Study 4 M “M” 2001 No Yes Late LB >3
1Adaptation state (early or late).
2Growth medium for the experiments: Synthetic Cystic Fibrosis Sputum Medium (SCFSM), Luria-Bertani Broth (LB), or Beef Broth (BB).
3Optical density (OD) at 600 nm during cell harvest.
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where I is the identity matrix and D is a diagonal matrix
with the elements in the diagonal are sorted according
to their magnitude.
In k-means clustering S is constrained to be a binary
assignment matrix such that A = XST (SST)-1 represents
the Euclidean centers of each cluster.
Number of components
For AA, it is necessary to set the number of components
prior to analysis similar to k-means clustering. Our
choice of archetype component was guided by plotting
the explained variance as a function of number of com-
ponents (Figure 2). For the purpose of this study, we
chose to analyze seven components, which kept the num-
ber of components at a minimum while at the same time
explaining a large part (59.3%) of the variance. The stand-
ard deviation between 10 repeated iterations is very low,
which suggests that the solution is robust. The explained
variance for PCA and k-means clustering with seven com-
ponents were 54.4% and 68.4% respectively. As expected,
the PCA model, which is the most flexible of the con-
sidered models, has a higher explained variance than
AA that in turn has a higher explained variance than
the more restricted k-means clustering.
As a quality measure the deviation between the nth
original data point xn and the derived data point
XCsn based on the seven archetypes was calculated.
The measure is given as the Explained Sample Variance






ranging between 0 and 1
where 1 is a perfect match. By evaluating these ESV
values, it is possible to state which data points are well
described by the model. No conclusions should be made
for data points where ESV is low, because these data
points are poorly described by the model.
Figure 2 Explained variance. The explained variance plotted as a function of number of components for principal component analysis (PCA)
archetypal analysis (AA) and k-means clustering (K-means). The plotted values are the mean of 10 repeated iterations. The standard deviations are
indicated with error bars for k-means clustering. The standard deviations for archetypal analysis are very small and therefore not visible.
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Each archetype was characterized based on its specific gene
profile. This was done by identifying genes with statistically
significant transcriptional changes. Genes with more than
a two-fold change in expression value, compared to the
mean expression of the respective gene for all samples,
were indicated as up-regulated whereas genes with less
than 0.5-fold change were indicated as down-regulated.
Genes were assigned to 26 different gene ontology (GO)
classes based on the gene annotation for P. aeruginosa
PAO1 from the Pseudomonas Genome Database [25]. If a
gene was assigned to more than one GO class it was re-
assigned to the most overall GO class (Additional file 1:
Table S1). GO classes that were over-represented within
the group of up-or down-regulated genes were identified
by the Hypergeometric distribution test with significance
level p = 0.01 [26].
Matlab code
The methods mentioned above were implemented in
Matlab unless otherwise stated. The Matlab Code for
AA is available online at http://www.mortenmorup.dk.
This code estimates C and S using a projected gradient
descent iterative approach initialized by the FurthestSum
procedure, for details see also [5]. A brief description of
the Matlab Code is listed in Additional file 2.
Results and discussion
To explore the value of Archetypal Analysis in gene ex-
pression studies, we assembled microarray data from five
separate studies of clinical P. aeruginosa sampled from
CF lung infections [16-19]. These studies measured global
gene expression of different clonal P. aeruginosa isolates
under diverse in vitro growth conditions. The studied
bacterial isolates exhibited different clinically relevant
phenotypes such as mucoidy and hypermutability, were
different clone types, and were isolated from patients
at different time points in relation to disease progression
(Table 1).
Defining archetypes in the data set
AA was performed on a data set with 188 samples in total
(sum of duplicates and triplicates) using the code provided
in [5] and additional codes that are available online (see
Methods section). Seven archetypes were identified for the
integrated data set. The contribution of the individual ar-
chetypes to each sample is visualized as a heat map of the

































































































































































































































































































































Figure 3 Heatmap of archetypal analysis results. A. The relation of each sample to the seven different archetypes shown as a heat map of
the coefficient matrix S. Each row represents one of the archetypes and each column represents a sample. The corresponding studies are listed
above the heat map. The shading indicates how much the individual archetypes contribute to each sample. A strong correlation close to 100% is
black whereas a low or no correlation is white. The white dots that appear in archetype 5 indicate mucoid samples and the white dots that
appear in archetype 6 indicate samples that are hypermutators. B. Phenotypic data i.e. adaptation state (early/late), mucoid/non-mucoid and
hypermutability are indicated. Reference strains (PAO1 and PA14 from study 1 and 2) are categorized as “Early”, but they are distinguished with a
blue color. C. The values of Explained Sample Variance (ESV) are included to show how well the samples are described by the model.
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gene profiles of the seven archetypes is shown in a den-
drogram based on hierarchical clustering (Figure 3).
Archetypal analysis separates study 2 into two groups
representing adapted and non-adapted isolates
respectively
Archetype 1, 2 and 5 represent samples from study 2.
This appears from Figure 3 by these samples having co-
efficients close to one (100%) in one of the three arche-
types. Study 2 is composed of samples that were isolated
from cystic fibrosis patients from the Danish CF clinic
between 1973 and 2008 [17]. The samples from this study
can be divided into two groups; one group representing
isolates from early infection (hereafter referred to as ‘non-
adapted’ isolates), and one group representing isolates from
long-term chronic infection (hereafter referred to as
‘adapted’ isolates). Archetype 1 represents non-adapted iso-
lates from study 2 including the reference strain PAO1 and
an isolate called CF510-2006 that is considered as an an-
cestor to many of the isolates from study 2 [27]. CF510-
2006 has phenotypic characteristics similar to wild type
environmental P. aeruginosa strains [27]. Archetype 2 rep-
resents adapted isolates from study 2. One of the isolates
from study 2 (triplicate samples #78-80) is best explained
by archetype 2, although it was isolated in 1973 and is con-
sidered as an early isolate with respect to time of isolation.
However, from genomic studies of study 2 it is known that
this isolate has two mutations located in the genes rpoN
and mucA and these mutations are common to the
adapted isolates and they are associated with an adapted
phenotype [23]. This isolate therefore can justifiably be
considered to belong to the group of adapted isolates. The
archetypes 1 and 2 thereby successfully cluster study 2 into
two distinct groups based on adaptation level.
Some of the samples from both groups of study 2 are
also, to a greater or lesser degree, based on archetype 5.
These samples all have a mucoid phenotype characterized
by an over-production of alginate. The transition from a
non-mucoid to a mucoid phenotype is often observed dur-
ing adaptation of the bacteria to the CF lung and this shift
is important for establishment of chronic infections [28].
Characterization of archetype 1, 2 and 5
We next studied the up-and down-regulated genes within
each archetype to find patterns that would suggest specific
biological properties associated with archetype 1, 2 and 5.
Figure 4 shows the distribution of significantly up- and
down-regulated genes with respect to GO classes for these
three archetypes. GO classes that were over-represented
within the group of up-or down-regulated genes were
identified by Hypergeometric distribution test [26].
A full list of up-and down-regulated genes for all arche-
types can be found in Additional file 1: Table S1. From
the archetype characterization in Figure 4A, it appears
that the early strains represented by archetype 1 have a
high expression of genes belonging to the GO class
“Motility and Attachment”. At the same time, they have
a low expression of genes related to “Amino acid bio-
synthesis and metabolism”. The adapted strains repre-
sented by archetype 2 are characterized by up-regulation
of genes related to “Antibiotic resistance and suscep-
tibility”, “Two-component regulatory systems” and genes
“Related to phage, transposon and plasmid” (Figure 4B).
Down-regulated genes belong to the functional classes
“Adaptation, Protection” and “Secreted factors”. These ob-
servations are in agreement with earlier studies examin-
ing the phenotypic differences between non-adapted and
adapted isolates [17,23,24,29]. Archetype 5 was primarily
characterized by a strong up-regulation of genes related to
alginate biosynthesis belonging to the GO class “Secreted
factors” (Figure 4C). This is in agreement with the mucoid
phenotype, characterized by overproduction of alginate
that is observed for all the samples that have an apparent
coefficient for this archetype. This archetype is also charac-
terized by up-regulation of many genes encoding hypothet-
ical proteins and down-regulation of genes involved in
“Motility and Attachment” and “Protein secretion”.
AA succeeds in clustering study 2 into biologically
meaningful groups. At the same time, it is easy to ex-
tract biological features important for all groups. So far,
the AA analysis is verified since the characteristics of the
archetypes 1, 2 and 5 are consistent with results from
genotypic and phenotypic studies of study 2 [23].
The identification of these genes thereby validates this
model and we are able to find biological characteristics
of the different samples by analyzing the archetypes.
For each of the archetypes the lists of up-and down-
regulated genes also include genes encoding hypothet-
ical proteins and it is possible that such genes are also
involved in the adaptation process. For archetype 5
there are a large proportion of up-regulated genes be-
longing to the GO class “hypothetical proteins”. Fur-
ther experimental studies are required to understand
the function of these genes and their relation to the adapta-
tion process.
Parallel adaptation processes are observed between
study 1 and study 2
Archetype 3 is defined close to a subset of samples (#1-10)
from study 1. These samples all have the same genotype
(clone A) and they are considered as non-adapted since
they were isolated early during the infection history of
the patient (cf. Table 1) [16]. This archetype is charac-
terized by up-regulation of genes belonging to the GO
classes “Motility and attachment”, “Protein secretion” and
“Secreted factors” and many of these genes are related to
type III secretion and pilin biosynthesis. Archetype 3 is
characterized by down-regulation of “Antibiotic resistance
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and susceptibility” and genes “Related to phage, transposon
and plasmid” (Figure 5A).
Archetype 1 and 3 represent early isolates from study 2
and study 1 respectively. The two archetypes share charac-
teristics with respect to up-regulation of “Motility and at-
tachment” and down-regulation of genes with relation to
“Adaptation and antibiotic resistance”. Hierarchical clus-
tering of the seven archetypes also groups archetype 1 and
3 together shown in a dendrogram in Figure 3A.
Samples #11-15 are the earliest isolates of another
clone (clone B) from study 1 and they are also closely
related to archetype 3. Samples #25-30 represent early
1 Adaptation, Protection
2 Amino acid biosynthesis and metabolism
3 Antibiotic resistance and susceptibility
4 Biosynthesis of cofactors, prosthetic groups and carriers
5 Carbon compound metabolism
6 Cell division
7 Cell wall / LPS / capsule
8 Central intermediary metabolism
9 Chaperones & heat shock proteins
10 Chemotaxis
12 Energy metabolism
13 Fatty acid and phospholipid metabolism
15 Membrane proteins
16 Motility and attachment
17 Nucleotide biosynthesis and metabolism
18 Protein secretion / export apparatus
19 Putative enzymes
20 Related to phage, transposon or plasmid
21 Secreted factors (toxins, enzymes, alginate)
22 Transcription, RNA processing and degradation
23 Transcriptional regulation
25 Transport of small molecules









Figure 4 Characterization of archetype 1, 2 and 5. Number of up-and down-regulated genes within 26 gene ontology classes for archetype 1
(A), archetype 2 (B) and archetype 5 (C). Enriched gene-ontology classes are cross-hatched in green and red for up-and down-regulated genes
respectively. The values on the x-axes are number of genes.
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isolates of two other clones (clone Ca and Cb) from study
1 and they are best described by archetype 3. However,
they also show recognizable coefficients (weak bands in
Figure 3A) for archetype 1, which also indicates the simi-
larity between the non-adapted samples from study 1 and
study 2. This also applies to samples #9-10 that are the lat-
est isolate of the clonal group A from study 1. The refer-
ence strains PA14 and PAO1 are included in study 1 and
they are best described by archetype 1 that also represents
PAO1 samples from study 2. Differences between data
from study 1 and study 2 are therefore most likely to be
due to different clonal lineages more than experimental
differences. Samples #17-24 are late isolates of clone B
from study 1. Unfortunately, the samples are poorly de-
scribed by the model, as indicated by the low ESV values.
However, the samples show similarity to archetype 2
representing the adapted isolates from study 2. Together
these findings suggest that the adaptation processes from
the two studies 1 and 2 are parallel.
Samples #5-6, #9-10, and #27-30 are reported as mu-
coid but they do not appear to be similar to the mucoid
isolates from study 2, where archetype 5 identified all the
1 Adaptation, Protection
2 Amino acid biosynthesis and metabolism
3 Antibiotic resistance and susceptibility
4 Biosynthesis of cofactors, prosthetic groups and carriers
5 Carbon compound metabolism
6 Cell division
7 Cell wall / LPS / capsule
8 Central intermediary metabolism
9 Chaperones & heat shock proteins
10 Chemotaxis
12 Energy metabolism
13 Fatty acid and phospholipid metabolism
15 Membrane proteins
16 Motility and attachment
17 Nucleotide biosynthesis and metabolism
18 Protein secretion / export apparatus
19 Putative enzymes
20 Related to phage, transposon or plasmid
21 Secreted factors (toxins, enzymes, alginate)
22 Transcription, RNA processing and degradation
23 Transcriptional regulation
25 Transport of small molecules









Figure 5 Characterization of archetype 3, 6 and 7. Number of up-and down-regulated genes within 26 gene ontology classes for each
archetype for archetype 3 (A), archetype 6 (B) and archetype 7 (C). Enriched gene-ontology classes are cross-hatched in green and red for
up-and down-regulated genes respectively. The values on the x-axes are number of genes.
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mucoid isolates. However, archetype 5 succeeds in iden-
tifying the mucoid isolates for samples #20, #23-24 (weak
indication) and #33-34.
Archetypal analysis groups the samples from study 5
together with its clonal relatives from study 2 despite
different experimental conditions
Archetype 2 and 5 best describe study 5. The samples
that have a coefficient close to one for archetype 5 are
mucoid and this is consistent to the results for study 2.
The non-mucoid isolates are close to archetype 2, which
represents non-mucoid isolates from study 2 sharing the
same clonal type as the isolates in study 5. This shows
a strong consistency between study 2 and 5, although
study 5 was performed under experimental conditions
similar to those in study 3.
The five analyzed studies were performed under di-
verse experimental conditions including different media
types. We compare the characteristics of the seven de-
scribed archetypes and some of the differences are most
likely due to the effect of the different media. This study
does not account for how the different media alone
affect the transcriptome. However, when we compare the
different archetypes we have seen that the samples cluster
more into groups of clonally related bacteria than into
clusters of samples exposed to the same experimental pro-
cedure e.g. PAO1 in study 1 and study 2 and the samples
from study 2 and study 5. The effect of the diverse media
types does therefore not override the real biological rela-
tion between the bacteria and we justify comparing the
samples from the five studies despite different experimen-
tal procedures. Future investigations of clonally related
bacteria may further examine the effect from the media
alone on the transcriptome.
A single archetype represents hypermutators for study 3
and study 4
Archetype 4 mainly represents study 3. Study 3 is also
composed of samples derived from the Danish CF clinic
representing adapted isolates as for study 2. However,
the samples share another clonal type (DK1) and the ex-
periments are performed under different conditions than
those used for study 2. The differences between arche-
type 2 and 4 are most likely due to clonal differences
more than experimental differences since the same dif-
ferences in experimental conditions did not separate
study 2 and study 5 in this analysis. A plot of enriched
gene ontology classes for archetype 4 similar to plots in
Figure 4 is accessible in Additional file 3. The samples
from study 3 differ from each other as some of them
have a minor recognizable coefficient in archetype 5 or
archetype 6. Archetype 5 represented the mucoid iso-
lates from study 2. All the samples from study 3 that
have a recognizable coefficient for archetype 5 are in fact
mucoid. In this case, knowledge from one study can be
transferred to another study despite the different experi-
mental conditions and clonal types between the two
studies. Archetype 6 represents samples from study 4.
The samples that are closest to this archetype are all
hypermutators.
The samples from study 3 with recognizable coeffi-
cients for archetype 6 are also hypermutators. One of
the hypermutator samples in study 3 is not identified as
having a recognizable coefficient for archetype 6. However,
this sample stands out from the rest of the hypermutators
by also being mucoid. The analysis thereby suggests an
archetype that is able to characterize hypermutators in
general. The similarity of the hypermutators could be due
to similar selective pressures present in the lung environ-
ments of CF patients. This analysis could suggest that the
hypermutators follow the same path of evolution despite
many changes arising as a consequence of mutations.
Hypermutation is often due to mutations in the mutS
or mutL genes that are part of the mismatch repair sys-
tem [30]. The hypermutator trait is often observed for
adapted strains of P. aeruginosa [18,19,31,32] and the
high mutation rate is thought to be advantageous in the
changing host environment due to acceleration of adapta-
tion [18,30]. A reason for the hypermutators to develop a
similar adaptive phenotype, but different from the adapted
non-mutators, could be the chance of obtaining a combin-
ation of multiple adaptive mutations at one time, which is
less likely for strains with a normal mutation rate [32]. An-
other possibility is that the mutS gene or the mutL gene
possesses a regulatory function that is altered due to the
mutation in the respective gene. There is some evidence
that bacteria can sense the missing mismatch repair func-
tion and this will influence transcriptional regulation [33].
This would make a fingerprint on the gene expression
profiles for the hypermutators resulting in similarity be-
tween the gene expression profiles. A third possibility is
that the mutation targets of the hypermutators are biased
due to for example a preference of specific transversions
and transitions and other phenomena [34]. This analysis
suggests that there is a common phenotypic trait between
the hypermutators. The underlying reason needs further
investigation.
Amino acid biosynthesis and metabolism are important
for adaptation to the cystic fibrosis lung
The characteristics of archetype 6 might be used to bet-
ter understand the features shared by the hypermutators.
However, the experimental procedure used for study 4 is
markedly changed since the samples are harvested in
late-logarithmic growth phase (optical density read at
600 nm ≥ 3) compared with exponential growth condi-
tions for study 1, 2, 3 and 5. The observed up-and
down-regulated genes can therefore be ascribed to changes
Thøgersen et al. BMC Bioinformatics 2013, 14:279 Page 11 of 15
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Figure 6 (See legend on next page.)
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during the transition from exponential to stationary growth
phase more than to changes due to accumulated muta-
tions. In order to exclude effects due to the growth phase,
archetype 6 is compared to archetype 7. Both archetypes
represent samples from study 4. Archetype 7 is mainly rep-
resented by non-hypermutators that constitute isogenic
pairs to the samples represented by archetype 6.
For archetype 7 many GO classes are overrepresented
by either up-or downregulated genes (Figure 5C). This is
most likely due to the different growth conditions in
study 4 compared to the other four studies. The profile
of archetype 7 is very different from the other studies
suggesting significant changes in the transcriptome due to
the change in growth conditions. If we consider archetype
6 (Figure 5B), we do not observe the same dramatic
changes. This can also be seen from the dendrogram in
Figure 3 where archetype 6 is closer to the remaining ar-
chetypes than archetype 7. This could indicate that the
hypermutators represented by archetype 6 are not that
sensitive to the changes in growth conditions compared to
the non-mutators, represented by archetype 7. An explan-
ation for this could be that the hypermutators possess mu-
tations in regulatory genes that make the gene expression
less sensitive to the surrounding conditions, in this case
growth phase and cell density.
Archetype 6 is also characterized by up-regulation of
genes involved in the GO-class 2 (‘Amino acid biosyn-
thesis and metabolism’) and down-regulation of genes
from GO-class 4 (‘Biosynthesis of cofactors, prosthetic
groups and carriers’) suggesting that these are important
during adaptation of P. aeruginosa to the CF lung for
the hypermutators.
These findings are to a certain extent similar to what
Hoboth et al. [18] found when comparing hypermutator
isolates with a non-mutator isolate. They also found amino
acid biosynthesis and metabolism to be important for
adaptation together with other metabolic pathways [18].
One difference in the comparison is that they compared
(See figure on previous page.)
Figure 6 Comparison between archetypal analysis, principal component analysis and k-means clustering. Visual representation of a
seven-component analysis using archetypal analysis (AA), principal component analysis (PCA) and k-means clustering (K-means). Explained sample
variance (ESV) for each analysis is included. For each PCA component the contribution to explained variance is indicated. The explained variance
for a seven component analysis is indicated in brackets for each analysis.



































Figure 7 Principal component analysis scatter plot. Each sample is plotted with respect to the loadings of first and second PCA component.
The seven archetypes from archetypal analysis are transformed into the PCA space through a basis transformation. Each Study is indicated with a
specific color. Study 1: GREEN, study 2: CYAN (samples #48-74) and BLUE (samples #75-128), study 3: RED, study 4: MAGENTA, study 5: ORANGE.
The phenotypes are indicated with symbols as “Early”, “Late”, “Mucoid” and “Hypermutator”. The reference strains PAO1 and PA14 from study 1
and 2 are indicated with a symbol as “Reference”.
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the transcriptomic profiles directly, whereas in this analysis
the two proposed archetypal gene expression profiles
for archetype 6 and 7 are compared, where archetype
6 represents hypermutators and archetype 7 represents
non-mutators. We suggest that the characteristics of the
archetype 6 are representative for general hypermutator
characteristics, since archetype 6 accounts for hyper-
mutators across different clonal types and across differ-
ent experimental conditions (study 3 and 4). The gene
expression profile of archetype 6 therefore most likely
can be linked to the hypermutator trait and its influence
on adaptation in the CF lung.
Archetypal analysis supplements principal component
analysis and k-means clustering
Results of k-means clustering and PCA of the data set
are illustrated together with the results of AA in Figure 6.
The results of k-means clustering show how samples are
divided into seven groups. The clustering pattern is similar
to the pattern from AA but each sample is assigned to
only one cluster making k-means clustering rigid com-
pared to AA.
PCA captures most of the explained variance in the
first three components (50.3%). However, the compo-
nents do not give an apparent grouping of samples in
Figure 6. PCA solutions are often visualized by plotting
the first two components in a two-dimensional scatter
plot as shown in Figure 7. Together the first two compo-
nents account for 40.7% of the variance present in the
data set. From the scatter plot it is neither possible to
see any grouping correlated to the mucoid phenotype
nor the hypermutator phenotype as identified by AA.
This illustrates the value of AA compared to PCA. For
the present analysis we were fortunate to know some
phenotypic traits (mucoidy and hypermutability) of the
samples in the data set. These properties were captured
by AA. Even if this information was not available it
would still be possible to suggest similarities within the
data set based on AA. A drawback of AA and k-means
compared to PCA is that the choice of the number of
components influences how the components are defined
while the iterative estimation procedures for extracting
the components may terminate at suboptimal solutions.
As the archetypes are constrained to be convex combi-
nations of the observations AA relies on the presence of
observations that well represent the distinct aspects in
the data.
Conclusions
This is the first time Archetypal Analysis has been ap-
plied to analysis of gene expression data. Seven arche-
types were able to extract the main characteristics of the
dataset. The results show that Archetypal Analysis is
successful in clustering of data into biologically meaningful
groups. At the same time, the analysis is strengthened by
matrix factorization making it possible to describe data
points as a combination of archetypes.
Archetype 1 and 2 represent non-adapted and adapted
isolates respectively, and characterization of the two ar-
chetypes identifies the main changes during adaptation
of the bacteria to the CF lung. In this study, it is shown
that one archetype represents a group of hypermutators
(result of clustering) and other data points share charac-
teristics with this group (result of factorization) enabling
identification of hypermutators from another group. The
analysis provides results that are easy to interpret and
we suggest that this analysis could be used to supple-
ment current methods of gene expression analysis.
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Paper	  1	  -­‐	  Additional	  file	  1:	  List	  of	  up-­‐and	  down-­‐regulated	  genes	  for	  each	  archetype	  	  
(Table	  S1)	  
Available	  online	  at:	  http://www.biomedcentral.com/1471-­‐2105/14/279/additional	  
Paper	  1	  -­‐	  Additional	  file	  2:	  Short description of Matlab scripts	  
GeneArc.m	  
The	  script	  GeneArc.m	   imports	  microarray	  data	   from	  a	  specified	   text	   file.	  This	   text	   file	  contains	   the	  
expression	  matrix	  with	  the	  gene	  expression	  values	   for	  all	  samples.	  The	  number	  of	  components	   for	  
the	  analysis	  should	  be	  given	  as	  input	  before.	  Archetypal	  analysis	  of	  the	  data	  set	  is	  executed.	  The	  A	  
and	  S	  matrices	  are	  computed	  using	  the	  function	  PCHA	  and	  the	  explained	  variance	  for	  the	  analysis	  is	  
calculated.	  PCHA	  was	  described	  by	  Mørup	  and	  Hansen	  (2011),	  and	  Matlab	  code	  is	  available.	  The	  ma-­‐
trix	  S	  is	  illustrated	  as	  a	  heat	  map,	  which	  allows	  easy	  detection	  of	  sample	  clusters.	  Results	  from	  Prin-­‐
cipal	  component	  analysis	  (PCA)	  and	  K-­‐means	  clustering	  are	  also	  displayed	  as	  heat	  maps	  for	  compari-­‐
son.	  
Varexp.m	  
This	  script	  is	  useful	  for	  determination	  of	  number	  of	  components.	  Varexp.m	  calculates	  the	  explained	  
variance	  for	  a	  1	  to	  k	  component	  archetypal	  analysis	  and	  displays	  explained	  variance	  as	  a	  function	  of	  
number	  of	  components.	  The	  maximal	  number	  of	  components,	  k,	  must	  be	  given	  as	  input.	  The	  results	  
are	  displayed	  as	  an	  average	  of	  a	  specified	  number	  of	  runs.	  Similar	  plots	  for	  PCA	  and	  k-­‐means	  cluster-­‐
ing	  are	  made.	  For	  k-­‐means	  clustering	  a	  high	  value	  of	  k	  can	  result	  in	  empty	  clusters,	  which	  will	  inter-­‐
rupt	  the	  calculations.	   In	  this	  case,	  a	  different	  value	  of	  k	  can	  be	  defined	  for	  k-­‐means	  clustering	  and	  
the	  calculations	  can	  proceed.	  
GeneList.m	  
The	  script	  GeneList.m	  finds	  significantly	  up-­‐	  and	  down-­‐regulated	  genes	  for	  each	  archetype	  compared	  
to	  the	  mean	  values	  of	  all	  samples.	  The	  archetypes	  must	  be	  defined	  using	  the	  script	  GeneArc.m	  be-­‐
fore	   this	   script	   is	   applied.	   Genes	   that	   are	   found	   significantly	   up-­‐regulated	   are	   saved	   in	   a	   matrix	  
"Genes_high"	   whereas	   genes	   that	   are	   significantly	   down-­‐regulated	   are	   saved	   in	   a	   matrix	  
"Genes_low".	  In	  addition	  to	  this,	   information	  for	  each	  gene	  can	  be	  extracted	  from	  a	  specified	  data	  
file	   including	  gene	  annotation,	  pathways	  and	  functional	  classes	  belonging	  to	  each	  gene.	  This	   infor-­‐
mation	   is	   saved	   in	   two	  matrices	   called	   "Genes_high_list"	   and	   "Genes_low_list"	   for	  up-­‐	   and	  down-­‐
regulated	  genes	   respectively.	  The	   log2	  expression	  values	  of	   these	  genes	  are	   listed	   in	   two	  matrices	  
called	  "Genes_value_high"	  and	  "Genes_value_low".	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Figure S3-1.  Characterization of Archetype 4.  Number of up- and down-regulated genes within 26 gene 
ontology classes for archetype 4. Enriched gene-ontology classes are high-lighted in green and red for up- and 
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ABSTRACT 34 
Successful bacterial pathogens must satisfy specific metabolic requirements to avoid eradication by the 35 
human host during chronic infections. Identification of metabolic pathways that adapt during the course 36 
of an infection provides novel targets for potential therapeutic intervention, but distilling broad 37 
metabolic changes into specific and targetable mechanistic contributors to adaptation is challenging. We 38 
use long-term Pseudomonas aeruginosa infections in cystic fibrosis patients as a model system to study 39 
this evolutionary process and interrogate adapting metabolic pathways using an integrated 40 
computational and experimental systems approach. Activity in central metabolism of patient isolates 41 
was determined experimentally using growth profiling and isotope-labeling experiments. We developed 42 
isolate-specific genome-scale metabolic models through integration of transcriptomic and genomic data; 43 
these models contextualize our experimental findings from a systems perspective and elucidate specific 44 
and novel pathway adaptations during chronic infections in the CF lung. We find strong experimental 45 
evidence for a shift in metabolism towards fixation of carbon dioxide through reversal of the glycine 46 
cleavage system, which may operate as an alternative redox recycling reaction as supported by our 47 
computational modeling. This particular metabolic shift may be necessary for the bacteria to survive the 48 
oxidative stresses in the human lung environment; we provide support for this hypothesis with 49 
computational predictions of isolate-specific essential genes and altered redox pathway activity. Redox-50 
related metabolic adaptation merits greater consideration as an important enabler of pathogen 51 
persistence and a potential therapeutic target in Pseudomonas aeruginosa and other emerging pathogens. 52 
 53 
IMPORTANCE 54 
While studies of chronic microbial infections have identified virulence factors that contribute to initial 55 
pathogen colonization as well as mutated transcriptional regulators that appear to alter a broad network 56 
of pathways, there is more limited insight into mechanistic metabolic changes that also directly 57 
contribute to successful pathogenesis. Here we study the metabolic adaptation of cystic fibrosis isolates 58 
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of Pseudomonas aeruginosa, a highly problematic nosocomial pathogen known for its resistance to 59 
treatment. We use an integrated framework of systems modeling and experiments to perform a 60 
comprehensive examination of changes in metabolic activity. Our results highlight an array of broad 61 
systemic changes, identify targetable genes that are essential for these changes, and propose important 62 
adaptive changes in redox metabolism through unorthodox activity of the glycine cleavage system as 63 
provider of a novel route of carbon fixation.  64 
 65 
INTRODUCTION 66 
Opportunistic pathogens change their metabolism in response to the conditions they encounter when 67 
they colonize their host. This metabolic reprogramming is facilitated through complex regulatory and 68 
metabolic networks encoded in the genomes of bacterial pathogens. Metabolic adaptation is necessary to 69 
capitalize on available nutrients for growth and survival and such shifts are essential for successful 70 
pathogenesis (1–3). However, the underlying metabolic mechanisms that contribute to colonization and 71 
persistence are unclear in many bacteria and how these metabolic systems develop during pathogen 72 
adaptation remains unknown. The opportunistic pathogen Pseudomonas aeruginosa is an ideal model 73 
system for understanding these processes. It has principally evolved in its natural habitat outside the 74 
human host, where its specific regulatory and metabolic repertoire enables growth in soil and water 75 
environments.  However, during chronic infections with P. aeruginosa in cystic fibrosis (CF) patients, 76 
some clinical P. aeruginosa strains have developed into host-specific organisms by adaptive mutations 77 
that enhance survival in the human lung environment (4, 5).  How these particular P. aeruginosa strains 78 
persist to become the dominant, chronic pathogens in the lung in contrast to other initial infecting 79 
species is poorly understood. Improving our understanding of microbial adaptation to the human host 80 
will have important implications in treatment of infectious disease, development of probiotic therapies, 81 
and other applications.  82 
 83 
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Compared to the natural environment of P. aeruginosa, the host environment is characterized by a 84 
complex and novel combination of stressors that could be mitigated by various adaptive strategies. In the 85 
CF lung, most of the bacterial population grows within CF sputum, which is rich in nutrient sources and 86 
has a low oxygen tension (6–8). Patient airways have elevated numbers of polymorphonuclear 87 
neutrophilic leukocytes (PMNs), alveolar macrophages and antibodies; phagocytosis of bacteria by 88 
PMNs promotes the generation of reactive oxygen species (ROS) by host cells (9). In addition to the 89 
host immune response, P. aeruginosa is exposed to a range of antibiotics during the course of infection 90 
in CF patients and resistance towards antibiotics is a common feature observed for adapted strains (10–91 
12).  92 
 93 
We know from previous studies that adaptation of P. aeruginosa to the CF lung environment involves 94 
many gene regulatory mutations that affect metabolism as well as mutations in metabolic enzymes (4), 95 
but connecting these underlying mechanisms to their global impacts on pathogen behaviour is difficult. 96 
The aim of this study is to identify novel metabolic systems that contribute to successful adaptation of P. 97 
aeruginosa in the host. Specific metabolic pathways that are undergoing changes in activity during the 98 
course of adaptation may be essential for the bacteria in order to persist in the lungs of the patients and 99 
could serve as targets for future antibiotics.  100 
 101 
We identify these pathways of interest using a systems-level computational and experimental approach 102 
to characterize and compare the metabolic activity of clinical bacterial isolates. By integrating and 103 
contextualizing our multi-scale experimental data using a genome-scale computational metabolic model, 104 
we can streamline the prediction and comparison of early and late stage isolate phenotypes to connect 105 
shifts in the activity of a single enzyme to systems-level changes in metabolism. The results have broad 106 
implications in understanding mechanisms underlying pathogen adaptation in chronic infections and 107 
microbial evolution under selective pressures. 108 
Chapter 6 │ Paper 2 	  
	  
PhD Thesis by Juliane C. Thøgersen Page 49 of 121 
 
	  
Metabolic rewiring in adapting human pathogen 
 
Page 5 of 37 
RESULTS  109 
Previously, we studied genomic evolution in an epidemic P. aeruginosa clone type (DK2) during its 110 
dissemination across multiple patients over a 40 year time period (4, 13). The DK2 clone has been 111 
successfully transmitted between patients and replaced previously colonizing P. aeruginosa clone types 112 
(14). Thus, DK2 is highly adapted to the CF airway environment, which likely includes optimization of 113 
its metabolic activity for growth within the CF lung. Here, we use DK2 patient isolates to study 114 
metabolic adaptation, focusing on DK2-WT (which represents the ancestral genotype at the time of first 115 
colonization of the CF niche), and two isolates collected at later stages of clone evolution (DK2-91 and 116 
DK2-07) representing host-adapted isolates. We also included the well-studied reference strain P. 117 
aeruginosa PAO1 (PAO1) (see Materials and Methods for detailed description of the strains). 118 
 119 
Major changes in central metabolism occur during adaptation 120 
Growth experiments with DK2-WT, DK2-91 and DK2-07 in glucose minimal medium showed a 121 
significant reduction in growth rate for DK2-91 (µmax = 0.46 h-1) and DK2-07 (µmax = 0.23 h-1) compared 122 
to DK2-WT (µmax = 0.87 h-1) (Fig. S1). The growth rate of DK2-WT was higher but similar to the 123 
growth rate of PAO1 (µmax = 0.63 h-1). Closer inspection of the growth curves revealed diauxic growth 124 
curves for DK2-91 and DK2-07, which were not observed for PAO1 and DK2-WT. This observation led 125 
us to hypothesize that DK2-91 and DK2-07 excreted one or more metabolites that were later degraded 126 
and metabolized after glucose depletion.  We then measured extracellular metabolites via GC-MS 127 
analysis, (Fig. S2) revealing that the oxidized glucose derivatives gluconate and 2-ketogluconate were 128 
accumulating in the medium for DK2-91 and DK2-07. Gluconate and 2-ketogluconate were not detected 129 
for the reference strain PAO1 and only a small amount of gluconate was detected for DK2-WT. These 130 
results indicate activity in the oxidative route of glucose degradation via gluconate and 2-ketogluconate 131 
for DK2-91 and DK2-07 as an alternative to the phosphorylative route where glucose is phosphorylated 132 
to glucose-6-phosphate (Fig. 1).  133 
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Pseudomonas shifts its metabolism towards fixation of carbon dioxide 134 
To further investigate the central metabolism of P. aeruginosa, we performed substrate-labelling 135 
experiments. We used a mixture of [1-13C]-labelled glucose and [13C6]-labelled glucose. Using 136 
uniformly [13C6]-labelled glucose has been referred to as reciprocal labelling and it is particularly useful 137 
for investigating catabolism of co-substrates (15). By increasing the background labelling of position 2-5 138 
of glucose, incorporation of an unlabelled carbon source (e.g. carbon dioxide) could be detected.  The 139 
[1-13C]-labelled glucose can be used to track activities of different convergent pathways since the 140 
labelled C-atom will end up at different positions in the carbon skeleton of metabolic intermediates 141 
depending on which pathway is used to degrade glucose. This method cannot be used to differentiate 142 
between the phosphorylative and oxidative route of glucose degradation to 6-phosphogluconate (Fig. 1) 143 
since the resulting carbon skeleton of 6-phosphogluconate is the same regardless of the two alternative 144 
routes. However, the method makes it possible to distinguish between the three glycolytic pathways: the 145 
Embden-Meyerhof Parnas (EMP) pathway, the pentose phosphate (PP) pathway and the Entner-146 
Doudoroff (ED) pathway (16). Different labelling patterns of pyruvate occur depending on which 147 
pathway is used to catabolize glucose. By inspecting the labelling patterns of amino acids derived from 148 
pyruvate (Fig. S4), we found that the labelling degree of the carbon atom at position 1 in pyruvate was 149 
around 50% for all strains grown in 100% [1-13C]-glucose indicating that most if not all glucose was 150 
degraded through the ED pathway. It is well known that the EMP pathway is inactive in Pseudomonas 151 
species due to a missing enzyme and the PP pathway has previously been found only to serve 152 
biosynthetic purposes for other Pseudomonas species including P. putida and P. fluorescens (17–20).   153 
 154 
When we further examined the labelling patterns of amino acids derived from central metabolites from 155 
the combined [1-13C]-glucose and 13C6-glucose experiment, we found that glycine had a significantly 156 
lower labelling degree than the labelled carbon substrate the cells were growing on for all strains (Fig. 157 
2A). This observation was most noteworthy for DK2-91 and DK2-07. The minimal medium contained 158 
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56% 13C6-glucose and 44% [1-13C]-glucose and we would therefore expect the average labelling degree 159 
for each carbon atom to be 56% at minimum. Surprisingly, the data showed that the carbon atoms in 160 
glycine had an average labelling degree of approximately 30% for DK2-91 and DK2-07 compared to 161 
approximately 50% for PAO1 and DK2-WT; all were significantly lower than 56%. Since the labelled 162 
substrate was the only carbon source available for the cells in the experiment, we hypothesized that the 163 
cells have the capacity to fix carbon through glycine metabolism.  164 
 165 
A literature search identified instances of non-canonical reversal of the glycine cleavage system (GCS) 166 
in Clostridia species (21),  using CO2 as a carbon source for the synthesis of glycine. To test this, we 167 
added 13C-labeled bicarbonate into a growing culture in minimal medium with unlabelled glucose. Since 168 
the bicarbonate was the only source of the 13C isotope (except for 1.1% natural prevalence), any excess 169 
labelling on glycine would indicate CO2 fixation. Bicarbonate was added during exponential growth and 170 
DK2-91 and PAO1 cells were harvested after one and two generation times. The results were a 171 
qualitative measure of the ability of the cells to fix CO2 (see Materials and Methods). Fig. 2B shows the 172 
labelling patterns of glycine for PAO1 and DK2-91 from the 13C-bicarbonate experiment. We find a 173 
significant enrichment of 13C in glycine for both PAO1 and DK2-91 one generation time after 13C-174 
bicarbonate addition and for PAO1 the same observation was made after two generation times. Based on 175 
these results we confirmed that CO2 could be fixed into glycine when P. aeruginosa is growing in 176 
glucose minimal medium. No significant enrichment of 13C-isotope was measured after two generation 177 
times in DK2-91, but since the generation time of DK2-91 is 1.4 fold longer than PAO1, dilution and 178 
vaporization of 13C-bicarbonate during the course of the experiment can account for this difference. We 179 
included the labelling patterns of serine in Fig. 2C since serine can be produced from glycine. We find a 180 
significant enrichment of the 13C-isotope for DK2-91 harvested two generation times after 13C-181 
bicarbonate addition. The lack of 13C-labeling in serine for the other samples confirms that carbon 182 
dioxide is fixed directly into glycine and not into upstream metabolic intermediates in glycolysis, since 183 
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otherwise we would expect at least the same degree of labelling in serine as for glycine. In conclusion, 184 
we find that the Pseudomonas strains are incorporating carbon dioxide into glycine and under normal 185 
laboratory conditions with normal carbon dioxide pressure in glucose minimal medium (Fig. 2A), this 186 
observation is more pronounced in DK2-91 and DK2-07 compared to DK2-WT and PAO1. Our 187 
experimental analysis of central metabolism therefore resulted in two specific findings related to 188 
metabolic adaptation in the late stage isolates: (1) metabolism is shifted towards excretion of gluconate 189 
and 2-ketogluconate and (2) the activity of the glycine cleavage system is altered to enable fixation of 190 
carbon dioxide in a non-canonical reversal of associated pathways. 191 
 192 
The glycine cleavage system may operate as an alternative redox recycling reaction 193 
The ability of P. aeruginosa to fix carbon dioxide into glycine has not been reported previously, and 194 
alterations in glycine synthesis indicated by our labelling experiments support our hypothesis that 195 
carbon fixation is occurring through the glycine cleavage system (Fig. 2D) (21). A potential selective 196 
advantage for the activity of this altered glycine synthesis route may be linked to the regeneration of 197 
NAD+ from NADH coupled to this reaction. We propose that this unconventional pathway phenotype 198 
operates as an electron sink for the recycling of reduced electron carriers, alleviating redox stress as also 199 
suggested for some anaerobic bacteria (21). Different factors in the lung environment may contribute to 200 
redox stress in P. aeruginosa including oxidative stress from immune system defenses and low 201 
availability of electron acceptors. The relative contribution of antibiotic exposure to increased oxidative 202 
stress in bacteria is currently under debate (22, 23), but most recently, Dwyer et al. (24) provided 203 
evidence for antibiotic-induced redox alterations in E. coli. We cannot specify whether the source of 204 
redox stress is limited oxygen, antibiotic exposure or the immune defense within the CF lung; it is 205 
possibly a combination of all three factors. However, we hypothesize that the impact of these stressors is 206 
substantial, driving the enhanced carbon fixation into glycine for the late-stage clinical isolates and 207 
therefore improving the balance of redox equivalents. 208 
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Metabolic models evaluate the feasibility of adapted redox metabolism 209 
In light of our experimental observations, we focused our studies on the global effects of our proposed 210 
isolate-specific phenotypes of glycine metabolism via a well-curated and recently updated genome-scale 211 
metabolic model of P. aeruginosa, iPA1139 (http://bme.virginia.edu/csbl/downloads-pseudomonas-212 
v3.php). This approach allowed us to systematically evaluate our observed phenotypes in context with 213 
model-integrated transcriptomics and sequencing data. Our experimental examination of glycine 214 
metabolism supports non-canonical activity for two connected routes of carbon fixation: glycine 215 
dehydrogenase and formate dehydrogenase (as shown in Fig. 2D). To create isolate-specific models 216 
using iPA1139, we first altered the possible activity of the glycine cleavage system and formate 217 
dehydrogenase (both canonically modelled in the forward direction); we allowed these reactions to run 218 
only in the reverse direction in our in silico models of DK2-91 and DK2-07 (mDK2-91 and mDK2-07) 219 
while they were modelled as reversible in our in silico model of DK2-WT (mDK2-WT) and the base 220 
model (iPA1139) during our data integration process. This enabled us to evaluate the feasibility and 221 
systemic impacts of the novel carbon fixation phenotypes indicated by our labelling experiments.  222 
 223 
We additionally constrained the models to replicate isolate-specific phenotypes in our experimental 224 
conditions by integrating isolate-specific single nucleotide polymorphisms (SNP) and transcriptome data 225 
collected during growth on glucose minimal medium; this effort substantially expands our data 226 
integration approach from our earlier study of metabolic activity within CF isolates using a previous 227 
genome-scale model of P. aeruginosa (25). In brief, a SNP introducing a nonsense mutation in a given 228 
gene resulted in inactivation of that gene in the model; the Sorting Intolerant From Tolerant (SIFT) 229 
algorithm (26) was used to predict the functional impact of other SNPs resulting in missense mutations. 230 
These data were interpreted as “levels” of gene activity reduction (minimal, moderate, or maximal) 231 
implemented in context with transcriptome expression levels (off, potentially active, on) consistent with 232 
the gene-protein-reaction relationships to develop activity constraints for associated reactions (further 233 
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details of our constraint-based integration of SNP and transcriptome data are described in Materials and 234 
Methods). These methods resulted in isolate-specific models that are consistent with the substantial 235 
activity changes in pathways suggested by our experimental observations, and also enabled prediction of 236 
activity changes that were not highlighted by analysis of the in vitro data. 237 
 238 
Constrained purine metabolism activity contributes to improved redox balance during adaptation  239 
Results from the constraint-based flux modelling support the feasibility of alterations in glycine 240 
metabolism that result in novel carbon fixation; our isolate-specific models predict comparable levels of 241 
optimal biomass production regardless of GCS and formate dehydrogenase directionality. We 242 
hypothesized that the experimental phenotypes shown by the late stage isolates might indicate a shift 243 
from aerobic growth with high biomass production to microaerobic conditions where redox cofactor 244 
recycling was prioritized in addition to biomass production. Given our additional experimental evidence 245 
for a novel route of CO2 fixation, we evaluated the effects of limitations of O2 and CO2 uptake and 246 
biomass production levels on the ability for each strain model to produce redox cofactors. We 247 
specifically compared the ratio of maximized NADH vs. NAD+ production fluxes under varied uptake 248 
constraints and growth requirements for mDK2-WT and mDK2-07, as shown in Fig. 3A. mDK2-07 249 
predicts a stable redox cofactor production ratio across varied O2 and CO2 uptake conditions while the 250 
redox ratio of mDK2-WT varies with O2 uptake, CO2 fixation, and biomass production.  251 
 252 
To identify contributors to these differential predictions between mDK2-WT and mDK2-07, we 253 
modulated the gene and SNP-based constraints applied to each model. We identified the restriction of 254 
the purine metabolism enzyme phosphoribosylformylglycinamidine synthase (purL) due to an applied 255 
SNP constraint (Dataset S1) as the main contributor to the stability of the redox ratio in mDK2-07. 256 
While mDK2-WT has several SNPs resulting in model reaction constraints including a SNP affecting 257 
GMP synthase (guaA) that also plays a role in purine metabolism, a SNP in purL is not present and thus 258 
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the associated activity of this reaction is unconstrained. We were surprised to find that a single SNP 259 
contributed so substantially to this phenotype of a stable redox ratio under varying uptake and growth 260 
constraints; further investigation of our model identified the functional relationship between glycine 261 
metabolism and purL as shown in Fig. 3B, which is a non-canonical mapping of pathways that usually 262 
would not be obviously linked together. By incrementally increasing the constraints applied to the 263 
phosphoribosylformylglycinamidine synthase reaction due to the SNP in purL from unconstrained 264 
(mDK2-WT phenotype) to the moderate constraints applied in mDK2-07, we showed that the redox 265 
ratio of mDK2-07 transitions to a balanced state as purL activity is constrained. The graded impact on 266 
redox metabolism due to the purL constraint is clear in microaerobic conditions at low levels of CO2 267 
uptake; high biomass production requirements magnify the impact of purL constraints on the transition 268 
to a balanced redox state. We propose that the close connections between the altered glycine metabolism 269 
reactions and purL as shown in Fig. 3B support the potential role of purL as a modulator of redox 270 
recycling via reversal of the glycine cleavage pathway. Our original constraints based on the SIFT 271 
predictions of SNP impact in purL were a broad estimate of how function might be altered; further fine-272 
tuning may reflect the actual degree of impact of the SNP in connection to the experimentally-observed 273 
phenotype. Ultimately, our models predict that the purL SNP is tightly tied to improved redox balance 274 
via novel CO2 fixation in the late stage isolates.  275 
 276 
Many metabolic systems may contribute to the redox balance of a cell in addition to the contributions 277 
we have shown from glycine and purine metabolism. Using flux variability analysis (FVA) (27) we 278 
evaluated potential changes in redox metabolism by comparing changes in reaction activity within 279 
reactions where redox cofactors (here defined as NAD+, NADH, NADP+, NADPH, FAD+, and/or 280 
FADH) participate versus changes in reaction activity across all reactions as shown in “FVA activity 281 
analysis” in Dataset S2. We then used a global metric of total flux activity (the sum of the ranges 282 
between minimum and maximum potential flux predicted for all reactions using FVA in a given model 283 
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divided by the same calculation performed for iPA1139) for each isolate model normalized by the same 284 
measure in iPA1139. Albeit a coarse representation of “metabolic capability” of the network, this metric 285 
provides a single snapshot of changes in metabolism as a function of changes in the underlying network 286 
characteristics. The late stage models predict 73.2% and 74.7% of the iPA1139 global activity metric 287 
compared to 69% by mDK2-WT, indicating a total flux activity increase in mDK2-91 and mDK2-07 288 
compared to mDK2-WT with this global metabolic metric. However, the late stage models predict 85% 289 
and 84.4% of the iPA1139 redox activity metric compared to 90.1% by mDK2-WT within the subset of 290 
reactions that utilize redox cofactors, showing a reduction in the redox-related flux activity of the late 291 
stage strain models compared to mDK2-WT. We interpret these opposing changes between global and 292 
redox metabolism potential activity as an indication of systemic shifts in redox-related reaction activity 293 
between the wild-type and late stage isolates.   294 
 295 
Genome-scale metabolic modelling contextualizes global metabolic changes 296 
The isolate-specific metabolic models allow us to evaluate altered activity across a far greater expanse 297 
of metabolic systems than just glucose and glycine metabolism. They account for the effects of other 298 
SNPs in addition to the purL SNP that we previously highlighted as well as the reprogramming of the 299 
transcriptome due to adapted regulation and/or mutation. We can readily perturb specific genes and 300 
reactions computationally to investigate both the underlying drivers and potential consequences of 301 
genetic and transcriptomic adaptations at the genome scale. Here, we performed routine predictions of 302 
essential genes and flux variability that are often used to identify novel treatment targets by prioritizing 303 
genes and reactions important for growth (28). Our results indicate broad systemic rewiring in the late 304 
stage isolates that both complement our conclusions about glycine and redox metabolism as well as 305 
highlight other potential therapeutic targets important to adaptation during adaptation to a host 306 
environment. 307 
 308 
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Essential metabolic activity alters during adaptation 309 
The isolate-specific models enable us to evaluate genes essential to strain growth phenotypes in glucose 310 
minimal medium by inactivating a given gene in the models and then predicting maximum possible 311 
growth in silico. Fig. 4 shows a Venn diagram categorizing all essential genes across our base model 312 
iPA1139, mDK2-WT, mDK2-91, and mDK2-07 together with a stacked histogram of reactions 313 
associated with the DK2-specific essential genes. The full list of essential genes is available in Dataset 314 
S2. 315 
 316 
Isolate-specific SNPs were located in six genes predicted to be essential for growth in all models.  Of 317 
these, constraints applied due to the SNP in PA3769, encoding GMP synthase (guaA), were the main 318 
driver of reduced in silico growth in mDK2-WT compared to the base model; constraints applied due to 319 
a SNP in PA1609, encoding beta-ketoacyl-ACP synthase I (fabB), affected growth to a lesser degree in 320 
the same strain. In contrast, constraints based on the purL SNP located in PA3763 were the main driver 321 
of reduced in silico growth in mDK2-91 and mDK2-07. The presence of SNPs in these genes predicted 322 
to be critical in metabolic activity according to our computational models adds emphasis to their 323 
potential importance to adaptive selection during infection. 324 
 325 
While an array of interesting pathways have altered gene essentiality between strains, we found the 326 
changes in glucose metabolism, glycine metabolism, and oxidative phosphorylation as indicated in Fig. 327 
4B to be of particular interest when compared with the results of our previous experiments. These 328 
changes are the result of integrating SNP and expression data into our models; we therefore can identify 329 
the experimental data underlying the specific constraints that contribute to these gains in gene 330 
essentiality. Upregulated pentose phosphate pathway genes in DK2-91 and DK2-07 contribute to 331 
differences in essentiality predicted by the late stage isolate models, highlighting adaptation in glucose 332 
metabolism. Select glycine cleavage system genes are essential in mDK2-07 due to expression-based 333 
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constraints; glycine dehydrogenase is identified as an essential reaction in mDK2-91 and mDK2-07 in 334 
contrast to mDK2-WT for similar reasons. In oxidative phosphorylation, there is a switch in preferred 335 
cytochrome complexes in oxidative phosphorylation between model mDK2-WT and mDK2-91, which 336 
rely on cytochrome bc1 complex genes (PA4429-4431), while model mDK2-07 relies on cytochrome c 337 
oxidase genes (PA1317-1321). This phenotype results from transcriptomic changes in DK2-91 and 338 
DK2-07 compared to DK2-WT in glucose minimal medium that shows significant downregulation of 339 
the nuo operon encoding NADH dehydrogenase (complex I of the electron chain) in the late stage 340 
isolates (Dataset S3). The lack of active oxidative phosphorylation could explain the need for alternative 341 
redox recycling reactions such as glycine synthesis through the glycine cleavage system. These 342 
hypotheses regarding mechanistic drivers of altered essentiality between strains are a key contribution 343 
enabled by our integrated systems approach. Identifying the strain-specific genes important to the 344 
adaptations occurring in the DK2 lineage allows us to highlight functionally impactful SNPs and offer 345 
specific, novel treatment targets within key pathways reprogrammed during evolution within the host.   346 
 347 
Changes in pathway activity highlight adapting systems 348 
We evaluated the results of flux variability analysis that predicts the minimum and maximum levels of a 349 
reaction’s flux while maintaining maximum biomass production; this enables calculation of the range of 350 
potential activity for a given reaction. Fig. 5 shows a full-scale map of the metabolic network where 351 
directional differences in adapting reaction activity in mDK2-WT and mDK2-07 are identified by 352 
reaction colour and dashed lines identify SNPs in associated reactions. Decreases in the range of 353 
reaction activity likely indicate a SNP- or gene expression-associated constraint, while increases in 354 
range could be interpreted as increased flexibility of this pathway that is required to enable the 355 
expression-associated constraints or produce necessary biomass components by an alternate pathway; 356 
broadly, altered range in either direction may indicate areas of potentially important metabolic 357 
adaptation.  358 
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Notable trends visualized on the map include increased constraint of "Purine metabolism" flexibility in 359 
mDK2-07 and changes in range of reaction activity in "Glycine, serine & threonine metabolism". These 360 
specific metabolic pathways were also identified through our study of central metabolism. However, the 361 
network map includes a list of additional metabolic pathways with differential activity including 362 
pathways related to "Lysine degradation", "Folate metabolism", "Valine, leucine, and isoleucine 363 
degradation", "Pyrimidine metabolism", and "Histidine metabolism". The mentioned pathways showed 364 
the highest degree of altered system activity in comparisons between early and late stage isolates (see 365 
Materials and Methods). Our systems analysis highlights areas of potential adaptation due to SNPs and 366 
altered transcriptomics in a broad array of pathways, suggesting new avenues of future experimental 367 
investigation that could elucidate other important mechanisms of adaptation in addition to our novel 368 
relationship between altered carbon fixation and redox metabolism. 369 
 370 
DISCUSSION  371 
In this study we have used a systems biology approach to investigate metabolic behaviour during 372 
adaptation of a pathogen to the human host. We used genome-scale metabolic models integrated with 373 
high throughput data to evaluate the feasibility and potential impacts of novel metabolic adaptations 374 
suggested by experimental characterization of glucose metabolism in P. aeruginosa clinical isolates. 375 
There is value in evaluating both broad changes in high level systems and specific, detailed molecular 376 
mechanisms using systems biology approaches; the former enables the prediction of systemic network 377 
production and quantification of network elements while the latter offers specific hypotheses regarding 378 
functional roles of the smallest network components (29). Here, we provide a systems level perspective 379 
of key pathways connected to metabolic adaptation, but focus our analysis on specific systems suggested 380 
by targeted experiments that indicated major changes in metabolism between initial infecting strains of 381 
P. aeruginosa and late-stage clinical isolates. We confirmed that the ED pathway is the only active 382 
glycolytic pathway in P. aeruginosa, consistent with other Pseudomonas species. Experimental profiling 383 
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identified a transition towards accumulation of gluconate and 2-ketogluconate and enhanced fixation of 384 
carbon dioxide into glycine specifically in the late stage isolates. Computational modelling supported the 385 
feasibility of reversed utilization of the glycine cleavage system, enabling a novel route of carbon 386 
fixation that in combination with a previously inconspicuous mutation in purine metabolism contributed 387 
to improved redox balance in the late stage isolates. We identify genes and pathways key to the adaptive 388 
processes we see in the DK2 lineage using gene essentiality and flux variability analysis, which may 389 
contribute to the design of novel treatment strategies. Our approach results in a metabolic map that 390 
provides mechanistic insight into how SNP and transcriptional changes affect metabolism at a genome 391 
scale, bridging the difficult gap between molecular mechanisms and broad, system-wide adaptation and 392 
prioritizing novel areas of metabolic reprogramming that can be targeted therapeutically. 393 
 394 
The production of gluconate has previously been observed for clinical isolates of P. aeruginosa. 395 
Behrends et al. (30) found that gluconate excretion is associated with higher tolerance towards 396 
antibiotics and another study by Galet et al. (31) found that gluconate produced by P. aeruginosa 397 
inhibits production of an antibiotic in Streptomyces coelicolor. In the context of the above analysis 398 
indicating the shift in redox balancing, it might also be possible that the accumulation of gluconate and 399 
2-ketogluconate is driven by the production of two equivalents of NADPH coupled to the oxidation 400 
reactions of glucose to 2-ketogluconate via gluconate in the periplasmic space (Fig. 1). This suggestion 401 
is not necessarily in disagreement with the correlation between gluconate and antibiotic resistance since 402 
there may also be a link between NADPH generation and antibiotic resistance given the literature on 403 
antibiotics and oxidative stress (32, 33). The identification of the ED pathway as the only active 404 
glycolytic route in P. aeruginosa can also be linked to generation of NADPH. The ED pathway is found 405 
to be essential for glucose metabolism in other Pseudomonas species; in P. putida, its activity has 406 
recently been associated with resistance towards oxidative stress (20). The activity of these pathways 407 
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can thereby be a mechanism to accommodate the conditions within the lung environment including both 408 
antibiotics and ROS generated by PMNs, both of which are sources of oxidative stress.  409 
 410 
The genome scale models support the potential for novel carbon fixation routes in the late stage isolates; 411 
they also enable us to connect the late stage isolate glycine metabolism phenotype and altered redox 412 
balance in microaerobic conditions to a specific SNP in purine metabolism through network analysis. A 413 
study by Ryssel et al. (34) recently identified upregulated purine metabolism activity as a contributor to 414 
poor stress response in Lactococcus lactis, citing the production of guanine nucleotides in inducing 415 
stress sensitivity (34) while a prior study had noted the essentiality of purine synthesis in  Escherichia 416 
coli during blood infections (35). To our knowledge, adaptation in purine metabolism has not been 417 
identified as noteworthy in cystic fibrosis infections; we evaluated published genotyping studies of 418 
cystic fibrosis isolates and identified purine SNPs in other clinical isolates (36). We suggest that altered 419 
purine metabolism may be tied to the reversal of the glycine cleavage system and contributes to resultant 420 
altered redox physiology. Whether the purL SNP also contributes to the need for glycine production via 421 
the GCS or is a simple way to modulate effects of the reversed GCS phenotype is currently uncertain. 422 
However, it is likely that the downregulated oxidative phosphorylation highlighted by our late stage 423 
isolate gene essentiality predictions is a way to avoid generation of oxygen radicals through the electron 424 
chain. The bacteria therefore need to redirect the metabolic flux through the glycine cleavage system to 425 
ensure regeneration of NAD+ that is used in glycolysis.  426 
 427 
Our hypothesis regarding the role of the glycine cleavage system as an important mediator of successful 428 
adaptation in P. aeruginosa led to our investigation of other cases where the glycine cleavage system is 429 
important. The glycine cleavage system is not only present in bacteria but is present across all domains 430 
of life (21). In cancer cells, elevated activity of the glycine cleavage system has been associated with 431 
tumorigenesis; glycine decarboxylase activity was correlated with reduced survival of patients with lung 432 
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cancer (37).  Further investigation of the GCS in other bacterial pathogens and disordered human cells 433 
such as cancer cells may merit evaluation of a potential reversal of the pathway that enables beneficial 434 
adaptation in redox metabolism during cell proliferation in stressful environments. 435 
 436 
Changes in metabolism in P. aeruginosa during adaptation have previously been considered as 437 
pleiotropic effects of regulatory actions on other targets, such as virulence factor production (38, 39). 438 
Here, we suggest that changes in metabolism are a direct target of adaptation and a driving force is 439 
selection for improved redox balance. Our systems-based analysis highlights important genes and 440 
metabolic activities involved in these adaptive processes, proposing specific pathways for novel 441 
therapeutic measures that could be used to pre-emptively combat an organism’s evolutionary goals such 442 
as rewired redox metabolism. We suggest a concrete example of redox balancing through the glycine 443 
cleavage system, identifying a future target of interest for unwanted cell growth in the human body. 444 
 445 
MATERIALS AND METHODS 446 
 447 
Pseudomonas aeruginosa strains used in this study  448 
We selected three isolates of the DK2 clone type for our analysis. Two of them, DK2-91 and DK2-07, 449 
are late-stage clinical isolates isolated from the same patient in 1991 and 2007, respectively (DK2-91 450 
and DK2-07 are referred to as CF333-1991 and CF333-2007 respectively in (14)). The third isolate, 451 
DK2-WT (referred to as CF510-2006 in (13)) also shares the DK2 clone type, but has a phenotype 452 
similar to strains isolated from outside the CF lung (P. aeruginosa PAO1 (40) and P. aeruginosa PA14 453 
(41)) and its genotype is similar to the predicted most common recent ancestor for DK2 dated back to 454 
1970 (13). DK2-WT therefore resembles a non-adapted isolate of DK2 and this isolate serves as our 455 
point of reference for the DK2 lineage. Other early isolates of the DK2-lineage collected in the early 456 
1970s exist. However, we chose DK2-WT as our reference for the DK2 lineage since its phylogenetic 457 
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branching from the most common recent ancestor is distinct from the adaptation path of DK2-91 and 458 
DK2-07 in contrast to the other early isolates. We therefore expect to capture most adaptive events in 459 
DK2-91 and DK2-07 by comparing to DK2-WT. P. aeruginosa PAO1 (PAO1) is also included as 460 
reference throughout most of our experimental and in silico analyses. PAO1 was originally isolated from 461 
a burn wound (40) and has been widely used as a reference strain for studies of P. aeruginosa. 462 
 463 
Cell storage and cultivation  464 
Cells were stored at -80°C in a 20% glycerol solution. DK2-91 and DK2-07 were streaked on a Luria-465 
Bertani (LB) agar plate and incubated at 37°C for 48 hours. Individual colonies were inoculated in 10 466 
mL of morpholinepropanesulfonic acid (MOPS)-buffered medium supplemented with glucose and 467 
grown aerobically at 37°C for 24-36 hours (depending on growth rate). The total composition of the 468 
MOPS minimal medium was 40 mM MOPS, 9.5 mM NH4Cl, 0.28 mM K2SO4, 1.3 mM KH2PO4, 10 469 
mM glucose and vitamins (0.4 µM biotin, 10 µM pyroxidal-HCl, 2.3 µM folic acid, 2.6 µM riboflavin, 8 470 
µM niacinamide, 3 µM thiamine-HCl and 2 µM pantotheneate) (42). 471 
DK2-WT and PA01 were streaked on LB agar plates and incubated at 37°C for 24 hours. Individual 472 
colonies were inoculated in 10 mL of MOPS minimal medium supplemented with glucose and grown 473 
aerobically at 37°C for 16 hours. After initial incubation cells were transferred to a 250 mL baffled flask 474 
with 50 mL MOPS minimal medium supplemented with 10 mM of defined carbon source to an optical 475 
density (OD600) of 0.01 measured at 600 nm.  476 
Cell growth was determined by measuring OD600 during growth. Cells were harvested for GC-MS and 477 
DNA microarray analyses at OD600 = 0.4 during the exponential growth phase. Supernatant was 478 
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Biomass yield calculations 483 
Glucose concentrations were determined enzymatically using a glucose reagent (catalogue no. 7200-484 
017A, from Thermo Electron, Australia). The dry weight biomass concentration was estimated using a 485 
correlation factor of 0.360 g cellular dry weight per OD unit. This correlation factor was determined for 486 
an Escherichia coli strain (43) and is assumed to be valid for P. aeruginosa. The biomass yield on 487 
glucose was determined using the concentration data for biomass and glucose, respectively. 488 
 489 
Labelling experiments 490 
The experimental protocol for labelling determination was modified from (44). Cells were grown in 491 
MOPS minimal medium to an OD600 of 0.4. 10 mM [1-13C]-glucose (D-glucose-13C, 99% 13C, from 492 
Isotec, Miamisburg, Ohio, USA, CAS no. 297046) was used as a carbon source. For some experiments, 493 
a mixture of 44 mol-% [1-13C]-glucose and 56 mol-% 13C6 glucose (D-glucose-13C6, 99 % 13C, from 494 
Isotec, Miamisburg, Ohio, USA, CAS no. 110187-42-3) were used to give a final glucose concentration 495 
of 10 mM. 496 
30 ml culture was harvested and the samples were spun down for 10 minutes at 5,000 rpm at 4°C. The 497 
pellet was resuspended in 2 mL 0.9 % NaCl and the volume was divided into two Eppendorf tubes. The 498 
Eppendorf tubes were further spun down for two minutes at 10,000 rpm at 4°C and the pellets were 499 
finally stored at -80°C until hydrolysis and subsequent derivatization and amino acid analysis by GC-500 
MS. The supernatant was stored in 4 individual Eppendorf tubes of 1 mL at -80°C for later GC-MS 501 
analysis of extracellular metabolites. Proteinogenic amino acid analysis from 13C-labeled biomass and 502 
GC-MS analysis for extracellular are fully described in Supplemental Text S1. 503 
 504 
Testing for CO2 incorporation into glycine 505 
PAO1 and DK2-91 were grown in MOPS minimal medium supplemented with 10 mM unlabelled 506 
glucose. At OD600=0.01 20 mM of NaH13CO3 was added. Cells were harvested at OD600=0.2 and 507 
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OD600=0.4 and labelling patterns of amino acids were determined as described above. We chose PAO1 508 
instead of DK2-WT to find out if the potential of carbon fixation into glycine is general for P. 509 
aeruginosa or just a feature of the DK2 lineage. We chose DK2-91 to represent the late-stage clinical 510 
isolates, since the growth rate of DK2-91 was higher than that for DK2-07 (slow growth of the cells 511 
would allow more bicarbonate to vaporize before cell harvest). We used a high concentration of 512 
bicarbonate (20 mM) to make sure that some bicarbonate would remain in the medium at the time of 513 
harvesting despite dilution with unlabelled bicarbonate/carbon dioxide and vaporization. Ideally, the 514 
experiment would be carried out with concentrations of bicarbonate and carbon dioxide corresponding 515 
to the initial experiments. However, the labelled bicarbonate and carbon dioxide would be diluted out 516 
from unlabelled carbon dioxide produced under glycolysis in the growing culture. Therefore this 517 
experimental setup only addresses the question whether carbon dioxide is fixated in glycine synthesis 518 
and the results cannot be used quantitatively.  519 
 520 
DNA microarray analysis 521 
Cells were grown in MOPS minimal medium supplemented with 10 mM glucose to an OD600 of 0.4 522 
prior to Affymetrix P. aeruginosa GeneChip microarray analysis. Microarray data were generated using 523 
Affymetrix protocols as previously described (4). Data processing was carried out according to 524 
Thøgersen et al, 2013 (46). The raw cel-files were extracted in R by use of the package affy (47) 525 
followed by qspline normalization (48) and calculation of gene expression index values using robust 526 
multiarray average expression measure (49). Differentially expressed genes for DK2-91 and DK2-07 527 
compared to DK2-WT were determined with Bonferroni adjusted p-values (significance level p=0.05) 528 
using the R package "limma" (50). Enriched gene ontology classes among differentially expressed genes 529 
were identified by the Hypergeometric distribution test with significance level p = 0.01. 530 
 531 
 532 
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Sorting Intolerant from Tolerant (SIFT) Analysis of SNPs 533 
The SNP data were obtained from previous studies of the DK2-WT, DK2-91 and DK2-07 strains (4, 534 
13). Strain specific SNPs are listed in Dataset S1 including our SIFT (Sorting Intolerant From Tolerant 535 
(26)) analysis of missense mutations in metabolic genes. The SIFT analysis is used to predict if a 536 
missense mutation would affect protein function of the given gene product, providing numeric scores 537 
that indicate the degree to which a missense SNP is tolerated or affects protein function. 538 
 539 
Isolate-specific genome-scale metabolic models 540 
The genome scale metabolic reconstruction for P. aeruginosa PAO1, iPA1139, was used as the base for 541 
all computational modelling in this study. This model accounts for the function of 1139 genes, 1491 542 
reactions, and 1280 metabolites involved in the metabolism of P. aeruginosa. Isolate-specific genome-543 
scale metabolic models were created by a semi-automated approach in order to incorporate both SNP 544 
and gene expression-based constraints using the TIGER Toolbox 1.2.0 (51, 52). Further details on 545 
construction of the isolate specific models are included in Supplemental text S1, the resulting isolate 546 
specific models are included in Dataset S4, and base model iPA1139 and SBML versions of the isolate-547 
specific models are available at http://bme.virginia.edu/csbl/downloads-pseudomonas-v3.php. 548 
 549 
The isolate specific models were then used to evaluate metabolic activity using several methods of 550 
constraint-based modelling. Flux balance analysis (FBA) was used to predict the ability of each isolate 551 
model to grow (produce biomass) in ‘wild type’ conditions as well as with single genes deleted to 552 
identify in silico genes essential for growth. Flux variability analysis (FVA) was used to predict changes 553 
in potential reaction activity by calculating the minimum and maximum flux of a given reaction when 554 
the model was required to produce maximum biomass. We calculated the flux range from the maximum 555 
and minimum flux values for each reaction, and then determined whether the range increased or 556 
decreased compared to unconstrained iPA1139, sorting results into 5 categories: decreased range in 557 
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mDK2-07 compared to mDK2-WT, increased range in mDK2-07 compared to mDK2-WT, or 558 
comparable changes in the ranges in both strains that are increased, the same, or decreased compared to 559 
iPA1139. To identify subsystems with high concentrations of changes in activity that we interpret here 560 
as potential adaptive processes, we counted the number of reactions in these altered activity categories 561 
within each subsystem and then normalized by the number of active subsystem reactions in iPA1139 as 562 
shown in Dataset S2. 563 
 564 
The redox cofactor production analysis presented in Fig. 3 was performed by optimizing for the 565 
maximum production capacity of NAD+ and NADH separately while constraining the maximum uptake 566 
rates of O2 and CO2 to 0.2, 2, 5, and 20 mmol/gDW/hr (low to high uptake rates) and fixing the 567 
production rate of biomass at 0 to 100% of optimum production when only growth is maximized. The 568 
command-line implementation of Metdraw (also available at www.metdraw.com) was used to build a 569 
full-sized map of the base model on which FVA results were overlaid automatically (53). 570 
 571 
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 754 
FIGURE LEGENDS 755 
 756 
Figure 1 - Glucose metabolism in Pseudomonas aeruginosa.  757 
Glucose can enter the cell through the phosphorylative or the oxidative route. The oxidative route 758 
involves conversion of glucose into gluconate or 2-ketogluconate. In the cytoplasm, further degradation 759 
of pyruvate may occur through three alternate pathways. The blue arrows indicate alternative convergent 760 
pathways and their respective names (17–19, 55–58). Fig. S3 shows an expanded version of Fig. 1 761 
including gene locus names assigned to each reaction. Abbreviations: ED (Entner-Doudoroff), PP 762 
(pentose phosphate), EMP (Embden-Meyerhof-Parnas), TCA (Tricarboxylic acid), P (phosphate). 763 
 764 
Figure 2 - Carbon dioxide fixation into glycine through the glycine cleavage system.  765 
A Labelling of glycine derived from cultivation in glucose minimal medium (56% 13C6-glucose and 44% 766 
[1-13C]-glucose). The amount of background labelling from 13C6-glucose (56%) is indicated as a 767 
separate column.  768 
B Labelling of glycine derived from cultivation in unlabelled glucose and labelled bicarbonate  769 
(H13CO3-).  770 
C Labelling of serine derived from cultivation in unlabelled glucose and labelled bicarbonate (H13CO3).  771 
D The glycine cleavage system in reverse. Two molecules of carbon dioxide are fixated into glycine - 772 
one of them via formate formation. Figure adapted from (21). Abbreviations: Reduced electron donor 773 
(AH2), oxidized electron donor (A), tetrahydrofolate (THF), lipoyl protein (LP).  774 
 775 
In A-C the (m+1)-columns indicate the percentages of compounds with one labelled C-atom, whereas 776 
the (m+2)-columns indicate the percentages of compound with both carbon atoms labelled. The control 777 
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is a measure of the naturally occurring 13C-isotope in bovine serum albumin (BSA). In  A, (*) denotes 778 
where the labelling percentages of (m+2)-labelling are significantly lower (Student's t-test, two-sided, 779 
significance level, p = 0.05) than the background level from labelled glucose in the medium. In B-C, (*) 780 
denotes where the percentages of (m+1)-labelling of strains are significantly higher (Student's t-test, 781 
significance level, two-sided, p = 0.05) than the level of the naturally occurring isotope (control). Note 782 
that panels A-C have different scales.   783 
 784 
Figure 3 - Redox cofactor production differences between mDK2-WT and mDK2-07 due to SNP in 785 
purine metabolism.  786 
A An evaluation of the effects of altered O2 and CO2 uptake on the ratio of NADH production to NAD+ 787 
production under a range of biomass production constraints for mDK2-WT (blue), mDK2-07 (red), and 788 
mDK2-07 with reduced purL activity constraints (shades of purple).   789 
B Pathway illustration of the connection between glycine metabolism and purine metabolism, 790 
specifically highlighting purL, a gene that contains a SNP in DK2-07 that the model predicts is 791 
connected to differential redox metabolism activity between strains. Abbreviations: Glycinamide 792 
ribonucleotide (GAR), 5'-phosphoribosylformylglycinamidine (FGAM), lipoyl protein (LP). 793 
 794 
Figure 4 - Isolate-specific gene essentiality and associated functions.  795 
A Stacked histogram of reactions associated with DK2-specific essential genes, as shown by % 796 
associated reactions within a particular KEGG subsystem. Total reactions assigned in the KEGG 797 
subsystem are included in parentheses in each subsystem label. Results for the essential reaction 798 
distribution across the base model and three isolate-specific models are shown in each subsystem 799 
category as indicated by colours corresponding to the categories of the Venn diagram in panel B. Bolded 800 
histogram labels highlight subsystems that show variation in reaction distributions between isolate 801 
models.  802 
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B Venn diagram of the distribution of in silico essential gene predictions, highlighting the differences in 803 
unique versus shared essential genes between mDK2-WT, mDK2-91, mDK2-07 and the base model 804 
(iPA1139). 805 
 806 
Figure 5 - Flux variability analysis displayed on global metabolic map.  807 
Differential reaction activity ranges between mDK2-WT and mDK2-07 predicted by flux variability 808 
analysis under 100% biomass demands. Increase/decrease in flexibility was identified through 809 
comparison of mDK2-WT and mDK2-07 reaction predictions with base model iPA1139 reaction 810 
predictions. Dashed lines indicate SNPs present in DK2-WT and DK2-07. The map provides an 811 
overview of metabolic changes between DK2-WT and DK2-07, with enlarged panels of purine 812 
metabolism and glycine, serine and threonine metabolism presented to highlight the important changes 813 
identified in these subsystems. Users can zoom in to identify specific compounds and reactions 814 
connected to highlighted areas of differential activity. Associated implementation of the compounds and 815 
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SUPPLEMENTAL LEGENDS  821 
 822 
Supplemental Text S1 - Expanded materials and methods. 823 
 824 
Figure S1 - Growth data.  825 
A Growth of the P. aeruginosa strains PA01, DK2-WT, DK2-91 and DK2-07 in 826 
morpholinepropanesulfonic acid (MOPS)-buffered minimal medium supplemented with 10 mM [1-13C]-827 
glucose. The curves show optical density measured at 600 nm.  828 
B Specific growth rates for P. aeruginosa strains used in this study. All of the growth rates are 829 
significantly different from each other (Student’s t-test, two-sided, significance level p = 0.05).  830 
C Biomass yields determined for P. aeruginosa strains used in this study.  831 
For panels B-C the values are based on biological triplicates and error bars indicate standard deviations. 832 
Abbreviations: Dry weight (DW). 833 
 834 
Figure S2 - GC-MS analysis of extracellular metabolites.  835 
Comparison of GC-MS profiles (derivatised by methoximation and silylation) of lyophilized broth, 836 
showing a shift towards 2-ketogluconate and gluconate production in DK2-91 and DK2-07. Reference 837 
standards of all glucose, gluconate, as well as 2- and 5-ketogluconate were co-analysed in the sequence. 838 
Two chromatographic peaks are formed per sugar due to the derivatization process. 839 
 840 
Figure S3 - Expanded figure of glucose metabolism in Pseudomonas aeruginosa. 841 
Glucose can enter the cell through the phosphorylative or the oxidative route. The oxidative route 842 
involves conversion of glucose into gluconate or 2-ketogluconate..In the cytoplasm, further degradation 843 
to pyruvate can happen through three alternate pathways. The blue arrows indicate alternative 844 
convergent pathways and their respective names. Gene locus names according to P. aeruginosa PAO1 845 
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(59) are assigned to each reaction. Abbreviations: ED (Entner-Doudoroff), PP (pentose phosphate), 846 
EMP (Embden-Meyerhof-Parnas), TCA (Tricarboxylic acid), P (phosphate). 847 
 848 
Figure S4 - Labelling patterns of pyruvate from the [1-13C]-glucose experiment.  849 
Summed fractional labelings (%) for derivatised amino acids (the number indicates the mass of the 850 
amino acid fragment for the lowest mass isotopomer). The shown amino acids are all derived from 851 
pyruvate and the corresponding carbon positions in pyruvate (PYR) are indicated in brackets. The values 852 
are based on biological triplicates and the error bars show the standard deviations.  853 
The data from Valine144 show low standard deviations from triplicate analyses. We can therefore 854 
conclude with high degree of certainty that position 2 and 3 have average labelling degrees of around 1.1 855 
% (corresponding to natural prevalence of 13C). 856 
There are some uncertainties in determining the labelling patterns of Alanine158 and Valine186. The 857 
labelling degree of the carbon atom at position 1 in Pyruvate can be calculated by subtracting the value 858 
of Alanine116 from Alanine158 or Valine144 from Valine186. This calculation gives a rough estimate 859 
on the labelling degree of the Pyruvate position 1 being around 50%. 860 
 861 
Figure S5 - Converting ‘omics’ data to isolate-specific model constraints.  862 
Counts of genes and SNPs binned into their respective functional categories (shown in top two tables) 863 
are manually evaluated for combined expression-SNP functional impact and then provided to the 864 
TIGER implementation of iMAT for constraint development. Resulting iMAT predictions of ‘off’ genes 865 
that should be inactivated and ‘on’ genes that should result in associated reactions carrying at least a 866 
minimum level of flux during growth are shown. After enforcing the requirement that all models must 867 
be able to produce biomass (grow), the resulting number of reactions with constrained flux activity in 868 
each isolate-specific model is presented in the last table. 869 
 870 
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Dataset S1. Gene expression data. 871 
Differentially expressed genes in glucose minimal media for DK2-91 (sheet 2) and DK2-07 (sheet 3) 872 
compared to DK2-WT. Sheet 1 includes a hypergeometric distribution test of enriched gene ontology 873 
classes among differentially expressed genes for DK2-91 and DK2-07 compared to DK2-WT.  874 
 875 
Dataset S2. SNP and expression constraints. 876 
Data supporting the conversion of identified SNP and expression levels into constraints applied to 877 
genome scale models to create isolate-specific models. Includes SIFT predictions for each SNP 878 
(categorized by affected strain), comparison of SIFT predicted impact and gene expression constraints as 879 
implemented through gene-protein-reaction relationships, and final inactivated gene sets for each strain 880 
model. Further details are included in S8 and legends within sub-sheets of the file. 881 
 882 
 883 
Dataset S3. In silico essential gene analysis and flux variability analysis. 884 
Included are essential genes predicted by iPA1139 and each isolate specific model, all reactions 885 
associated with these essential genes, flux variability analysis for all reactions under 100% biomass 886 
production constraints, subsystem-based FVA analysis, and FVA-based comparison of redox 887 
metabolism activity to global activity. Further details are included in Dataset S4 and legends within sub-888 
sheets of the file. 889 
 890 
Dataset S4. Genome scale metabolic models. 891 
File contains each isolate-specific model in spreadsheet form with all applied gene and reaction 892 
constraints (and their corresponding reaction bounds as interpreted via gene-to-protein relationships). 893 
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Supplemental text S1: Expanded materials and methods 
 
GC-MS analysis for extracellular metabolites 
The experimental procedure of labelling determination was modified from Kind et al. 2010 (1). 
Supernatants were centrifuged at 15000 g and 100µL supernatant lyophilized in 2-ml silanized 
glass vials, and then derivatised by 20 µL O-methylhydroxylamine in pyridine for 2 hrs, before 
adding 180 µL of N-methyl-N-trimethylsilyltrifluoroacetamide with 1% trimethylchlorosilane 
(Thermo Fischer) heating in an oven at 40 °C for 30 min. The samples were analysed by GC-MS 
on a Thermo Electron DSQII GCMS systems using the same parameters as described in (1) for 
their Agilent GC-MS, and peaks matched in the Fiehn Lib (Agilent technologies) using the 
AMDIS 2.71 (http://chemdata.nist.gov/mass-spc/amdis/downloads/). Reference standards of 
glucose, gluconate, 5-ketogluconate and 2-ketogluconate were co-analysed in the sequence with 
real samples for verification. 
 
Proteinogenic amino acid analysis from 13C-labeled biomass 
Hydrolysis:  
The pellet was resuspended in 600 µL of 6 M hydrochloric acid and the volume was transferred 
to a 2 mL glass vial. The vial was capped with an aluminium cap (able to withstand high 
temperatures) and kept at 105°C for hydrolysis overnight. After overnight hydrolysis the content 
of the vial was transferred to an Eppendorf tube and centrifuged at 15000 rpm for two minutes. 
Supernatant was transferred to two clean glass vials (280 µL each). The vials were dried for three 
hours at 105°C without caps. After drying one of the vials was capped and stored at -80°C for 
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backup. The other vial was added 200 µL of milliQ water and vortexed for 30 seconds. Another 
800 µL of milliQ water was added followed by vortexing. A control sample containing bovine 
serum albumin (BSA) was included to test if the hydrolysis step was completed successfully.  
 
Purification:  
The biomass hydrolysate was loaded on a cat-ion exchange solid phase extraction column 
packed in a 1–ml syringe  (200 mg Dowex 50W X8, 200- 400 mesh, H+-form, Sigma-Aldrich, 
St. Louis, MO), that had been conditioned by 1 ml methanol and 1 ml water, and the sample was 
passed through by gravity. Waste was discarded. The sample was washed with 1 mL of ethanol 
in water (1:1). 0.2 mL of 1 M NaOH was added to increase the pH of the column and waste was 
discarded. A 2 mL glass vial was placed under the column to collect the purified amino acids. 1 
mL of a mixture of 1% (wt/v) NaOH in saline, ethanol and pyridine in a 9:5:1 proportion was 
added and the eluate was collected. The content was divided into two parts, 500 µL in an 
Eppendorf tube for ethylchloroformate (ECF) derivatization and 500 µL in a glass vial for N-
dimethyl-amino-methylene-methyl-esters (DMFDMA) derivatization respectively. The samples 
were kept at -20°C until derivatization. A control sample containing a mixture of amino acids 
was included to test if the purification step was completed successfully. 
 
ECF Derivatization:  
50 µL of ethylchloroformate was added to the 500 µL SPE column eluate. Pipetting in and out 
using a 1 mL pipette followed by a gentle vortexing gently mixed the content. The Eppendorf 
tube was uncapped to release the pressure. This step was repeated until no CO2 was observed. 5 
additional µL of ECF was added followed by vortexing and release of pressure. 200 µL of propyl 
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acetate was added, the tube was vortexed for 30 seconds and pressure was released. 50 µL of 1 
M HCl was added followed by vortexing and release of pressure. The fluid was allowed to 
separate for 1 minute. Thereafter 175 µL of the upper organic layer was transferred to a new 
Eppendorf tube. A small amount of anhydrous NaSO4 or MgSO4 was added followed by 
vortexing. The supernatant was transferred to a 2 mL glass vial and kept at -20°C until GC-MS 
analysis. 
 
DMFDMA Derivatization:  
200 µL 1 M HCl was added to the 500 µL SPE column eluate and mixed well. The vial was kept 
for drying for 2 to 4 hours at 105°C without cap. The vial was allowed to cool down for ten 
minutes. 200 µL DMFDMA and 200 µL acetonitrile was added to the vial. The vial was capped 
with a screw cap and kept for derivatization at 100°C for 20 minutes. After derivatization the vial 
was placed at -20°C for 10 min. The supernatant was transferred to an Eppendorf tube and 
centrifuged at 15.000 rpm for 2 min. The supernatant was transferred to a new glass vial with a 
screw cap and kept at -20°C until GC-MS. 
 
GC-MS analysis of proteinogenic amino acids 
Sample were analysed by GC-MS one an Agilent 6890 gas chromatograph (Agilent 
Technologies,  Waldbronn, Germany)  coupled to an Agilent 5973 quadruple MS run in electron 
impact ionization (EI+) mode using an electron energy of 70 eV. The GC was equipped with a 
4.0 mm i.d. Siltek gooseneck splitless deactivated liner (Restek, Bellefonte, PA, USA), and a 
Supelco (Bellefonte, PA, .US) Equity®-1701 (15 m, 0.25 mm i.d., 0.25 µm film) column. 
Helium was used as carrier gas at a constant linear gas velocity of 38 cm/s. Transfer line 
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temperature was 280ºC, quadruple temperature 150 ºC and MS source 230 ºC. The GC-MS 
system was controlled from Agilent MSD Chemstation v. D.01.02.16, and auto tuned for prior to 
every sequence. Samples of 1 µL was injected using a Combi PAL autosampler (CTC Analytics 
AG, Zwingen, Switzerland). 
 
Analysis of amino acid-ECF derivatives was done at an injection temperature of 220ºC, and oven 
temperature was initially held at 75 °C for one min. Hereafter the temperature was raised 40 °C 
min-1 until 165 °C, then 4 °C min-1 until 190 °C and then 40 °C min-1 to 240 °C. At the end, 
temperature was increased to 260 °C at 4 °C min-1 and held constant for 4 minutes.  
Analysis of the amino acid-DMFDMA derivatives was done at an injection temperature of 
230ºC, and oven temperature was initially held at 60 °C for one min. Hereafter the temperature 
was raised at 20 °C min-1 until 130 °C, then 4 °C min-1 until 150 °C and 40 °C min-1 to 260 °C 
and held constant for 4.25 minutes.  
 
Construction of isolate-specific genome-scale metabolic models 
Raw expression levels from microarrays were used to develop proposed ‘off’ and ‘on’ gene 
activity levels using 25th and 75th percentile cutoffs of the expression data similar to methods 
described by Machado and Herrgard (2014) (2)  These gene levels were converted into tri-valued 
logic levels (‘off’ – 0, ‘unconstrained’ – 1, and ‘on’ – 2) as the input for the TIGER 
implementation of iMAT. Different levels of SNP constraints were also used, ranging from 
minor impact (silent and SIFT-predicted tolerated missense SNPs), moderate impact (missense 
SNPs with SIFT-predicted functional impact), and maximum impact (nonsense SNPs). In order 
to integrate these datasets before iMAT was used to create strain-specific models, any Boolean 
gene-to-protein-to-reaction (GPR) relationship that incorporated a gene associated with a SNP 
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was manually evaluated in the context of the gene expression levels. If only the SNP-affected 
gene was associated with the reaction, the activity of the connected reaction was limited by 
modifying the reaction bounds. If the GPR was a more complex Boolean statement involving 
multiple genes (gene duplications, isozymes, or multiple subunits of an enzyme), the GPR was 
evaluated to see whether any genes were present that could compensate for the affected function 
of the SNP-associated gene. If these compensatory genes also had ‘off’ expression levels, the 
SNP-based constraint was applied. If the compensatory genes were unconstrained or ‘on’, the 
SNP-based constraint was not applied. Instead of reducing the potential activity of SNP-targeted 
reactions by their base model bounds (usually -1000 to 1000 for reversible reactions and 0 to 
1000 for irreversible reactions), we conducted flux variability analysis of the base model at 
100% biomass production to calculate the normal range of activity of each reaction in glucose 
minimal medium conditions. Any minor impact SNP being implemented resulted in a 10% 
reduction of the FVA-predicted base activity range enforced via reaction bounds while a 
moderate impact SNP resulted in a 50% reduction applied in the same manner. SNPs 
implemented with maximum impact resulted in associated reactions being turned entirely off via 
modification of reaction bounds. This GPR-based evaluation of SNP and expression levels is 
available in Dataset S2. 
 
The above SNP integration method was applied to each strain-specific model prior to the use of 
the TIGER implementation of iMAT. Using an objective function threshold of 10% of the 
maximum and Gurobi 5.6.2 as the solver, iMAT predicted new sets of genes that could feasibly 
be turned ‘off’ or ‘on’ while maintaining production of biomass at 10% in each SNP-constrained 
isolate-specific model. The ‘off’ genes were inactivated in the model. The predicted ‘on’ genes 
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were implemented by applying a lower bound constraint of 0.001 or -0.001 to ensure a minimum 
level of activity in the appropriate direction of reaction activity. Reaction direction was evaluated 
via FVA, and if there was not a clear preference for direction of activity (for example, the FVA 
max and min indicated the reaction was fully reversible (a range of -0.001 to 0.001 or larger)), 
then the ‘on’ minimum constraint was not applied to avoid inappropriate/unsupported bias in 
reaction directionality. This evaluation meant that it was not feasible to apply all constraints 
predicted by iMAT, and a summary of the gene constraints and the difference between predicted 
and applied isolate-specific model constraints is presented in Figure S5. 
1.  Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, Fiehn O. 2010. FiehnLib – mass 
spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight 
gaschromatography/mass spectrometry. Anal. Chem. 81:10038–10048. 
2.  Machado D, Herrgård M. 2014. Systematic evaluation of methods for integration of transcriptomic data 
into constraint-based models of metabolism. PLoS Comput. Biol. 10:e1003580.  
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The	  main	  objective	  of	   this	   PhD	  project	  was	   to	   gain	  more	   knowledge	  of	   the	   adaptation	  process	  of	  
human	  pathogens	  during	  chronic	  infections	  through	  a	  systems	  biology	  approach.	  
In	  Paper	  1	  we	  use	  archetypal	  analysis	  to	  extract	  phenotypes	  of	  adapted	  P.	  aeruginosa	  isolates	  from	  
global	  gene	  expression	  data	  sets	  derived	  from	  five	  diverse	  studies	  of	  P.	  aeruginosa.	  We	  are	  able	  to	  
group	  P.	  aeruginosa	   isolates	  based	  on	  adaptation	  level	  and	  to	  represent	  the	  diverse	  data	  points	  as	  
representative	  archetypes.	  The	  characterization	  of	  archetypes	  reveals	  that	  one	  archetype	  represents	  
the	   mucoid	   phenotype	   and	   another	   archetype	   represents	   the	   hypermutator	   phenotype,	   both	   of	  
which	  are	  frequently	  observed	  phenotypes	  isolated	  from	  chronic	  infections.	  Further	  characterization	  
of	   the	   archetypes	   uncovers	   typical	   differential	   gene	   expression	   between	   isolates	   from	   early	   and	  
chronic	  infections	  respectively.	  
In	  Paper	  2	  we	  use	  long-­‐term	  chronic	  infections	  of	  cystic	  fibrosis	  airways	  by	  P.	  aeruginosa	  as	  a	  model	  
system	   for	   systematic	   analysis	   of	   how	  evolution	   shapes	   the	  metabolism	  of	   infecting	   bacteria.	   The	  
study	   sheds	   light	   on	   specific	   metabolic	   pathways	   that	   have	   not	   previously	   been	   considered	   im-­‐
portant	   for	  pathogen	  adaptation	  and	  persistence.	  We	  show	  that	  our	  approach	  of	   integrating	  high-­‐
throughput	   data	   into	   genome	   scale	  models	   can	  deliver	   novel	   insight	   into	  within-­‐host	   evolution	  of	  
bacterial	  pathogens.	  	  
The	  key	  contributions	  from	  Paper	  2	  are:	  	  
• We	   provide	   direct	   evidence	   for	  metabolic	   activity	   towards	   fixation	   of	   carbon	   dioxide	   into	  
glycine	  -­‐	  a	  new	  discovered	  adaptive	  phenotype	  of	  the	  opportunistic	  pathogen	  P.	  aeruginosa.	  
• We	   present	   a	   novel	   methodological	   framework	   of	   integrating	   multiple	   data	   sets	   into	   ge-­‐
nome	  scale	  metabolic	  models	  facilitating	  a	  systems	  level	  characterization	  of	  metabolism	  dur-­‐
ing	  adaptation.	  
• Through	  our	   combined	  experimental	   and	   computational	   approach,	  we	   can	   (i)	   connect	   the	  
observed	   changes	   in	   metabolism	   to	   altered	   redox	   balance	   during	   adaptation	   (ii)	   predict	  
which	  single	  nucleotide	  polymorphism	  is	  contributing	  to	  this	  change,	  (ii)	  develop	  specific	  lists	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of	   predicted	   essential	   genes	   for	   the	   host-­‐adapted	   isolates,	  which	   can	   serve	   as	   alternative	  
therapeutic	  targets	  and	  (iv)	  prioritize	  impacted	  subsystems	  for	  future	  investigation.	  
The	  finding	  of	  the	  metabolic	  shift	  through	  the	  glycine	  cleavage	  system	  in	  Paper	  2	  is	  a	  new	  discovery,	  
which	  is	  made	  possible	  through	  our	  approach	  with	  labeling	  experiments	  and	  computational	  model-­‐
ing.	   If	  we	  consider	  the	  genomic	  data	  or	  transcriptomic	  data	  alone,	  we	  do	  not	  find	  any	  SNPs	  or	  any	  
differential	  gene	  expression	   in	  the	  genes	  coupled	  to	  the	  glycine	  cleavage	  system.	  We	  do	   identify	  a	  
SNP	   in	  a	  neighboring	  system	  (purine	  metabolism),	  but	  connecting	   this	  SNP	  to	   the	  glycine	  cleavage	  
system	  is	  unique	  to	  this	  study.	  We	  have	  identified	  a	  potential	  important	  pathway	  through	  the	  study	  
of	  metabolism	  in	  P.	  aeruginosa,	  where	  no	  clear	  identification	  was	  possible	  through	  investigation	  of	  
genomic	  or	  transcriptomic	  data	  alone.	  I	  think	  this	  is	  a	  great	  example	  of	  a	  successful	  outcome	  of	  data	  
integration	   and	  metabolic	  modeling,	  where	   new	  discoveries	   appear	   from	  data	   sets	   that	  were	   not	  
made	  by	  analyzing	  the	  data	  sets	  individually.	  	  
Is	  the	  glycine	  cleavage	  system	  also	  affected	  in	  other	  studies	  of	  P.	  aeruginosa	  adaptation?	  
The	   use	   of	   the	  P.	   aeruginosa	   DK2	   lineage	   to	   represent	   general	   P.	   aeruginosa	   adaptation	   or	   even	  
general	  pathogen	  adaptation	  may	  be	  argued.	  The	  results	   from	  Paper	   1	   show	  that	   the	  DK2	   lineage	  
has	  adaptive	  traits	  common	  to	  other	  adapted	  lineages	  of	  P.	  aeruginosa.	  In	  addition	  to	  that,	  the	  DK2	  
lineage	  has	  undergone	  parallel	  evolution	  in	  multiple	  patients	  where	  it	  has	  outcompeted	  other	  P.	  ae-­‐
ruginosa	  strains	  (Jelsbak	  et	  al,	  2007;	  Yang	  et	  al,	  2011).	  I	  think	  that	  these	  examples	  are	  justifying	  the	  
choice	  of	  DK2	  to	  represent	  at	   least	  a	  common	  path	  of	  P.	  aeruginosa	  adaptation.	  Of	  course,	   it	   is	  al-­‐
ways	  desired	  to	  confirm	  whether	  the	  specific	  adaptive	  changes	  found	  for	  the	  DK2	  lineage	  (e.g.	   the	  
altered	   glycine	   cleavage	   system)	   are	   observed	   for	   other	   lineages	   of	   P.	   aeruginosa.	   Interestingly,	  
adaptive	  mutations	  have	  recently	  been	  discovered	  in	  a	  gene	  of	  the	  glycine	  cleavage	  system	  (gcvP1)	  
among	  other	  clinical	  isolates	  of	  P.	  aeruginosa	  (Feliziani	  et	  al,	  2014)	  indicating	  that	  this	  system	  is	  also	  
altered	   in	  other	  P.	  aeruginosa	   lineages	  where	   it	   is	   even	  a	  direct	   target	  of	   genetic	   adaptation.	   The	  
altered	  glycine	  cleavage	  system	  is	  therefore	  not	  unique	  to	  the	  DK2	  lineage.	  Whether	  the	  identified	  
adaptive	  mechanisms	  for	  within-­‐host	  persistence	  are	  valid	  for	  other	  pathogens	  requires	  further	   in-­‐
vestigation.	  	  
In	  the	  introduction	  I	  mentioned	  a	  comprehensive	  study	  of	  P.	  aeruginosa	  adaptation	  focusing	  on	  ge-­‐
nomics	  (Marvig	  et	  al,	  2015).	  With	  our	  gained	  attention	  to	  the	  glycine	  cleavage	  system	  and	  surround-­‐
ing	  metabolic	  pathways,	  it	  could	  be	  interesting	  to	  evaluate	  whether	  an	  increased	  frequency	  of	  muta-­‐
tions	  within	  the	  defined	  set	  of	  metabolic	  pathways	  is	  present	  in	  the	  collection	  of	  474	  whole-­‐genome	  
sequences	  of	  P.	  aeruginosa	  clinical	  CF	  isolates	  from	  Marvig	  et	  al.	  The	  analysis	  is	  available	  in	  Appendix	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A.	   In	  order	   to	  evaluate	   this	  we	  need	   to	  define	  which	  genes	  belong	   to	   the	  metabolic	   subsystem	  of	  
interest.	  We	   chose	   to	   use	   Figure	   5	   as	   the	   delimiter	   of	   the	   subsystem	   and	   hence	   focus	   on	   the	   19	  
genes	  that	  are	   involved	   in	  the	  reactions	   included	   in	  Figure	  5.	  None	  of	   the	  19	  genes	  that	  appear	   in	  
Figure	  5	  were	  identified	  as	  pathoadaptive	  in	  the	  study	  by	  Marvig	  et	  al	  (Marvig	  et	  al,	  2015).	  However,	  
if	  we	   count	   the	   number	   of	  mutations	   (including	  missense	  mutations,	   silent	  mutations	   and	   indels)	  
that	  appear	  in	  the	  19	  genes	  we	  find	  that	  the	  system	  is	  significantly	  enriched	  for	  mutations	  compared	  
to	  the	  average	  mutation	  frequency	  of	  all	  genes	  in	  the	  36	  lineages	  (Poisson	  distribution	  test,	  p	  =0.05).	  
This	  means	  that	  the	  metabolic	  subsystem	  in	  Figure	  5	  is	  a	  target	  of	  genomic	  adaptation	  although	  not	  
identified	  by	  the	  genomic	  study	  alone.	  I	  think	  this	  example	  is	  a	  step	  forward	  in	  moving	  from	  the	  gen-­‐
otype	  to	  the	  phenotype.	  Our	  modeling	  approach	  allows	  us	  to	  identify	  a	  subsystem	  of	  metabolic	  reac-­‐
tions	   that	   should	  be	   considered	   together	  and	   this	  now	  enable	  us	   to	  predict	   a	  new	  phenotype	   (al-­‐
tered	  glycine	  cleavage	  system)	  from	  the	  genomic	  data.	  
I	  wish	  to	  emphasize	  that	  the	  identification	  of	  the	  metabolic	  shift	  through	  the	  glycine	  cleavage	  system	  
in	   itself	   is	   a	  major	   result	   of	   this	   PhD	  project.	   The	   finding	   of	   course	   gives	   rise	   to	   new	  project	   pro-­‐
posals,	  where	  the	  direct	  role	  of	  the	  glycine	  cleavage	  system	  connected	  to	  P.	  aeruginosa	  persistence	  
could	  be	  investigated.	  	  
Is	  the	  metabolic	  shift	  through	  the	  glycine	  cleavage	  system	  relevant	  for	  other	  organisms?	  
Our	  increasing	  interest	  for	  the	  glycine	  cleavage	  system	  also	  inspired	  us	  to	  look	  for	  other	  disease	  cas-­‐
es,	  where	  the	  glycine	  cleavage	  system	  has	  shown	  to	  be	  important.	  As	  also	  mentioned	  in	  Paper	  2,	  the	  
enzyme	  glycine	  decarboxylase	   (part	   of	   the	   glycine	   cleavage	   system)	  was	  previously	   identified	   as	   a	  
promoter	  of	   cellular	   transformation	   in	   cancer	   cells	   and	   the	   activity	   of	   this	   enzyme	  was	   correlated	  
with	  poorer	  survival	  of	  patients	  with	  lung	  cancer	  (Zhang	  et	  al,	  2012).	  	  A	  very	  interesting	  link	  between	  
our	  study	  and	  these	  previously	  published	  observations	  is	  that	  in	  both	  cases	  (i)	  the	  lung	  environment	  
has	  a	  high	  partial	  pressure	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  of	  CO2,	   (ii)	   changes	   in	  metabolism	   indicate	  decreased	  oxidative	  phosphorylation,	   and	   (iii)	   changes	  
are	   observed	   in	   glycine	  metabolism	   and	   the	   glycine	   cleavage	   system.	   A	   key	   difference	   is	   that	  we	  
propose	   that	   the	  mechanism	  of	   the	  glycine	  cleavage	   system	   is	   to	   regenerate	   reducing	  equivalents	  
through	  glycine	  synthesis,	  whereas	  in	  the	  study	  by	  Zhang	  et	  al.	  (Zhang	  et	  al,	  2012),	  the	  glycine	  cleav-­‐
age	  system	  is	  considered	  irreversible	  in	  the	  direction	  of	  glycine	  cleavage.	  However,	  the	  system	  is	  bi-­‐
directional	  (Bar-­‐Even	  et	  al,	  2012)	  and	  we	  suggest	  that	  the	  function	  of	  the	  glycine	  cleavage	  system	  in	  
cancer	  cells	  could	  be	  similar	  to	  the	  mechanisms	  found	  in	  P.	  aeruginosa	  where	  it	   is	  operating	  in	  the	  
direction	   of	   glycine	   synthesis.	   Carbon	   fixation	   through	   the	   glycine	   cleavage	   system	   in	   cancer	   cells	  
	  
Figure 5.  The glycine cleavage system in 
reverse.  Two molecules of carbon dioxide are fix-
ated into glycine - one of them via formate for-
mation. Genes are assigned to each reaction. Figure 
adapted from (Bar-Even et al, 2012). Abbreviations: 
Reduced electron donor (AH2), oxidized electron 
donor (A), tetrahydrofolate (THF), lipoyl protein 
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could	   be	   a	  way	   to	   fuel	   glycolysis	  with	   redox	   compounds	   thereby	   achieving	   the	  Warburg	   effect,	   a	  
well-­‐known	  phenomenon	  in	  cancer	  cells	  characterized	  by	  high	  glycolytic	  activity	  and	  low	  (or	  normal)	  
level	   of	   oxidative	   phosphorylation	   (Chen	   et	   al,	   2015).	   Future	   studies	   could	   examine	   the	   potential	  
reversal	  of	  the	  glycine	  cleavage	  system	  by	  evaluating	  growth	  of	  malignant	  cancer	  cells	  provided	  with	  
labeled	   carbon	  dioxide	  or	  bicarbonate	   to	  evaluate	  whether	   a	   similar	   redox-­‐related	  driving	  mecha-­‐
nism	  is	  associated	  with	  lung	  cancer	  metabolism.	  
Can	  we	  derive	  what	  the	  driving	  force	  of	  selection	  is	  in	  the	  CF	  lung	  environment?	  
The	  often	  observed	  slow-­‐growth	  phenotype	  among	  the	  P.	  aeruginosa	  isolates	  from	  chronic	  patients	  
indicate	  that	  optimization	  of	  biomass	  yield	  may	  not	  be	  the	  strongest	  selective	  pressure	  in	  the	  lung	  
environment,	  although	   it	   is	  contrary	   to	   the	  general	  assumption	  that	  bacteria	  have	  been	  optimized	  
evolutionarily	   for	  growth	  (Oberhardt	  et	  al,	  2008;	  Schuetz	  et	  al,	  2007).	  As	  described	  by	  Shoval	  et	  al	  
(2012),	  a	  bacterial	  phenotype	  cannot	  be	  optimal,	  at	  the	  same	  time,	  for	  two	  different	  tasks	  such	  as	  
rapid	  growth	  and	  survival,	  but	  the	  bacteria	  will	  meet	  a	  tradeoff	  between	  the	  two	  objectives	  (Shoval	  
et	  al,	  2012).	  The	  question	  is	   if	  we	  can	  identify	  the	  important	  tasks	  that	  contribute	  to	  the	  fitness	  of	  
the	  bacteria	  in	  the	  CF	  lung	  environment.	  
When	  the	  first	  genome-­‐scale	  metabolic	  model	  of	  P.	  aeruginosa	  was	  published	  in	  2008,	  it	  was	  stated	  
that	  some	  future	  application	  of	  that	  model	  could	  be	  to	  model	  different	  hypothesis	  about	  selective	  
pressures	  in	  the	  lung	  and	  to	  analyze	  the	  causes	  of	  these	  selective	  pressures	  (Oberhardt	  et	  al,	  2008).	  I	  
think	  that	  our	  work	  presented	  in	  Paper	  2	  is	  an	  example	  of	  this.	  In	  Paper	  2	  we	  simulate	  an	  effect	  of	  
carbon	  dioxide	  and	  oxygen	   levels	  on	   redox	  potential	  between	   two	   isolates	  where	  we	   find	   that	   for	  
the	  adapted	  isolate,	  the	  redox	  potential	  stays	  balanced	  despite	  fluctuating	  carbon	  dioxide	  and	  oxy-­‐
gen	   levels,	   which	   could	   mean	   decreased	   sensitivity	   to	   surrounding	   conditions	   including	   oxidative	  
stress.	  The	  work	  therefore	  has	  led	  to	  the	  hypothesis:	  
Hypothesis:	  
Pseudomonas	  aeruginosa	  is	  able	  to	  resist	  oxidative	  stress	  in	  the	  cystic	  fibrosis	  lung	  environment	  due	  
to	  metabolic	  reprogramming	  of	  the	  glycine	  cleavage	  system.	  	  
It	  is	  possible	  that	  balancing	  redox	  potential	  in	  the	  cells	  is	  one	  of	  the	  driving	  forces	  of	  selection	  in	  the	  
CF	   lung	   environment.	   Future	  work	   could	   include	  measurements	   of	   redox	   potential	   under	   various	  
stress	  conditions	  (including	  oxidative	  stress)	  and	  comparisons	  between	  a	  wild	  type	  P.	  aeruginosa	  and	  
an	  isogenic	  purL	  mutant	  (the	  mutation	  that	  we	  predict	  is	  causing	  the	  metabolic	  shift).	  In	  Paper	  2,	  we	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also	  show	  that	  the	  purL	  mutation	  causes	  an	   in	  silico	  growth	  defect	  and	  therefore	  the	  potential	  ad-­‐
vantage	  of	  resisting	  oxidative	  stress	  through	  redox	  balancing	  seems	  to	  pay	  a	  price	  on	  growth.	  
Can	  we	  extract	  in	  vivo	  phenotypes	  from	  in	  vitro	  data?	  
One	  often	  argued	  question	   is	  how	  we	  can	  relate	   laboratory	  experiments	  to	  reality.	  One	  advantage	  
with	  our	  model	  system	  is	  that	  the	  evolutionary	  process	  of	  P.	  aeruginosa	  that	  we	  investigate	  has	  tak-­‐
en	  place	  in	  vivo	  that	  means	  in	  the	  natural	  host	  environment	  within	  the	  CF	  lung.	  The	  bacterial	  isolates	  
collected	  from	  the	  CF	  patients	  should	  represent	  a	  snapshot	  of	  the	  stage	  of	  adaptation	  at	  the	  time	  of	  
isolation.	  However,	  when	  we	  characterize	  the	  bacterial	   isolates,	  we	  make	  a	   transition	   from	   in	  vivo	  
(the	   host)	   to	   in	   vitro	   (the	   laboratory).	   When	   we	   evaluate	   in	   vitro	   phenotypes	   between	   bacterial	  
strains	  we	  need	  to	  consider	   that	   these	  phenotypes	  might	  be	  affected	  by	   the	   laboratory	  setup	  and	  
one	  challenge	  is	  how	  we	  mimic	  the	  authentic	  environmental	  conditions	  in	  the	  laboratory.	  The	  nutri-­‐
ent	   composition	   of	   CF	   sputum	  has	   been	   characterized	   in	   order	   to	  make	   a	   synthetic	  medium	   that	  
should	   represent	  CF	   sputum	   (Palmer	  et	  al,	   2007)	  but	  many	  parameters	  of	   the	  CF	   lung	  ecology	   re-­‐
mains	  unknown.	  Also,	  these	  conditions	  are	  not	  always	  applicable	  to	  the	  experimental	  investigations.	  
One	  example	  is	  isotope-­‐labeling	  experiments	  where	  you	  want	  to	  avoid	  presence	  of	  unlabeled	  carbon	  
sources	  and	  for	  our	  study	  in	  Paper	  2	  this	  is	  accomplished	  by	  growing	  cells	  in	  glucose	  minimal	  medi-­‐
um,	  which	  is	  different	  from	  the	  nutrient	  rich	  sputum	  medium.	  Another	  aspect	  is	  the	  mode	  of	  growth	  
and	  whether	  the	  bacteria	  grow	  as	  static	  cells,	  planktonic	  cells	  or	  maybe	  as	  biofilm	  structures,	  which	  
can	  also	  affect	  other	  in	  vitro	  measured	  phenotypes.	  	  
In	  our	  experiment	  with	  labeled	  glucose	  we	  aim	  at	  investigating	  central	  metabolism.	  Central	  metabo-­‐
lism	   is	   definitely	   affected	   by	   which	   nutrients	   are	   present	   and	   measured	   activities	   of	   pathways	  
through	  central	  metabolism	  are	  most	  likely	  different	  from	  the	  actual	  metabolism	   in	  vivo.	  However,	  
our	  focus	  is	  on	  the	  metabolic	  differences	  between	  bacterial	  isolates	  representing	  different	  stages	  of	  
adaptation.	  Our	  main	   interest	   is	  not	  the	  actual	  reaction	  activities,	  which	  are	  subject	  to	  the	  bias	  by	  
the	  dissimilar	  in	  vitro	  environment,	  but	  rather	  the	  pathways	  that	  have	  differential	  activities	  between	  
bacterial	  isolates.	  The	  results	  connected	  to	  these	  differential	  activities	  should	  more	  likely	  be	  due	  to	  
genetic	  differences	   in	   the	  bacteria	   rather	   than	   regulatory	  effects	  of	   the	   surrounding	  environment.	  
We	  thereby	  attempt	  to	  cancel	  out	  the	  in	  vitro	  bias	  through	  our	  comparative	  analysis.	  	  
In	  Paper	  1	  we	  also	  deal	  with	  the	  issue	  of	  laboratory	  conditions.	  Again,	  our	  focus	  is	  on	  adaptation	  and	  
we	  merge	  data	  from	  five	  distinct	  studies	  with	  varied	  laboratory	  conditions	  applied.	  We	  identify	  two	  
distinctive	   phenotypes	   (the	   mucoid	   phenotype	   and	   the	   hypermutator	   phenotype)	   in	   our	   tran-­‐
scriptomic	   data	   analysis	   across	   experimental	   conditions.	   The	   conditions	   in	  which	   the	   bacteria	   are	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cultivated	  will	  affect	  the	  transcriptome,	  but	  we	  show	  that	  through	  appropriate	  choice	  of	  analytical	  
method,	  we	  can	  extract	   the	   relevant	  phenotypes	   from	  the	  data	   set	  and	  neglect	   the	  bias	   from	  the	  
experimental	   setup.	   The	   results	   from	  Paper	   1	   also	   show	   that	  other	  methods	   including	  PCA	   fail	   to	  
identify	  these	  patterns.	  This	  can	  be	  caused	  by	  the	  fact	  that	  PCA	  is	  an	  algorithm	  that	  directs	  our	  at-­‐
tention	   to	   most	   variance	   in	   data	   and	   this	   method	   can	   therefore	   be	   very	   sensitive	   to	   variations	  
caused	  by	  diverse	  experimental	  conditions.	   It	   is	   therefore	   important	   to	  take	  these	   issues	   into	  con-­‐
sideration	  in	  design	  of	  experiments	  and	  connected	  analytical	  frameworks.	  
Our	   finding	  of	   the	  shared	  gene	  expression	  pattern	  among	  hypermutators	   in	  Paper	  1	  suggests	   that	  
the	  hypermutators	  have	  similar	  adaptive	  phenotypes.	  One	   interesting	  observation	   from	  Paper	   1	   is	  
that	  the	  transcriptome	  profiles	  of	  the	  hypermutators	  compared	  to	  their	  non-­‐hypermutator	  relatives	  
are	  less	  different	  from	  the	  average	  transcription	  profile	  for	  all	  samples	  included	  in	  the	  study.	  I	  sug-­‐
gest	   that	   this	  could	  be	  caused	  by	  decreased	  sensitivity	   to	   the	  change	   in	  environmental	  conditions.	  
Mutations	   in	   global	   regulators	   have	   previously	   been	   associated	   with	   adaptation	   of	   P.	   aeruginosa	  
(Yang	  et	  al,	  2011;	  Damkiær	  et	  al,	  2013;	  Smith	  et	  al,	  2006)	  and	  maybe	  one	  selective	  advantage	  is	  to	  
diminish	  the	  regulatory	  response	  to	  environmental	  changes.	  	  
Concluding	  discussion	  and	  future	  perspectives	  
We	  have	  successfully	  applied	  system	  biology	  approaches	  to	  the	  study	  of	  P.	  aeruginosa	  adaptation.	  
We	  have	  developed	  isolate-­‐specific	  genome-­‐scale	  metabolic	  models	  that	  were	  able	  to	  identify	  par-­‐
ticular	  metabolic	  subsystems	  that	  are	  subject	  to	  changes	  during	  adaptation	  of	  P.	  aeruginosa	   in	  the	  
CF	   lung	  environment.	   In	  addition	  to	  that	  the	  analysis	  has	   identified	  genes	  that	  most	   likely	  become	  
essential	  during	  adaption.	  Both	   results	  can	  be	  valuable	  as	   targets	   for	   future	   intervention.	  Multiple	  
studies	  have	  reported	  parallel	  evolution	  of	  different	  P.	  aeruginosa	  lineages	  inside	  the	  CF	  lung	  (Huse	  
et	  al,	  2010;	  Weigand	  &	  Sundin,	  2012;	  Yang	  et	  al,	  2011;	  Marvig	  et	  al,	  2013)	  and	  therefore	  I	  think	  that	  
it	  is	  most	  likely	  that	  the	  observed	  metabolic	  changes	  and	  essential	  genes	  are	  valid	  for	  other	  P.	  aeru-­‐
ginosa	  strains.	  Our	  focus	  on	  the	  glycine	  cleavage	  system	  revealed	  that	  this	  particular	  metabolic	  sub-­‐
system	  was	  also	  a	  target	  of	  adaptive	  mutations	  in	  other	  lineages	  of	  P.	  aeruginosa.	  	  
For	   future	   studies	   it	   could	  be	   interesting	   to	  model	  a	   core	  and	  pan	  metabolic	   capacity	   for	  multiple	  
diverse	   P.	   aeruginosa	   strains	   similar	   to	   the	   study	   of	   core	   and	   pan	  metabolism	   of	  multiple	   E.	   coli	  
strains	  by	  (Monk	  et	  al,	  2013).	  The	  core	  metabolism	  would	  account	  for	  metabolic	  reactions	  that	  are	  
present	   in	  all	   isolates,	  whereas	   the	  pan	  metabolism	  would	  be	   the	  overall	  metabolic	   capacity	  of	  P.	  
aeruginosa	   accounting	   for	   all	   metabolic	   genes	   present	   in	   any	   P.	   aeruginosa	   strain.	   From	   such	   a	  
study,	   it	   is	  possible	   that	  activities	   in	  some	  parts	  of	  metabolism	  can	  be	  related	   to	  successful	  estab-­‐
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lishment	  of	  chronic	  P.	  aeruginosa	  infections	  in	  CF	  patients.	  Another	  possible	  expansion	  on	  the	  mod-­‐
eling	  work	   could	   be	   to	   build	  multi-­‐species	  metabolic	  models,	  where	   the	   interactions	   between	   for	  
example	  S.	  aureus	  and	  P.	  aeruginosa	  are	  investigated.	  	  
One	  issue	  that	  remains	  a	  challenge	  to	  our	  use	  of	  systems	  biology	  is	  the	  trust	  in	  the	  metabolic	  mod-­‐
els.	  When	  do	  we	  think	  the	  models	  are	  perfect	  enough	  to	  trust	  the	  predictions	  without	  experimental	  
validation?	  	  Or	  will	  we	  ever	  reach	  a	  state	  where	  we	  can	  circumvent	  the	  need	  for	  experimental	  vali-­‐
dation?	   And	   are	   our	   synthetic	   laboratory	   setups	   even	   more	   precise	   than	   our	   modeling	   results?	  
Sometimes	  it	  can	  be	  difficult	  or	  technically	  infeasible	  to	  set	  up	  adequate	  validation	  experiments	  for	  
model	  predictions.	  I	  think	  these	  model	  predictions	  are	  very	  interesting	  because	  they	  allow	  us	  to	  get	  
insight	  into	  some	  parts	  of	  metabolism	  that	  we	  have	  so	  far	  not	  been	  able	  to	  characterize	  in	  the	  labor-­‐
atory.	  	  
The	   genome-­‐scale	   metabolic	   models	   will	   represent	   a	   simplification	   of	   cellular	   function,	   since	   the	  
combination	  of	  metabolism,	  regulation	  and	  signaling	  that	  are	  network	  components	  of	  a	  living	  cell	  is	  
much	  more	  complicated	   than	  we	  can	  model	   (Oberhardt	  et	  al,	  2009).	   I	   think	  we	  should	   remember	  
that	  creating	  perfect	  models	  of	  metabolism	  is	  not	  the	  ultimate	  aim.	  As	  described	  by	  Heinemann	  and	  
Sauer	  (2010),	  the	  aim	  in	  systems	  biology	  is	  a	  global	  system	  understanding	  where	  the	  core	  interest	  is	  
the	   general	   principles	   underlying	   a	   particular	   system	   rather	   than	   exact	   molecular	   mechanisms	  
(Heinemann	  &	  Sauer,	  2010).	  The	  aim	  is	  therefore	  to	  be	  able	  to	  provide	  new	  biological	  understanding	  
through	  the	  applications	  of	  these	  models	  and	  I	  think	  that	  both	  correct	  and	  incorrect	  predictions	  can	  
contribute	  to	  that.	  Incorrect	  predictions	  will	  assist	  in	  identifying	  parts	  of	  metabolism	  that	  we	  need	  to	  
investigate	  further.	  Correct	  predictions	  of	  unknown	  cellular	  function	  will	  most	  likely	  help	  us	  reaching	  
a	  knowledge	  level	  faster	  than	  if	  we	  only	  employed	  an	  experimental	  approach.	  I	  don't	  think	  we	  will	  or	  
should	  pursue	  to	  reach	  a	  stage	  where	  experimental	  validation	  becomes	  negligible	  for	  genome-­‐wide	  
analyses.	  However,	  I	  do	  think	  that	  we	  will	  be	  able	  to	  validate	  subsets	  of	  metabolism	  so	  that	  we	  are	  
able	  to	  trust	  future	  predictions	  within	  the	  same	  subsystem	  without	  experimental	  confirmation.	  
I	  started	  out	  this	  thesis	  with	  a	  quote:	  “All	  models	  are	  wrong.	  Some	  are	  useful”	  (Box,	  1979).	  In	  an	  es-­‐
say	  from	  1993,	  Daniel	  Hillis	  elaborates	  on	  this:	  “Those	  [models]	  that	  are	  most	  useful	  will	  probably	  not	  
predict	  any	  particular	  experimental	  data,	  but	  instead	  they	  will	  give	  some	  surprising	  ideas	  about	  how	  
something	  might	  work”	  (Hillis,	  1993).	  I	  think	  this	  is	  exactly	  what	  we	  should	  remember	  when	  we	  deal	  
with	  modeling	  in	  systems	  biology.	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The	   analysis	   of	   genome-­‐scale	  metabolism	   in	  P.	   aeruginosa	   presented	   in	  Paper	   2	   revealed	   a	  metabolic	   shift	  
through	  the	  glycine	  cleavage	  system	  and	  surrounding	  reactions	  (Figure	  5).	  We	  wanted	  to	  test	  if	  the	  metabolic	  
subsystem	  depicted	  in	  Figure	  5	  was	  also	  subject	  to	  changes	  in	  other	  lineages	  of	  Pseudomonas	  aeruginosa.	  	  
We	  decided	  to	  look	  for	  mutations	  (missense,	  nonsense	  and	  indels)	  within	  the	  listed	  genes	  from	  Figure	  5	  among	  
the	  recently	  published	  genome-­‐sequences	  of	  474	  clinical	  P.	  aeruginosa	  isolates	  representing	  36	  different	  line-­‐
ages	  (Marvig	  et	  al,	  2015).	  A	  mutation	  was	  counted	  for	  each	  unique	  mutation	  that	  was	  found	  for	  at	  least	  one	  
isolate	  within	  each	  lineage.	  The	  total	  number	  of	  unique	  mutations	  within	  the	  dataset	  was	  6738	  distributed	  on	  
5677	  genes	  (Marvig	  et	  al,	  2015).	  From	  the	  same	  dataset	  we	  found	  32	  mutations	  among	  the	  19	  genes	  from	  Fig-­‐
ure	  5.	  To	  test	  if	  32	  mutations	  among	  19	  genes	  were	  statistically	  different	  from	  what	  we	  would	  expect	  based	  on	  
the	  frequency	  of	  6738	  mutations	  in	  5677,	  we	  used	  a	  Poisson	  distribution	  test,	  where	  x	  is	  the	  number	  of	  counts	  
and	  the	  mean	  number	  of	  counts	  is	  λ	  (Johnson,	  2005):	  
f (x;λ) = λ
xe−λ
x!  for x = 0,1, 2,... λ > 0 	  
From	  the	  total	  data	  set	  we	  can	  calculate	  the	  frequency	  of	  mutations	  per	  gene,	  α:	  
Mutations per gene: α = total number of mutationstotal number of genes =
6738
5677 =1.19 	  
We	  can	  estimate	  λ	  for	  T	  genes	  (in	  this	  case	  19	  genes):	  	  
Mean mutation frequency in 19 genes: λ = T ⋅α =19 ⋅1.19 =  22.6
	  Now	  we	  can	  use	  the	  Poisson	  distribution	  for	  calculating	  the	  probability	  of	  32	  mutations	  in	  19	  genes:	  
P(X ≥ 32) =1−F(31, 22.6) =  0.035 	  
The	  probability	  of	  finding	  at	  least	  32	  mutations	  in	  19	  genes	  is	  therefore	  below	  5%	  (p<0.05).	  
	  
References:	  
Johnson	  RA	   (2005).	  Miller	   and	   Freund’s	  probability	   and	   Statistics	   for	   Engineers	   7th	  ed.	  Upper	   Saddle	  River,	  NJ:	   Pearson	  
Prentice	  Hall	  
Marvig	  RL,	  Sommer	  LM,	  Molin	  S	  &	  Johansen	  HK	  (2015).	  Convergent	  evolution	  and	  adaptation	  of	  Pseudomonas	  aeruginosa	  
within	  patients	  with	  cystic	  fibrosis.	  Nat.	  Genet.	  47:	  57–65	  
